{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "e107474c",
   "metadata": {},
   "outputs": [],
   "source": [
    "from dask.distributed import Client, SSHCluster\n",
    "import os\n",
    "import dask.bag as db\n",
    "import dask.dataframe as dd\n",
    "import json"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "c1588dcf",
   "metadata": {},
   "source": [
    "# Spin up Cluster and client"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "6f059cad",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2025-06-28 13:13:49,159 - distributed.deploy.ssh - INFO - 2025-06-28 13:13:49,158 - distributed.scheduler - INFO - State start\n",
      "2025-06-28 13:13:49,160 - distributed.deploy.ssh - INFO - 2025-06-28 13:13:49,159 - distributed.diskutils - INFO - Found stale lock file and directory '/tmp/dask-scratch-space/worker-orvdlxac', purging\n",
      "2025-06-28 13:13:49,162 - distributed.deploy.ssh - INFO - 2025-06-28 13:13:49,162 - distributed.scheduler - INFO -   Scheduler at:   tcp://10.67.22.252:8786\n",
      "2025-06-28 13:13:50,527 - distributed.deploy.ssh - INFO - 2025-06-28 13:13:50,526 - distributed.nanny - INFO -         Start Nanny at: 'tcp://10.67.22.252:36323'\n",
      "2025-06-28 13:13:50,881 - distributed.deploy.ssh - INFO - 2025-06-28 13:13:50,880 - distributed.worker - INFO -       Start worker at:   tcp://10.67.22.252:37265\n",
      "2025-06-28 13:13:50,897 - distributed.deploy.ssh - INFO - 2025-06-28 13:13:50,900 - distributed.nanny - INFO -         Start Nanny at: 'tcp://10.67.22.125:38757'\n",
      "2025-06-28 13:13:50,905 - distributed.deploy.ssh - INFO - 2025-06-28 13:13:50,909 - distributed.nanny - INFO -         Start Nanny at: 'tcp://10.67.22.89:45427'\n",
      "2025-06-28 13:13:50,910 - distributed.deploy.ssh - INFO - 2025-06-28 13:13:50,915 - distributed.nanny - INFO -         Start Nanny at: 'tcp://10.67.22.104:37945'\n",
      "2025-06-28 13:13:51,220 - distributed.deploy.ssh - INFO - 2025-06-28 13:13:51,223 - distributed.diskutils - INFO - Found stale lock file and directory '/tmp/dask-scratch-space/worker-jk0n4xrx', purging\n",
      "2025-06-28 13:13:51,233 - distributed.deploy.ssh - INFO - 2025-06-28 13:13:51,237 - distributed.worker - INFO -       Start worker at:   tcp://10.67.22.125:36219\n",
      "2025-06-28 13:13:51,234 - distributed.deploy.ssh - INFO - 2025-06-28 13:13:51,238 - distributed.diskutils - INFO - Found stale lock file and directory '/tmp/dask-scratch-space/worker-anlidfg3', purging\n",
      "2025-06-28 13:13:51,240 - distributed.deploy.ssh - INFO - 2025-06-28 13:13:51,245 - distributed.diskutils - INFO - Found stale lock file and directory '/tmp/dask-scratch-space/worker-gu3soc3w', purging\n",
      "2025-06-28 13:13:51,248 - distributed.deploy.ssh - INFO - 2025-06-28 13:13:51,251 - distributed.worker - INFO -       Start worker at:    tcp://10.67.22.89:45659\n",
      "2025-06-28 13:13:51,254 - distributed.deploy.ssh - INFO - 2025-06-28 13:13:51,259 - distributed.worker - INFO -       Start worker at:   tcp://10.67.22.104:37687\n"
     ]
    }
   ],
   "source": [
    "cluster = SSHCluster(['localhost', 'localhost', '10.67.22.125', '10.67.22.104', '10.67.22.89'],\n",
    "                     connect_options={'known_hosts':None},\n",
    "                        scheduler_options={\"port\": 8786, \"dashboard_address\": \":8797\"})"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "dd98d5cb",
   "metadata": {},
   "outputs": [],
   "source": [
    "client = Client('localhost:8786')"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "5dc0c8b9",
   "metadata": {},
   "source": [
    "# Code"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "eefb5993",
   "metadata": {},
   "outputs": [],
   "source": [
    "def cagatadoss(path):\n",
    "    with open(path) as fil: res = ''.join([line.strip() for line in fil.readlines()])\n",
    "    return res"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "106db4f1",
   "metadata": {},
   "outputs": [],
   "source": [
    "paths = []\n",
    "for subdir in ('pmc_json/', 'pdf_json/'):\n",
    "    with os.scandir('/mnt/data/document_parses/' + subdir) as dir:\n",
    "        for entry in dir:\n",
    "            if entry.name.endswith('.json'): paths.append(entry.path)\n",
    "b = db.from_sequence(paths).map(cagatadoss).map(json.loads)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "d819c240",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/home/ubuntu/miniconda3/envs/mapd/lib/python3.13/site-packages/distributed/client.py:3363: UserWarning: Sending large graph of size 35.28 MiB.\n",
      "This may cause some slowdown.\n",
      "Consider loading the data with Dask directly\n",
      " or using futures or delayed objects to embed the data into the graph without repetition.\n",
      "See also https://docs.dask.org/en/stable/best-practices.html#load-data-with-dask for more information.\n",
      "  warnings.warn(\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "({'paper_id': 'PMC7772178',\n",
       "  'metadata': {'title': 'The Impact of the Covid-19 Pandemic and the Lockdown on the Health and Living Conditions of Undocumented Migrants and Migrants Undergoing Legal Status Regularization',\n",
       "   'authors': [{'first': 'Claudine',\n",
       "     'middle': [],\n",
       "     'last': 'Burton-Jeangros',\n",
       "     'suffix': '',\n",
       "     'email': None,\n",
       "     'affiliation': {}},\n",
       "    {'first': 'Aline',\n",
       "     'middle': [],\n",
       "     'last': 'Duvoisin',\n",
       "     'suffix': '',\n",
       "     'email': None,\n",
       "     'affiliation': {}},\n",
       "    {'first': 'Sarah',\n",
       "     'middle': [],\n",
       "     'last': 'Lachat',\n",
       "     'suffix': '',\n",
       "     'email': None,\n",
       "     'affiliation': {}},\n",
       "    {'first': 'Liala',\n",
       "     'middle': [],\n",
       "     'last': 'Consoli',\n",
       "     'suffix': '',\n",
       "     'email': None,\n",
       "     'affiliation': {}},\n",
       "    {'first': 'Julien',\n",
       "     'middle': [],\n",
       "     'last': 'Fakhoury',\n",
       "     'suffix': '',\n",
       "     'email': None,\n",
       "     'affiliation': {}},\n",
       "    {'first': 'Yves',\n",
       "     'middle': [],\n",
       "     'last': 'Jackson',\n",
       "     'suffix': '',\n",
       "     'email': None,\n",
       "     'affiliation': {}}]},\n",
       "  'body_text': [{'text': 'Since they affect everyone, catastrophes and crises are often thought of as levelers of inequalities in society. However, even though anyone can suffer consequences, the differentiated distribution of resources across social groups make some better able to cope with these consequences than others. The COVID-19 crisis has rapidly confirmed that infectious disease outbreaks reinforce social inequalities (1). After an initial focus on the medical crisis induced by the spread of the new virus, the social and economic impact of the pandemic quickly became apparent among the most vulnerable groups of the population, notably undocumented migrants (2). The pandemic, and its associated public health measures, have thus acted as a magnifying lens on pre-existing structural risks and vulnerability (1, 3).',\n",
       "    'cite_spans': [{'start': 406,\n",
       "      'end': 407,\n",
       "      'mention': '1',\n",
       "      'ref_id': 'BIBREF0'},\n",
       "     {'start': 649, 'end': 650, 'mention': '2', 'ref_id': 'BIBREF11'},\n",
       "     {'start': 799, 'end': 800, 'mention': '1', 'ref_id': 'BIBREF0'},\n",
       "     {'start': 802, 'end': 803, 'mention': '3', 'ref_id': 'BIBREF22'}],\n",
       "    'section': 'Introduction',\n",
       "    'ref_spans': []},\n",
       "   {'text': \"Academic researchers and advocates well aware of undocumented migrants' precarious living conditions rapidly emphasized their unique position amidst the pandemic management. The World Health Organization and scholars have advocated for increased efforts to respond to the specific needs of these groups (2, 4, 5). Indeed undocumented migrants' pre-existing working and housing conditions increase their risk to be infected by the virus, while along recurrently observed social reactions toward infectious diseases (6) they are at additional risk to be blamed for their role in the dissemination of the virus (2). Policy recommendations to protect undocumented migrants were thus formulated in different contexts, as for example by the Migrant and Ethnic Health section of the European Public Health Association and the Platform for International Cooperation on Undocumented Migrants (PICUM), including requests for improved access to health care (2).\",\n",
       "    'cite_spans': [{'start': 304,\n",
       "      'end': 305,\n",
       "      'mention': '2',\n",
       "      'ref_id': 'BIBREF11'},\n",
       "     {'start': 307, 'end': 308, 'mention': '4', 'ref_id': 'BIBREF26'},\n",
       "     {'start': 310, 'end': 311, 'mention': '5', 'ref_id': 'BIBREF27'},\n",
       "     {'start': 515, 'end': 516, 'mention': '6', 'ref_id': 'BIBREF28'},\n",
       "     {'start': 609, 'end': 610, 'mention': '2', 'ref_id': 'BIBREF11'},\n",
       "     {'start': 947, 'end': 948, 'mention': '2', 'ref_id': 'BIBREF11'}],\n",
       "    'section': 'Introduction',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'To this day, several editorials or perspectives pieces in the medical literature (2, 7, 8) have called for attention toward undocumented migrants in the COVID-19 context. However, little empirical evidence is reported, as by definition this population is difficult to reach and knowledge on their circumstances is limited even in regular circumstances. Taking advantage of an on-going prospective study on undocumented migrants in Geneva Switzerland (9), we have been able to collect quantitative and qualitative data among over 100 persons in the midst of the local lockdown measures. The longitudinal project aims at assessing how a regularization policy is impacting the health and socioeconomic conditions of those who obtained a legal status, as compared to a control group of undocumented migrants. The objective of this paper is to describe the impact of the COVID-19 crisis on the health and living circumstances of precarious migrants in Geneva, Switzerland and to assess whether those undergoing legal status regularization fared better than undocumented migrants.',\n",
       "    'cite_spans': [{'start': 82,\n",
       "      'end': 83,\n",
       "      'mention': '2',\n",
       "      'ref_id': 'BIBREF11'},\n",
       "     {'start': 85, 'end': 86, 'mention': '7', 'ref_id': 'BIBREF29'},\n",
       "     {'start': 88, 'end': 89, 'mention': '8', 'ref_id': 'BIBREF30'},\n",
       "     {'start': 451, 'end': 452, 'mention': '9', 'ref_id': 'BIBREF31'}],\n",
       "    'section': 'Introduction',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Vulnerable groups of population including migrants, have experienced an excess in COVID-19 morbidity and mortality (10, 11). While increased morbidity and mortality secondary to the SARS-CoV-2 infection have primarily affected people with pre-existing chronic diseases and older age, delayed non-medical consequences are emerging among vulnerable groups of population. Migrants and refugees face particular challenges in regards to the current COVID-19 crisis such as those related to access to information and to medical attention. Furthermore, as observed previously, undocumented migrants are less likely to seek care or tend to delay health care seeking due to their status (7, 8). This can be explained by the acute contradiction between considering one as sick and the necessity to keep working in the absence of any sick leave mechanism (12).',\n",
       "    'cite_spans': [{'start': 116,\n",
       "      'end': 118,\n",
       "      'mention': '10',\n",
       "      'ref_id': 'BIBREF1'},\n",
       "     {'start': 120, 'end': 122, 'mention': '11', 'ref_id': 'BIBREF2'},\n",
       "     {'start': 679, 'end': 680, 'mention': '7', 'ref_id': 'BIBREF29'},\n",
       "     {'start': 682, 'end': 683, 'mention': '8', 'ref_id': 'BIBREF30'},\n",
       "     {'start': 845, 'end': 847, 'mention': '12', 'ref_id': 'BIBREF3'}],\n",
       "    'section': 'The COVID-19 Vulnerability of Undocumented Migrants',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Undocumented migrants live in their country of destination as workers employed in informal and precarious job sectors (13), incompatible with teleworking promoted by the lockdown measures and in positions typically hindering the capacity to observe social distancing (2). Often active in domestic and care work, looking after the elderly and children at home, they provide a crucial contribution in the destination countries while depending on volatile daily wages (3, 8). Due to the necessity to provide for themselves, their family living with them and possibly their relatives in their country of origin through remittances (7), the absence of work equating with the absence of income has devastating consequences for different circles of people.',\n",
       "    'cite_spans': [{'start': 119,\n",
       "      'end': 121,\n",
       "      'mention': '13',\n",
       "      'ref_id': 'BIBREF4'},\n",
       "     {'start': 268, 'end': 269, 'mention': '2', 'ref_id': 'BIBREF11'},\n",
       "     {'start': 466, 'end': 467, 'mention': '3', 'ref_id': 'BIBREF22'},\n",
       "     {'start': 469, 'end': 470, 'mention': '8', 'ref_id': 'BIBREF30'},\n",
       "     {'start': 628, 'end': 629, 'mention': '7', 'ref_id': 'BIBREF29'}],\n",
       "    'section': 'The COVID-19 Vulnerability of Undocumented Migrants',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Their access to stable accommodation and sufficient supply of quality food has been shown to be jeopardized by increased precariousness in time of economic crisis (14). In the COVID-19 context, their poor housing conditions further affect their elevated risks of infection since common overcrowding limits the capacity to isolate oneself when infected (14, 15). The absence of income brings the additional fear of homelessness (3). The lockdown measures also impacted access to food. For instance, estimates pointed to a four-fold increase in the number of food insecure people in the UK since the beginning of the crisis (16). In Geneva, migrants have been severely affected forcing the authorities and community organization to set up large-scale emergency food distributions (17).',\n",
       "    'cite_spans': [{'start': 164,\n",
       "      'end': 166,\n",
       "      'mention': '14',\n",
       "      'ref_id': 'BIBREF5'},\n",
       "     {'start': 353, 'end': 355, 'mention': '14', 'ref_id': 'BIBREF5'},\n",
       "     {'start': 357, 'end': 359, 'mention': '15', 'ref_id': 'BIBREF6'},\n",
       "     {'start': 428, 'end': 429, 'mention': '3', 'ref_id': 'BIBREF22'},\n",
       "     {'start': 623, 'end': 625, 'mention': '16', 'ref_id': 'BIBREF7'},\n",
       "     {'start': 779, 'end': 781, 'mention': '17', 'ref_id': 'BIBREF8'}],\n",
       "    'section': 'The COVID-19 Vulnerability of Undocumented Migrants',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Overcoming multiple challenges, undocumented migrants have managed to stay in destination countries thanks to their capacity to conduct their life without any encounter with governmental institutions. Over time, they have learned to cope with recurrent difficulties through their own means and thus prefer avoiding any formal help for fear it would jeopardize their chance to obtain a legal status (8). Indeed they tend to avoid seeking assistance outside their immediate social circle by fear of denunciation and expulsion (18). In the COVID-19 context, official messages encouraging them to seek help have thus been received with suspicion, due to a pre-existing limited trust in the government. Furthermore, along their traditional exclusion from social safety mechanisms, they were not included in exceptional measures adopted to respond to the COVID-19 pandemic in the US (8). In Switzerland also, domestic work was excluded from the federal measures offered to the working population.',\n",
       "    'cite_spans': [{'start': 399,\n",
       "      'end': 400,\n",
       "      'mention': '8',\n",
       "      'ref_id': 'BIBREF30'},\n",
       "     {'start': 525, 'end': 527, 'mention': '18', 'ref_id': 'BIBREF9'},\n",
       "     {'start': 878, 'end': 879, 'mention': '8', 'ref_id': 'BIBREF30'}],\n",
       "    'section': 'The COVID-19 Vulnerability of Undocumented Migrants',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'While undocumented migrants encompass individuals with distinct levels of resources and capacities, existing research shows that they tend to cumulate difficulties in their daily living and working conditions and to have limited access to different types of securities and resources that come along a residence status (19). Regularization of the residence status could theoretically entail better protection against social and health consequences of recessive economic cycles by fostering more resilience and resources. Set in the context of the COVID-19 crisis, this study aims at assessing whether undocumented migrants and migrants who have obtained a residency permit have been affected and have coped differently with the many challenges of the crisis. Better knowledge of such differences may allow for designing targeted health and social policies.',\n",
       "    'cite_spans': [{'start': 319,\n",
       "      'end': 321,\n",
       "      'mention': '19',\n",
       "      'ref_id': 'BIBREF10'}],\n",
       "    'section': 'The COVID-19 Vulnerability of Undocumented Migrants',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Undocumented migrants account for 10,000–15,000 of the 500,000 residents of the Canton of Geneva, Switzerland (20). In 2017, the local Council has implemented a conditional regularization policy (Operation Papyrus) that aimed to provide residency permit to undocumented migrants meeting the following criteria: (a) residence in Geneva for 10 years or 5 years for parents of children admitted at school; (b) financial independence; (c) social integration; and (d) lack of criminal record (21).',\n",
       "    'cite_spans': [{'start': 111,\n",
       "      'end': 113,\n",
       "      'mention': '20',\n",
       "      'ref_id': 'BIBREF12'},\n",
       "     {'start': 488, 'end': 490, 'mention': '21', 'ref_id': 'BIBREF13'}],\n",
       "    'section': 'Setting ::: Methods',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Switzerland was among the countries most rapidly and severely affected relative to its size by the COVID-19 epidemic in Europe during the March-April 2020 period (22). The first case was confirmed on February 26. Geneva along with Vaud and Ticino were the cantons most severely hit. The peak of incidence of new positive tests in Geneva was reached on March 30, 2020 with 280 cases. On April 20, 2020 when we launched our questionnaire, the incidence and mortality rates per 100,000 residents were 979.8 and 43.6 cases, respectively. In response, the Federal Government implemented swift measures from February 28, 2020 leading to a generalized lockdown by March 15, 2020. Control measures were progressively relaxed from April 27, 2020 with the reopening of few businesses, and on May 11, 2020 when primary schools re-opened and non-essential activities progressively re-started.',\n",
       "    'cite_spans': [{'start': 163,\n",
       "      'end': 165,\n",
       "      'mention': '22',\n",
       "      'ref_id': 'BIBREF14'}],\n",
       "    'section': 'Setting ::: Methods',\n",
       "    'ref_spans': []},\n",
       "   {'text': \"This mixed-methods study is nested within the prospective Parchemins Study which started in 2018 and aims at monitoring the impact of the Papyrus regularization policy on undocumented migrants' health and well-being (9). In short, the Parchemins Study collects qualitative and quantitative data annually among a cohort of migrants, whose initial sample included 464 participants recruited in the community and sharing similar background socioeconomic features but distinguished by legal status. The regularized group (n = 213) has successfully obtained a residency permit or is in the process of obtaining it while the undocumented group (n = 251) either lacks one or more regularization criteria or is unwilling to engage in such process. Details on inclusion criteria and recruitment into the Study can be found elsewhere (9).\",\n",
       "    'cite_spans': [{'start': 217,\n",
       "      'end': 218,\n",
       "      'mention': '9',\n",
       "      'ref_id': 'BIBREF31'},\n",
       "     {'start': 825, 'end': 826, 'mention': '9', 'ref_id': 'BIBREF31'}],\n",
       "    'section': 'Design ::: Methods',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'We invited all the Parchemins Study participants who had responded to the first two data collection waves (n = 379) to fill up an online questionnaire available in French, English, Spanish and Portuguese on April 20 (8 weeks after the first confirmed COVID-19 case in Switzerland). We closed the survey on May 10, 2020, the day before the second round of lockdown relaxation happened (Table 1). Invitation was sent by email and by short message texting. In absence of response, a second invitation was sent. The questionnaire was easily accessible on any electronic device connected to internet and was designed to take no more than 15 minutes to be filled. It was pre-tested with 5 persons before its implementation.',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Participants ::: Methods',\n",
       "    'ref_spans': [{'start': 385,\n",
       "      'end': 392,\n",
       "      'mention': 'Table 1',\n",
       "      'ref_id': 'TABREF0'}]},\n",
       "   {'text': \"We explored sociodemographic, health, living conditions, economic, and employment-related variables. Self-rated health was measured by using the first of the 12-Item Short-Form Survey (SF-12) and we regrouped the answers “excellent” and “very good” as indicating the absence of reserve regarding one's health evaluation (23). We assessed the direct health impact of COVID-19 by aggregating those with a positive diagnostic test (confirmed cases), those with evocative symptoms and close contacts with a confirmed case and those asymptomatic who had been asked by health authorities to self-isolate after a contact with a confirmed case. Satisfaction with life was included as an indicator of well-being. Participants had to grade their current level of satisfaction on a 10-point Likert scale. We also assessed participants' main immediate concerns in the pandemic context. They could provide several answers which were regrouped into five main categories (health, employment and income, situation in their country of origin, living conditions in Geneva and social isolation).\",\n",
       "    'cite_spans': [{'start': 321,\n",
       "      'end': 323,\n",
       "      'mention': '23',\n",
       "      'ref_id': 'BIBREF15'}],\n",
       "    'section': 'Questionnaire Variables ::: Methods',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'We assessed different types of difficulties related to basic needs. We screened for financial insecurity by asking about the ability to pay a CHF 1,500 (Euro 1,450, $ 1,500) bill at short notice. This question is used in population surveys in Switzerland with a higher threshold (CHF 2,500), but adjusted in our survey as the median income of undocumented migrants is well below the one of the general Swiss population (24). We are aware this level fares much higher than in most contexts, as for example in the United States, 40% of adults could not pay for a $400 emergency expense (25). Food insecurity was assessed by asking participants the following questions: “since the beginning of the COVID-19 crisis, have you had to purchase cheaper or lesser quality food?” and “since the beginning of the COVID-19 crisis have you had to eat less or to skip meals because you were running out of food?.” Food insecurity was considered present in case of a positive response to one of the two items. We then graded the severity of food insecurity by distinguishing those suffering from hunger from those who had not suffered from hunger. These items were adapted from the Short Form of the Household Food Security Scale (26). Housing insecurity was defined by the fear of losing the current accommodation at short notice and financial insecurity by the reduction or the absence of income.',\n",
       "    'cite_spans': [{'start': 420,\n",
       "      'end': 422,\n",
       "      'mention': '24',\n",
       "      'ref_id': 'BIBREF16'},\n",
       "     {'start': 585, 'end': 587, 'mention': '25', 'ref_id': 'BIBREF17'},\n",
       "     {'start': 1216, 'end': 1218, 'mention': '26', 'ref_id': 'BIBREF18'}],\n",
       "    'section': 'Questionnaire Variables ::: Methods',\n",
       "    'ref_spans': []},\n",
       "   {'text': \"Non-normally distributed continuous variables are presented as median and interquartile range (IQR), whereas categorical variables are listed as absolute number proportions and percentages. Continuous variables were compared with the Mann-Whitney test. Categorical variables were compared with the chi-square test or the Fisher's exact test, as appropriate. Considering that this study was purely descriptive and did not intend to determine causal relationships between the factors under observation, we presented the results of all analysis including those including missing data. The significance level was set at 0.05. All analysis were conducted using IBM SPSS Statistics version 26.\",\n",
       "    'cite_spans': [],\n",
       "    'section': 'Statistical Analysis ::: Methods',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'With the intention to obtain more in-depth information on the coping mechanisms put in place, participants were asked if they would be available for a short telephone interview. Among those who accepted, we selected a purposive subsample, looking for diversity in terms of gender, origin and status (undocumented vs. regularized), while focused on those who had reported financial or food insecurity in the questionnaire. The interview guide was designed on the basis of the preliminary results of the quantitative data. A specific emphasis was put on how they allocated their available resources and their likelihood of seeking (or not) external support from their friends and relatives, community, employers and the non-governmental associations or official institutions. Interviews were conducted May 4–8, 2020 once most of the quantitative data collection was done. They lasted between 20 and 75 minutes; they were conducted in French, English, Spanish and Portuguese.',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Qualitative Interviews ::: Methods',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'These interviews were recorded and fully transcribed. A deductive form of analysis was driven by key themes assessed in the quantitative survey and transcripts were coded accordingly in terms of encountered difficulties (main concerns, financial, and food insecurity), available resources and assistance-seeking. Inductive analysis was also conducted to explore coping mechanisms, social services uptake, and barriers to services uptake and transcripts were thus coded according to emerging themes. In the result section, interview citations will be used to extend and illustrate quantitative findings.',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Qualitative Interviews ::: Methods',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'All participants provided inform consent and this study was approved by the Ethics Committee of Geneva Canton, Switzerland (CCER 2017–00897).',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Ethics Approval and Consent to Participate ::: Methods',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'A total of 117 (30.9%) of the 379 Parchemins study participants responded to the questionnaire. Two persons had responded after the closure of the survey and were excluded as the lockdown had already been partially lifted, which may have impacted the answers. Five participants could not be appropriately identified as regard their legal status and 2 had not fully completed the questionnaire. We thus included 108 (92.3% of the 117 respondents and 23.3% of the whole study population) participants in the analyses. Compared to participants who had responded in the second study wave (2019) but not to the COVID-19 survey, the 2020 sample was similar in terms of gender distribution, age, origin, and legal status. Respondents and non-respondents to the COVID-19 survey were also comparable in terms of health profile at the time of the second data collection (Appendix 1).',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Participants ::: Results',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'More than two-thirds of the participants were regularized or in the process of regularization and a majority of them were middle-aged women from Latin-America (Table 2). Undocumented migrants were younger than their regularized counterparts. Only a minority of all participants had children at charge in Geneva.',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Participants ::: Results',\n",
       "    'ref_spans': [{'start': 160,\n",
       "      'end': 167,\n",
       "      'mention': 'Table 2',\n",
       "      'ref_id': 'TABREF1'}]},\n",
       "   {'text': 'Seventeen of these participants were further interviewed by telephone, this subsample included 11 women and 6 men (median age 45.1). Among them, 9 had applied for regularization and 8 were undocumented.',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Participants ::: Results',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Around one in eight participants had suffered direct health consequences of the COVID-19 infection: four had been tested COVID-19 positive and nine thought they had contracted it but had not been tested. Two had to be hospitalized and 13 self-isolated at home during at least 10 days. A large majority declared feeling anxious or depressed in relation to the current global situation and around one in eight thought their health had worsened since the beginning of the COVID-19 crisis. Half of the respondents rated their health as very good or excellent. A majority of undocumented participants had avoided health care since the beginning of the COVID-19 crisis, which was significantly more than in the regularized group (Table 2).',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Health and Access to Care ::: Results',\n",
       "    'ref_spans': [{'start': 724,\n",
       "      'end': 731,\n",
       "      'mention': 'Table 2',\n",
       "      'ref_id': 'TABREF1'}]},\n",
       "   {'text': \"In total, 86.9% participants were employed before the crisis' onset and three in four employees had witnessed a partial or total loss of working hours in the last 2 months. Only 22.3% declared having enough financial resources to cover their basic needs for the next 3 or more months if the lockdown was to continue and a similar proportion was able to pay an unexpected CHF 1,500 bill at short notice. Yet, more than half kept sending remittances to relatives in their country of origin. There was no statistically significant differences between the two groups. Overall, undocumented migrants tended to rate their satisfaction with life lower than those regularized.\",\n",
       "    'cite_spans': [],\n",
       "    'section': 'Living Conditions and Satisfaction With Life ::: Results',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'A large majority of participants rated the loss of employment and income as their main immediate concern during the lockdown (Figure 1). The political and health situation in the country of origin and the risk of COVID-19 infection in Geneva were also important preoccupations but at a lower level. Living conditions and social isolation were less frequently mentioned. These preoccupations were reported in similar proportions by the 2 groups. The immediate economic impact of the lockdown has been detailed in the telephone interviews, as illustrated by this participant:',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Main Preoccupations During the COVID-19 Crisis ::: Results',\n",
       "    'ref_spans': [{'start': 126,\n",
       "      'end': 134,\n",
       "      'mention': 'Figure 1',\n",
       "      'ref_id': 'FIGREF0'}]},\n",
       "   {'text': \"Financial, housing, and food difficulties were all highly prevalent (Table 3). More than two thirds of participants presented financial or housing insecurity and 61% declared being food insecure. Among those suffering food insecurity, one quarter had been hungry but decided not to eat by lack of financial resources since the beginning of the lockdown. Undocumented migrants were significantly more exposed to housing and food insecurity than regularized migrants. The tension between paying one's rent and still having money to buy food has been raised in several interviews:\",\n",
       "    'cite_spans': [],\n",
       "    'section': 'Presence and Accumulation of Difficulties ::: Results',\n",
       "    'ref_spans': [{'start': 69,\n",
       "      'end': 76,\n",
       "      'mention': 'Table 3',\n",
       "      'ref_id': 'TABREF2'}]},\n",
       "   {'text': 'Overall, participants reported a median of 2 (IQR = 2) difficulties with significant difference between undocumented (3; IQR = 2) and regularized (2; IQR = 2) migrants (p-value 0.032) (Figure 2).',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Presence and Accumulation of Difficulties ::: Results',\n",
       "    'ref_spans': [{'start': 185,\n",
       "      'end': 193,\n",
       "      'mention': 'Figure 2',\n",
       "      'ref_id': 'FIGREF1'}]},\n",
       "   {'text': \"A total of 51.9% of participants had engaged in seeking external support to fulfill their financial, material and food needs (Table 4). Undocumented migrants reported doing it more frequently, while not significantly. The main strategy was to request a financial loan from the immediate social circle of friends or relatives, while asking for support from one's employers or a public or non-governmental organization was less frequent. Regularized migrants tended to specifically avoid the latter source of support. Solidarity among undocumented migrants was expressed in this interview: “My friend helps me a lot. He often offers me to join him for diner and as soon as he receives his salary, he gives me 50 or 100 francs [CHF].” (Senegalese man, 42 years old, undocumented). While many employers quit paying wages during the lockdown, some continued to do so and allowed to cope with the situation: “Most of my employers continue to pay me even though I am not working for them. Only two have stopped. This helps me a lot.” (Bolivian woman, 45 years old, undocumented).\",\n",
       "    'cite_spans': [],\n",
       "    'section': 'Assistance-Seeking Behavior ::: Results',\n",
       "    'ref_spans': [{'start': 126,\n",
       "      'end': 133,\n",
       "      'mention': 'Table 4',\n",
       "      'ref_id': 'TABREF3'}]},\n",
       "   {'text': 'Half of those who had not sought help said it was not necessary, one third were worried about the adverse consequences this could have on their legal status and one quarter reported they preferred to manage by themselves (Table 4). This was expressed by this participant: “I want to find more working hours, at least one job, so that I do not ask help from anyone. I prefer to work” (Bolivian woman, 66 years old, waiting for residency permit). Reasons for not seeking assistance significantly differed between the two groups: while undocumented migrants reported preferring to manage by themselves, regularized migrants mainly mentioned that it was not necessary. Both groups feared the potential administrative consequences of applying for public support on their ability to receive or renew their residency permit in the near future in similar proportions. This fear was reported on several occasions during the interviews:',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Assistance-Seeking Behavior ::: Results',\n",
       "    'ref_spans': [{'start': 222,\n",
       "      'end': 229,\n",
       "      'mention': 'Table 4',\n",
       "      'ref_id': 'TABREF3'}]},\n",
       "   {'text': 'Quantitative data mostly collected 4–5 weeks after the initiation of the lockdown measures highlight the capacity and willingness of this population to handle the economic and material impact of the COVID-19 crisis on their own, or through informal sources of help. Compared to the survey, the qualitative interviews, conducted over 6 weeks after the beginning of the lockdown showed how financial hardship increased with time and how migrants were facing further difficulties as an additional rent had to be paid.',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Assistance-Seeking Behavior ::: Results',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Interviews also showed how coping strategies changed over time. Solidarity among vulnerable migrants declined as a result of the lasting situation: “None of my friends can lend me money as they are all facing difficulties. They do not have any money left either” (Indian man, 35 years old, undocumented). This led some to consider looking for help from governmental or non-governmental sources:',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Assistance-Seeking Behavior ::: Results',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'While participants acknowledged during the interviews that they considered looking for help, they also reported a range of barriers hampering uptake. Access problems were discussed: information was not easily available and well-known social services were closed due to the lockdown: “I did not know where to go and nobody could tell me, above all with regard to food assistance” (Bolivian woman, 66 years old, waiting for residency permit). Language barriers and procedures also hindered possibilities to be helped:',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Assistance-Seeking Behavior ::: Results',\n",
       "    'ref_spans': []},\n",
       "   {'text': \"In addition, the complexity of assistance mechanisms was highlighted. While she was aware of her employer's obligation to pay her wages despite the lockdown, this participant prioritized finding a job over claiming her rights:\",\n",
       "    'cite_spans': [],\n",
       "    'section': 'Assistance-Seeking Behavior ::: Results',\n",
       "    'ref_spans': []},\n",
       "   {'text': \"Ineligibility or illegitimacy were an additional source of renouncement to assistance: We don't feel legitimate to ask for assistance because we are illegal here. I try to stay invisible and I don't know whether there is any assistance for people like me (Algerian man, 39 years old, undocumented). Finally, feelings of shame or indignity were also reported as reasons to not ask for any help:\",\n",
       "    'cite_spans': [],\n",
       "    'section': 'Assistance-Seeking Behavior ::: Results',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Interviews thus emphasized the tension between the important consequences of the lockdown and the multi-fold barriers to support, including ideas about not deserving to receive any formal assistance.',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Assistance-Seeking Behavior ::: Results',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'This study provides empirical evidence on the early and severe health and socioeconomic impact of the COVID-19 pandemic and the associated lockdown in spring 2020 on undocumented or recently regularized migrants in a high-income country. Over the mixed data collection period, the accumulation and rapidly progressing difficulties in their living conditions could be observed. The duration of the public health measures put them at risk of not being able to meet their basic needs, as access to work and its associated income was limited.',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Discussion',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'This is the first study in Europe to directly document the social and health impact of the COVID-19 crisis among this hard-to-reach group. The more frequent exposure to COVID-19 than in the general population, associated with housing difficulties, confirms the specific risks this group faces in the ability to adopt preventive and protective measure (2, 8). Indeed, the capacity to respect social distancing is socially distributed along teleworking opportunities (27). Most participants in our study work in jobs (domestic or construction work) requiring their presence, which added to their dense housing conditions, puts them at higher risk of infection than the general population, across a number of settings. Their frequently limited access to medical care may further fuel this dynamic of transmission (8, 27). In the COVID-19 context, access to the public hospital has been tightly channeled by security staff, with the likely consequence to repel undocumented migrants.',\n",
       "    'cite_spans': [{'start': 352,\n",
       "      'end': 353,\n",
       "      'mention': '2',\n",
       "      'ref_id': 'BIBREF11'},\n",
       "     {'start': 355, 'end': 356, 'mention': '8', 'ref_id': 'BIBREF30'},\n",
       "     {'start': 466, 'end': 468, 'mention': '27', 'ref_id': 'BIBREF19'},\n",
       "     {'start': 811, 'end': 812, 'mention': '8', 'ref_id': 'BIBREF30'},\n",
       "     {'start': 814, 'end': 816, 'mention': '27', 'ref_id': 'BIBREF19'}],\n",
       "    'section': 'Discussion',\n",
       "    'ref_spans': []},\n",
       "   {'text': \"In presence of different sources of preoccupations, including acquiring COVID-19, migrants frequently presented poor psychological health. It can be hypothesized that besides concerns about their own health, the fear of not being able to generate a sufficient income to satisfy their own and their family' basic needs in Geneva and to continue supporting their family back home in a period of deep global economy downturn may be sources of acute and severe stress. Yet, even though a majority of participants had experienced a sharp reduction in their income, more than half were still sending remittances back home which may be seen either as a source of supplementary stress or as a way to show resilience by maintaining one's role of breadwinner. Of interest, while nearly half of the participants declared some reserve regarding their actual health, only a minority mentioned it had worsened since the beginning of the pandemic. This may reflect the focus on the somatic dimension of health when precarious migrants are asked to self-rate their health. Our findings highlight the need for universal health coverage for undocumented migrants with an emphasis on mental health services taking into account the specific circumstance they are facing in order to reduce the further health consequences and strengthen their capacity of resilience (28–30). This is particularly important considering results showing that in the COVID-19 context poor mental health is related with the avoidance of health care (31).\",\n",
       "    'cite_spans': [{'start': 1346,\n",
       "      'end': 1348,\n",
       "      'mention': '28',\n",
       "      'ref_id': 'BIBREF20'},\n",
       "     {'start': 1349, 'end': 1351, 'mention': '30', 'ref_id': 'BIBREF23'},\n",
       "     {'start': 1507, 'end': 1509, 'mention': '31', 'ref_id': 'BIBREF24'}],\n",
       "    'section': 'Discussion',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'We found migrants faced cumulative and evolving difficulties to meet their basic needs in the context of financial hardship. Food insecurity often overlapped with other types of difficulties. It can be postulated that food insecurity may represent the tip of the insecurity iceberg in this group as, unlike the rent or the medical insurance, it is not a fixed and regular expense. Our data suggests migrants may adopt trade-off strategies to preserve what they consider as essential securities such as housing by cutting on other less urgent expenses such as medical care and food. Indeed, a very tight local housing market like in Geneva makes homelessness a concrete preoccupation. Of concern, a proportion of participants had already severely cut on food expenses and declared themselves as hungry which may both affect their health and well-being and their ability to rapidly bounce back once the lockdown is lifted.',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Discussion',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'While the two groups of participants had similar exposure to financial insecurity, undocumented migrants reported significantly more often housing and food insecurity. This is not explained by differences in assistance seeking behaviors as regularized migrants tended to renounce to sources of support more frequently. Rather, it may suggest the latter had more reserves to face a sudden drop in income and could better tackle the situation of crisis thanks to the resources accumulated previously. Yet, only 22.3% declared having enough resource to meet their basic needs for 3 or more months, which indicated that even though regularization may entail better protection against short-term difficulties, mid-term perspectives remained bleak. The fact that financial autonomy is a demand for any permit application or renewal constitutes a major barrier to assistance uptake for migrant workers in time of crisis.',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Discussion',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Overall, this population had clearly internalized that looking for formal assistance could jeopardize their chances to become regularized. This reluctance to seek support reflects their long-standing capacity to manage on their own. Indeed over time, undocumented migrants develop skills for camouflage in order to live, work, send their children to school in the hope to eventually get access to a legal status (32). In this study, the qualitative interviews notably offered additional insights on the rationale behind the norm of autonomy emphasized by the quantitative results: these workers have managed to stay in the destination country thanks to their ability to not interact with formal structures. Interviews suggested that the length of the lockdown measures was however putting more and more pressure on limited available resources, thus making assistance-seeking inevitable despite its perceived risks and downsides.',\n",
       "    'cite_spans': [{'start': 413,\n",
       "      'end': 415,\n",
       "      'mention': '32',\n",
       "      'ref_id': 'BIBREF25'}],\n",
       "    'section': 'Discussion',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'This study has some limitations to account for. First, it only reflects the situation at a specific time point during the COVID-19 lockdown within a period marked by rapid epidemiological, economic and political evolutions. The time lapse between the survey and the qualitative interviews provides an insightful illustration of potential variations both in terms of evolving difficulties and coping mechanisms over a relatively short period. Second, data was collected with a limited sub-sample recruited from our larger cohort study; however considering the general difficulty to reach this population, we consider they offer valuable information in a context making empirical research particularly challenging. In addition, the different environments in neighboring countries prevent from generalizing our findings to all undocumented or recently regularized migrants in Europe. Yet, we believe our findings honestly describe the situation in Switzerland in the midst of the COVID-19 lockdown given the bond of trust built with the study participants along the first two waves of data collection.',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Discussion',\n",
       "    'ref_spans': []},\n",
       "   {'text': \"As in our larger longitudinal project, we consider quantitative and qualitative data usefully complement each other to understand the trajectories and preoccupations of undocumented migrants. In the present study, interviews helped to better grasp their stressful conditions, especially since these were rapidly changing as the lockdown consequences accumulated over weeks. The strength of mixed methods lies in its combined capacity to offer quantitative findings providing support to public policies elaboration and qualitative material giving insights on how people's consider their own circumstances, allowing to develop interventions aligned with their actual needs.\",\n",
       "    'cite_spans': [],\n",
       "    'section': 'Discussion',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'The cumulated difficulties faced by migrants in this period of crisis and their limited search for assistance highlight the need to implement trust-building strategies to bridge the access gap to governmental and non-governmental sources of support. Indeed, migrants in irregular situation have lived for years with the necessity to hide from authorities and have internalized that calling for support may be detrimental to the provision or the renewal of a residency permit. In Switzerland, even though the Federal Government publicly declared that seeking assistance would not penalize migrants in their future demand for regularization, very few of them felt confident to seek support, confirming the statement that it is naive to think this population will trust authorities in such unprecedented time (2).',\n",
       "    'cite_spans': [{'start': 807,\n",
       "      'end': 808,\n",
       "      'mention': '2',\n",
       "      'ref_id': 'BIBREF11'}],\n",
       "    'section': 'Conclusion',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'These findings emphasize the importance of policy measures addressing both human rights and public health considerations. Policies that may prevent or mitigate the burden of poor health and life difficulties among migrants during COVID-19 like pandemics in Western countries may include: (a) enforcing the legal framework about the working conditions in order to protect employees of informal sectors from unfair dismissal and sudden loss of income without compensation; (b) ensuring that migrants with different legal situations access effective and rapidly accessible sources of financial, material, and food support during the economic crisis without risk for their current or future application for a residency permit; (c) facilitating access to temporary residency permit and to social security as long as the economic crisis puts undocumented migrants at consequent risks of not being able to meet their basic needs; and (d) continuing to monitor the situation as the context evolves rapidly and subsequent waves of widespread dissemination of the infection within the population may again cause severe economic consequences. By contributing to the overall public health response of mitigating the spread of the COVID-19 virus, these measures can also avoid vulnerable groups, like undocumented or recently regularized migrants, to be blamed and discriminated.',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Conclusion',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'The long lines of people waiting for food distribution made these groups highly visible, locally and internationally, against their will. This publicity offers a chance to emphasize the structural conditions that allow undocumented migrants to stay, i.e., needs in the economic market for cheap and unprotected labor while their presence is officially denied. The COVID-19 pandemic and the associated measures to slow the progression of the virus have somehow acted like a real life test of the importance to be regularized, as opposed to have no residency permit. Our findings indicate that regularization matter: the local regularization policy put in place in Geneva helped those who had obtained a legal status to better cope with the consequences of the COVID-19 crisis. However, even if they were less affected, their position remains fragile.',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Conclusion',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Data Availability Statement',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'The study was reviewed and approved by Geneva Canton board of ethics. The participants provided their written informed consent to participate in this study.',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Ethics Statement',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'CB-J: conceptualization, methodology, and original draft. AD: investigation, data curation, and analysis. SL: investigation, analysis, and original draft. LC and JF: methodology, review, and editing. YJ: conceptualization, supervision, and original draft. All authors contributed to the article and approved the submitted version.',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Author Contributions',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Conflict of Interest',\n",
       "    'ref_spans': []}],\n",
       "  'ref_entries': {'TABREF0': {'text': 'Table 1: Timeframe of the data collection in relation to the COVID-19 lockdown in Switzerland (March to June 2020).\\n',\n",
       "    'type': 'table'},\n",
       "   'TABREF1': {'text': 'Table 2: Demographics, health and living conditions of participants (n = 108).\\n',\n",
       "    'type': 'table'},\n",
       "   'TABREF2': {'text': 'Table 3: Prevalence of difficulties among migrants (n = 108).\\n',\n",
       "    'type': 'table'},\n",
       "   'TABREF3': {'text': 'Table 4: Types of assistance and reasons for not seeking assistance (n = 108).\\n',\n",
       "    'type': 'table'},\n",
       "   'FIGREF0': {'text': 'Figure 1: Main current preoccupations (several answers possible) (n = 108, missing values = 4).',\n",
       "    'type': 'figure'},\n",
       "   'FIGREF1': {'text': 'Figure 2: Number of difficulties among migrants (n = 108, missing values = 8).',\n",
       "    'type': 'figure'}},\n",
       "  'back_matter': [],\n",
       "  'bib_entries': {'BIBREF0': {'title': 'COVID-19 and the US response: accelerating health inequities',\n",
       "    'authors': [{'first': 'NE', 'middle': [], 'last': 'Okonkwo', 'suffix': ''},\n",
       "     {'first': 'UT', 'middle': [], 'last': 'Aguwa', 'suffix': ''},\n",
       "     {'first': 'M', 'middle': [], 'last': 'Jang', 'suffix': ''},\n",
       "     {'first': 'IA', 'middle': [], 'last': 'Barre', 'suffix': ''},\n",
       "     {'first': 'KR', 'middle': [], 'last': 'Page', 'suffix': ''},\n",
       "     {'first': 'PS', 'middle': [], 'last': 'Sullivan', 'suffix': ''}],\n",
       "    'year': None,\n",
       "    'venue': 'BMJ Evid. Based Med',\n",
       "    'volume': '',\n",
       "    'issn': '',\n",
       "    'pages': None,\n",
       "    'other_ids': {'DOI': ['10.1136/bmjebm-2020-111426']}},\n",
       "   'BIBREF1': {'title': '',\n",
       "    'authors': [],\n",
       "    'year': 2020,\n",
       "    'venue': 'Beyond the Data: Understanding the Impact of COVID-19 on BAME Groups',\n",
       "    'volume': '',\n",
       "    'issn': '',\n",
       "    'pages': None,\n",
       "    'other_ids': {'DOI': []}},\n",
       "   'BIBREF2': {'title': 'Policy recommendations to address high risk of COVID-19 among immigrants',\n",
       "    'authors': [{'first': 'BA',\n",
       "      'middle': [],\n",
       "      'last': 'Langellier',\n",
       "      'suffix': ''}],\n",
       "    'year': 2020,\n",
       "    'venue': 'Am. J. Public Health',\n",
       "    'volume': '110',\n",
       "    'issn': '',\n",
       "    'pages': '1137-9',\n",
       "    'other_ids': {'DOI': ['10.2105/AJPH.2020.305792']}},\n",
       "   'BIBREF3': {'title': 'Fragile fabric: illegality knowledge, social capital and health-seeking of undocumented Latin American migrants in Berlin',\n",
       "    'authors': [{'first': 'S', 'middle': [], 'last': 'Huschke', 'suffix': ''}],\n",
       "    'year': 2014,\n",
       "    'venue': 'J. Ethn. Migr. Stud.',\n",
       "    'volume': '40',\n",
       "    'issn': '',\n",
       "    'pages': '2010-29',\n",
       "    'other_ids': {'DOI': ['10.1080/1369183X.2014.907740']}},\n",
       "   'BIBREF4': {'title': '',\n",
       "    'authors': [],\n",
       "    'year': 2019,\n",
       "    'venue': 'ILO Global Estimates on International Migrant Workers – Results and Methodology',\n",
       "    'volume': '',\n",
       "    'issn': '',\n",
       "    'pages': None,\n",
       "    'other_ids': {'DOI': []}},\n",
       "   'BIBREF5': {'title': '',\n",
       "    'authors': [{'first': 'P', 'middle': [], 'last': 'Chauvin', 'suffix': ''},\n",
       "     {'first': 'I', 'middle': [], 'last': 'Parizot', 'suffix': ''},\n",
       "     {'first': 'N', 'middle': [], 'last': 'Simonnot', 'suffix': ''}],\n",
       "    'year': 2009,\n",
       "    'venue': 'Access to Healthcare for Undocumented Migrants in 11 European Countries',\n",
       "    'volume': '',\n",
       "    'issn': '',\n",
       "    'pages': None,\n",
       "    'other_ids': {'DOI': []}},\n",
       "   'BIBREF6': {'title': 'How are the undocumented migrants in Rome? Assessment of quality of life and its determinants among migrant population',\n",
       "    'authors': [{'first': 'V', 'middle': [], 'last': \"D'Egidio\", 'suffix': ''},\n",
       "     {'first': 'D', 'middle': [], 'last': 'Mipatrini', 'suffix': ''},\n",
       "     {'first': 'AP', 'middle': [], 'last': 'Massetti', 'suffix': ''},\n",
       "     {'first': 'V', 'middle': [], 'last': 'Vullo', 'suffix': ''},\n",
       "     {'first': 'G', 'middle': [], 'last': 'La Torre', 'suffix': ''}],\n",
       "    'year': 2017,\n",
       "    'venue': 'J. Public Health',\n",
       "    'volume': '39',\n",
       "    'issn': '',\n",
       "    'pages': '440-6',\n",
       "    'other_ids': {'DOI': ['10.1093/pubmed/fdw056']}},\n",
       "   'BIBREF7': {'title': '',\n",
       "    'authors': [{'first': 'R',\n",
       "      'middle': [],\n",
       "      'last': 'Loopstra',\n",
       "      'suffix': ''}],\n",
       "    'year': 2020,\n",
       "    'venue': 'Vulnerability to Food Insecurity Since the COVID-19 Lockdown',\n",
       "    'volume': '',\n",
       "    'issn': '',\n",
       "    'pages': None,\n",
       "    'other_ids': {'DOI': []}},\n",
       "   'BIBREF8': {'title': '',\n",
       "    'authors': [{'first': 'P',\n",
       "      'middle': [],\n",
       "      'last': 'Kingsley',\n",
       "      'suffix': ''}],\n",
       "    'year': 2020,\n",
       "    'venue': \"A Mile-Long Line for Free Food in Geneva, One of World's Richest Cities\",\n",
       "    'volume': '',\n",
       "    'issn': '',\n",
       "    'pages': None,\n",
       "    'other_ids': {'DOI': []}},\n",
       "   'BIBREF9': {'title': 'Intangible obstacles: health implications of stigmatization, structural violence, and fear among undocumented immigrants in France',\n",
       "    'authors': [{'first': 'S',\n",
       "      'middle': [],\n",
       "      'last': 'Larchanche',\n",
       "      'suffix': ''}],\n",
       "    'year': 2012,\n",
       "    'venue': 'Soc. Sci. Med',\n",
       "    'volume': '74',\n",
       "    'issn': '',\n",
       "    'pages': '858-63',\n",
       "    'other_ids': {'DOI': ['10.1016/j.socscimed.2011.08.016']}},\n",
       "   'BIBREF10': {'title': 'Right of access to health care for undocumented migrants in EU: a comparative study of national policies',\n",
       "    'authors': [{'first': 'CB', 'middle': [], 'last': 'Cuadra', 'suffix': ''}],\n",
       "    'year': 2012,\n",
       "    'venue': 'Eur. J. Public Health',\n",
       "    'volume': '22',\n",
       "    'issn': '',\n",
       "    'pages': '267-71',\n",
       "    'other_ids': {'DOI': ['10.1093/eurpub/ckr049']}},\n",
       "   'BIBREF11': {'title': 'COVID-19: immense necessity and challenges in meeting the needs of minorities, especially asylum seekers and undocumented migrants',\n",
       "    'authors': [{'first': 'RS', 'middle': [], 'last': 'Bhopal', 'suffix': ''}],\n",
       "    'year': 2020,\n",
       "    'venue': 'Public Health',\n",
       "    'volume': '182',\n",
       "    'issn': '',\n",
       "    'pages': '161-2',\n",
       "    'other_ids': {'DOI': ['10.1016/j.puhe.2020.04.010']}},\n",
       "   'BIBREF12': {'title': 'Les sans-papiers en Suisse en 2015',\n",
       "    'authors': [{'first': 'M', 'middle': [], 'last': 'Morlok', 'suffix': ''},\n",
       "     {'first': 'A', 'middle': [], 'last': 'Oswald', 'suffix': ''},\n",
       "     {'first': 'H', 'middle': [], 'last': 'Meier', 'suffix': ''},\n",
       "     {'first': 'D', 'middle': [], 'last': 'Efionayi-Mäder', 'suffix': ''},\n",
       "     {'first': 'D', 'middle': [], 'last': 'Ruedin', 'suffix': ''},\n",
       "     {'first': 'D', 'middle': [], 'last': 'Bader', 'suffix': ''}],\n",
       "    'year': 2016,\n",
       "    'venue': '',\n",
       "    'volume': '',\n",
       "    'issn': '',\n",
       "    'pages': None,\n",
       "    'other_ids': {'DOI': []}},\n",
       "   'BIBREF13': {'title': '',\n",
       "    'authors': [],\n",
       "    'year': 2017,\n",
       "    'venue': 'Opération Papyrus',\n",
       "    'volume': '',\n",
       "    'issn': '',\n",
       "    'pages': None,\n",
       "    'other_ids': {'DOI': []}},\n",
       "   'BIBREF14': {'title': '',\n",
       "    'authors': [],\n",
       "    'year': 2020,\n",
       "    'venue': 'New Coronavirus: Situation in Switzerland Bern',\n",
       "    'volume': '',\n",
       "    'issn': '',\n",
       "    'pages': None,\n",
       "    'other_ids': {'DOI': []}},\n",
       "   'BIBREF15': {'title': 'A 12-Item short-form health survey: construction of scales and preliminary tests of reliability and validity',\n",
       "    'authors': [{'first': 'J', 'middle': [], 'last': 'Ware', 'suffix': 'Jr'},\n",
       "     {'first': 'M', 'middle': [], 'last': 'Kosinski', 'suffix': ''},\n",
       "     {'first': 'SD', 'middle': [], 'last': 'Keller', 'suffix': ''}],\n",
       "    'year': 1996,\n",
       "    'venue': 'Med. Care',\n",
       "    'volume': '34',\n",
       "    'issn': '',\n",
       "    'pages': '220-33',\n",
       "    'other_ids': {'DOI': ['10.1097/00005650-199603000-00003']}},\n",
       "   'BIBREF16': {'title': 'Swiss Household Panel',\n",
       "    'authors': [],\n",
       "    'year': 2017,\n",
       "    'venue': 'Lausanne: Fondation suisse pour la recherche en sciences sociales',\n",
       "    'volume': '',\n",
       "    'issn': '',\n",
       "    'pages': None,\n",
       "    'other_ids': {'DOI': []}},\n",
       "   'BIBREF17': {'title': '',\n",
       "    'authors': [],\n",
       "    'year': 2020,\n",
       "    'venue': 'Report on the Economic Well-Being of U.S. Households in 2018',\n",
       "    'volume': '',\n",
       "    'issn': '',\n",
       "    'pages': None,\n",
       "    'other_ids': {'DOI': []}},\n",
       "   'BIBREF18': {'title': 'The effectiveness of a short form of the household food security scale',\n",
       "    'authors': [{'first': 'SJ',\n",
       "      'middle': [],\n",
       "      'last': 'Blumberg',\n",
       "      'suffix': ''},\n",
       "     {'first': 'K', 'middle': [], 'last': 'Bialostosky', 'suffix': ''},\n",
       "     {'first': 'WL', 'middle': [], 'last': 'Hamilton', 'suffix': ''},\n",
       "     {'first': 'RR', 'middle': [], 'last': 'Briefel', 'suffix': ''}],\n",
       "    'year': 1999,\n",
       "    'venue': 'Am. J. Public Health',\n",
       "    'volume': '89',\n",
       "    'issn': '',\n",
       "    'pages': '1231-4',\n",
       "    'other_ids': {'DOI': ['10.2105/AJPH.89.8.1231']}},\n",
       "   'BIBREF19': {'title': 'Social distancing responses to COVID-19 emergency declarations strongly differentiated by income',\n",
       "    'authors': [{'first': 'JA', 'middle': [], 'last': 'Weill', 'suffix': ''},\n",
       "     {'first': 'M', 'middle': [], 'last': 'Stigler', 'suffix': ''},\n",
       "     {'first': 'O', 'middle': [], 'last': 'Deschenes', 'suffix': ''},\n",
       "     {'first': 'MR', 'middle': [], 'last': 'Springborn', 'suffix': ''}],\n",
       "    'year': 2020,\n",
       "    'venue': 'Proc. Natl. Acad. Sci. U.S.A',\n",
       "    'volume': '117',\n",
       "    'issn': '',\n",
       "    'pages': '19658-60',\n",
       "    'other_ids': {'DOI': ['10.1073/pnas.2009412117']}},\n",
       "   'BIBREF20': {'title': 'The neglected health of international migrant workers in the COVID-19 epidemic',\n",
       "    'authors': [{'first': 'A', 'middle': [], 'last': 'Liem', 'suffix': ''},\n",
       "     {'first': 'C', 'middle': [], 'last': 'Wang', 'suffix': ''},\n",
       "     {'first': 'Y', 'middle': [], 'last': 'Wariyanti', 'suffix': ''},\n",
       "     {'first': 'CA', 'middle': [], 'last': 'Latkin', 'suffix': ''},\n",
       "     {'first': 'BJ', 'middle': [], 'last': 'Hall', 'suffix': ''}],\n",
       "    'year': 2020,\n",
       "    'venue': 'Lancet Psychiatry',\n",
       "    'volume': '7',\n",
       "    'issn': '',\n",
       "    'pages': None,\n",
       "    'other_ids': {'DOI': ['10.1016/S2215-0366(20)30076-6']}},\n",
       "   'BIBREF21': {'title': 'COVID-19: universal health coverage now more than ever',\n",
       "    'authors': [{'first': 'B', 'middle': [], 'last': 'Armocida', 'suffix': ''},\n",
       "     {'first': 'B', 'middle': [], 'last': 'Formenti', 'suffix': ''},\n",
       "     {'first': 'F', 'middle': [], 'last': 'Palestra', 'suffix': ''},\n",
       "     {'first': 'S', 'middle': [], 'last': 'Ussai', 'suffix': ''},\n",
       "     {'first': 'E', 'middle': [], 'last': 'Missoni', 'suffix': ''}],\n",
       "    'year': 2020,\n",
       "    'venue': 'J. Glob. Health',\n",
       "    'volume': '10',\n",
       "    'issn': '',\n",
       "    'pages': None,\n",
       "    'other_ids': {'DOI': ['10.7189/jogh.10.010350']}},\n",
       "   'BIBREF22': {'title': 'Structural vulnerability in the U.S. revealed in three waves of COVID-19',\n",
       "    'authors': [{'first': 'J', 'middle': [], 'last': 'Solis', 'suffix': ''},\n",
       "     {'first': 'C', 'middle': [], 'last': 'Franco-Paredes', 'suffix': ''},\n",
       "     {'first': 'AF', 'middle': [], 'last': 'Henao-Martinez', 'suffix': ''},\n",
       "     {'first': 'M', 'middle': [], 'last': 'Krsak', 'suffix': ''},\n",
       "     {'first': 'SM', 'middle': [], 'last': 'Zimmer', 'suffix': ''}],\n",
       "    'year': 2020,\n",
       "    'venue': 'Am. J. Trop. Med. Hyg',\n",
       "    'volume': '103',\n",
       "    'issn': '',\n",
       "    'pages': '25-7',\n",
       "    'other_ids': {'DOI': ['10.4269/ajtmh.20-0391']}},\n",
       "   'BIBREF23': {'title': 'US Policies increase vulnerability of immigrant communities to the COVID-19 pandemic',\n",
       "    'authors': [{'first': 'FA', 'middle': [], 'last': 'Wilson', 'suffix': ''},\n",
       "     {'first': 'JP', 'middle': [], 'last': 'Stimpson', 'suffix': ''}],\n",
       "    'year': 2020,\n",
       "    'venue': 'Ann. Glob. Health',\n",
       "    'volume': '86',\n",
       "    'issn': '',\n",
       "    'pages': None,\n",
       "    'other_ids': {'DOI': ['10.5334/aogh.2897']}},\n",
       "   'BIBREF24': {'title': 'Associations between anxiety and depression symptoms and medical care avoidance during COVID-19',\n",
       "    'authors': [{'first': 'KT', 'middle': [], 'last': 'Ganson', 'suffix': ''},\n",
       "     {'first': 'SD', 'middle': [], 'last': 'Weiser', 'suffix': ''},\n",
       "     {'first': 'AC', 'middle': [], 'last': 'Tsai', 'suffix': ''},\n",
       "     {'first': 'JM', 'middle': [], 'last': 'Nagata', 'suffix': ''}],\n",
       "    'year': 2020,\n",
       "    'venue': 'J. Gen. Intern. Med',\n",
       "    'volume': '35',\n",
       "    'issn': '',\n",
       "    'pages': '3406-8',\n",
       "    'other_ids': {'DOI': ['10.1007/s11606-020-06156-8']}},\n",
       "   'BIBREF25': {'title': 'Becoming less illegal: deservingness frames and undocumented migrant incorporation',\n",
       "    'authors': [{'first': 'S', 'middle': [], 'last': 'Chauvin', 'suffix': ''},\n",
       "     {'first': 'B', 'middle': [], 'last': 'Garcés-Mascareñas', 'suffix': ''}],\n",
       "    'year': 2014,\n",
       "    'venue': 'Soc. Compass',\n",
       "    'volume': '8',\n",
       "    'issn': '',\n",
       "    'pages': '422-432',\n",
       "    'other_ids': {'DOI': ['10.1111/soc4.12145']}},\n",
       "   'BIBREF26': {'title': 'Refugee and migrant health in the COVID-19 response',\n",
       "    'authors': [{'first': 'HHP', 'middle': [], 'last': 'Kluge', 'suffix': ''},\n",
       "     {'first': 'Z', 'middle': [], 'last': 'Jakab', 'suffix': ''},\n",
       "     {'first': 'J', 'middle': [], 'last': 'Bartovic', 'suffix': ''},\n",
       "     {'first': 'V', 'middle': [], 'last': \"D'Anna\", 'suffix': ''},\n",
       "     {'first': 'S', 'middle': [], 'last': 'Severoni', 'suffix': ''}],\n",
       "    'year': 2020,\n",
       "    'venue': 'Lancet',\n",
       "    'volume': '395',\n",
       "    'issn': '',\n",
       "    'pages': '1237-9',\n",
       "    'other_ids': {'DOI': ['10.1016/S0140-6736(20)30791-1']}},\n",
       "   'BIBREF27': {'title': 'Targeting COVID-19 interventions towards migrants in humanitarian settings',\n",
       "    'authors': [{'first': 'S',\n",
       "      'middle': [],\n",
       "      'last': 'Hargreaves',\n",
       "      'suffix': ''},\n",
       "     {'first': 'D', 'middle': [], 'last': 'Zenner', 'suffix': ''},\n",
       "     {'first': 'K', 'middle': [], 'last': 'Wickramage', 'suffix': ''},\n",
       "     {'first': 'A', 'middle': [], 'last': 'Deal', 'suffix': ''},\n",
       "     {'first': 'SE', 'middle': [], 'last': 'Hayward', 'suffix': ''}],\n",
       "    'year': 2020,\n",
       "    'venue': 'Lancet Infect. Dis',\n",
       "    'volume': '20',\n",
       "    'issn': '',\n",
       "    'pages': '645-6',\n",
       "    'other_ids': {'DOI': ['10.1016/S1473-3099(20)30292-9']}},\n",
       "   'BIBREF28': {'title': '',\n",
       "    'authors': [{'first': 'H', 'middle': [], 'last': 'Joffe', 'suffix': ''}],\n",
       "    'year': 1999,\n",
       "    'venue': 'Risk and ‘The Other’',\n",
       "    'volume': '',\n",
       "    'issn': '',\n",
       "    'pages': None,\n",
       "    'other_ids': {'DOI': ['10.1017/CBO9780511489846']}},\n",
       "   'BIBREF29': {'title': 'COVID-19: the great unequaliser',\n",
       "    'authors': [{'first': 'D',\n",
       "      'middle': [],\n",
       "      'last': 'Devakumar',\n",
       "      'suffix': ''},\n",
       "     {'first': 'SS', 'middle': [], 'last': 'Bhopal', 'suffix': ''},\n",
       "     {'first': 'G', 'middle': [], 'last': 'Shannon', 'suffix': ''}],\n",
       "    'year': 2020,\n",
       "    'venue': 'J. R. Soc. Med',\n",
       "    'volume': '113',\n",
       "    'issn': '',\n",
       "    'pages': '234-5',\n",
       "    'other_ids': {'DOI': ['10.1177/0141076820925434']}},\n",
       "   'BIBREF30': {'title': 'Undocumented U.S. immigrants and Covid-19',\n",
       "    'authors': [{'first': 'KR', 'middle': [], 'last': 'Page', 'suffix': ''},\n",
       "     {'first': 'M', 'middle': [], 'last': 'Venkataramani', 'suffix': ''},\n",
       "     {'first': 'C', 'middle': [], 'last': 'Beyrer', 'suffix': ''},\n",
       "     {'first': 'S', 'middle': [], 'last': 'Polk', 'suffix': ''}],\n",
       "    'year': 2020,\n",
       "    'venue': 'N. Engl. J. Med',\n",
       "    'volume': '382',\n",
       "    'issn': '',\n",
       "    'pages': None,\n",
       "    'other_ids': {'DOI': ['10.1056/NEJMp2005953']}},\n",
       "   'BIBREF31': {'title': \"Impact of legal status change on undocumented migrants' health and well-being (Parchemins): protocol of a 4-year, prospective, mixed-methods study\",\n",
       "    'authors': [{'first': 'Y', 'middle': [], 'last': 'Jackson', 'suffix': ''},\n",
       "     {'first': 'DS', 'middle': [], 'last': 'Courvoisier', 'suffix': ''},\n",
       "     {'first': 'A', 'middle': [], 'last': 'Duvoisin', 'suffix': ''},\n",
       "     {'first': 'G', 'middle': [], 'last': 'Ferro-Luzzi', 'suffix': ''},\n",
       "     {'first': 'P', 'middle': [], 'last': 'Bodenmann', 'suffix': ''},\n",
       "     {'first': 'P', 'middle': [], 'last': 'Chauvin', 'suffix': ''}],\n",
       "    'year': 2019,\n",
       "    'venue': 'BMJ Open',\n",
       "    'volume': '9',\n",
       "    'issn': '',\n",
       "    'pages': None,\n",
       "    'other_ids': {'DOI': ['10.1136/bmjopen-2018-028336']}}}},\n",
       " {'paper_id': 'PMC8420119',\n",
       "  'metadata': {'title': 'Nightmare content during the COVID‐19 pandemic: Influence of COVID‐related stress and sleep disruption in the United States',\n",
       "   'authors': [{'first': 'Kathryn',\n",
       "     'middle': ['E.', 'R.'],\n",
       "     'last': 'Kennedy',\n",
       "     'suffix': '',\n",
       "     'email': None,\n",
       "     'affiliation': {}},\n",
       "    {'first': 'Célyne',\n",
       "     'middle': ['H.'],\n",
       "     'last': 'Bastien',\n",
       "     'suffix': '',\n",
       "     'email': None,\n",
       "     'affiliation': {}},\n",
       "    {'first': 'Perrine',\n",
       "     'middle': ['M.'],\n",
       "     'last': 'Ruby',\n",
       "     'suffix': '',\n",
       "     'email': None,\n",
       "     'affiliation': {}},\n",
       "    {'first': 'William',\n",
       "     'middle': ['D.', 'S.'],\n",
       "     'last': 'Killgore',\n",
       "     'suffix': '',\n",
       "     'email': None,\n",
       "     'affiliation': {}},\n",
       "    {'first': 'Chloe',\n",
       "     'middle': ['C.', 'A.'],\n",
       "     'last': 'Wills',\n",
       "     'suffix': '',\n",
       "     'email': None,\n",
       "     'affiliation': {}},\n",
       "    {'first': 'Michael',\n",
       "     'middle': ['A.'],\n",
       "     'last': 'Grandner',\n",
       "     'suffix': '',\n",
       "     'email': 'grandner@email.arizona.edu',\n",
       "     'affiliation': {}}]},\n",
       "  'body_text': [{'text': 'The COVID‐19 pandemic has affected sleep and dreams for many individuals and has been linked to changes in mental health, lifestyle habits and social interactions (Pérez‐Carbonell et al., 2020; Shillington et al., 2021). Insomnia severity during this time has been linked to suicide ideation (Killgore et al., 2020) and much of the anxiety and stress associated with health and general well‐being has played out in dreams and nightmares with pandemic‐related themes (Guerrero‐Gomez et al., 2021; MacKay & DeCicco, 2020; Mota et al., 2020; Ruby, 2021).',\n",
       "    'cite_spans': [{'start': 188,\n",
       "      'end': 192,\n",
       "      'mention': '2020',\n",
       "      'ref_id': 'BIBREF24'},\n",
       "     {'start': 214, 'end': 218, 'mention': '2021', 'ref_id': 'BIBREF33'},\n",
       "     {'start': 310, 'end': 314, 'mention': '2020', 'ref_id': 'BIBREF39'},\n",
       "     {'start': 490, 'end': 494, 'mention': '2021', 'ref_id': 'BIBREF10'},\n",
       "     {'start': 514, 'end': 518, 'mention': '2020', 'ref_id': 'BIBREF17'},\n",
       "     {'start': 533, 'end': 537, 'mention': '2020', 'ref_id': 'BIBREF20'},\n",
       "     {'start': 545, 'end': 549, 'mention': '2021', 'ref_id': 'BIBREF31'}],\n",
       "    'section': 'INTRODUCTION',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'A nightmare is a bad dream that evokes a strong emotional response in the sleeper and leads to being awoken. Nightmares are associated with particular personality types more susceptible to threat perception and proposed by Nielsen and Levin (2007) to involve dysfunction of a network comprising the limbic, paralimbic and prefrontal regions of the brain involved in emotion regulation. A nightmare may either be idiopathic (of unknown cause) or post‐traumatic (following a traumatic event) and typically takes place during rapid eye movement (REM) sleep (Fisher et al., 1970; Spoormaker et al., 2006). Nightmares are more common in children than adults (20–30% vs. 11% of the general population) (Bixler et al., 1979; Leung & Robson, 1993), but those who experience them in adulthood are most likely to be young females (Spoormaker et al., 2006). This prevalence in females is thought to decline with age (Spoormaker et al., 2006). Nightmares are significantly associated with psychiatric disorders and anxiety, with persistence of nightmares linked to irregular sleep schedules, avoidance of addressing them, and fear of going to sleep (Hublin et al., 1999; Spoormaker et al., 2006). This can result in sleep deprivation, which increases anxiety levels and thus perpetuates the cycle (Pires et al., 2016).',\n",
       "    'cite_spans': [{'start': 242,\n",
       "      'end': 246,\n",
       "      'mention': '2007',\n",
       "      'ref_id': 'BIBREF22'},\n",
       "     {'start': 570, 'end': 574, 'mention': '1970', 'ref_id': 'BIBREF6'},\n",
       "     {'start': 595, 'end': 599, 'mention': '2006', 'ref_id': 'BIBREF36'},\n",
       "     {'start': 712, 'end': 716, 'mention': '1979', 'ref_id': 'BIBREF1'},\n",
       "     {'start': 734, 'end': 738, 'mention': '1993', 'ref_id': 'BIBREF16'},\n",
       "     {'start': 840, 'end': 844, 'mention': '2006', 'ref_id': 'BIBREF36'},\n",
       "     {'start': 925, 'end': 929, 'mention': '2006', 'ref_id': 'BIBREF36'},\n",
       "     {'start': 1153, 'end': 1157, 'mention': '1999', 'ref_id': 'BIBREF12'},\n",
       "     {'start': 1178, 'end': 1182, 'mention': '2006', 'ref_id': 'BIBREF36'},\n",
       "     {'start': 1300, 'end': 1304, 'mention': '2016', 'ref_id': 'BIBREF28'}],\n",
       "    'section': 'INTRODUCTION',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Robert and Zadra (2014) conducted a study to assess the most common nightmare themes and found these to include aggression, fear and unfortunate endings. Interestingly, they found that nightmares were less likely to reflect issues of personal competence and more likely to reflect negative external triggers. This falls in line with the Threat Simulation Theory, which suggests that a key function of dreams is to play out threatening scenarios while asleep and thus help prepare for and avoid or confront a threat in waking life (Revonsuo, 2000).',\n",
       "    'cite_spans': [{'start': 18,\n",
       "      'end': 22,\n",
       "      'mention': '2014',\n",
       "      'ref_id': 'BIBREF30'},\n",
       "     {'start': 541, 'end': 545, 'mention': '2000', 'ref_id': 'BIBREF29'}],\n",
       "    'section': 'INTRODUCTION',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'A general increase in dream and nightmare frequency during the COVID‐19 pandemic has been reported around the world. Scarpelli and colleagues (2021) and Gorgoni and colleagues (2021) both noted an increase in dreams with strong emotional content in Italy. In a sample of Canadian university students, an increase in nightmares was reported, with females disproportionately affected (Kilius et al., 2021). Another Canadian study noted an increase in dream imagery related to pandemic themes among participants (MacKay & DeCicco, 2020).',\n",
       "    'cite_spans': [{'start': 143,\n",
       "      'end': 147,\n",
       "      'mention': '2021',\n",
       "      'ref_id': 'BIBREF32'},\n",
       "     {'start': 177, 'end': 181, 'mention': '2021', 'ref_id': 'BIBREF8'},\n",
       "     {'start': 398, 'end': 402, 'mention': '2021', 'ref_id': 'BIBREF13'},\n",
       "     {'start': 528, 'end': 532, 'mention': '2020', 'ref_id': 'BIBREF17'}],\n",
       "    'section': 'INTRODUCTION',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'In the survey during the first lockdown in France, an increase in nightmare frequency was also observed (Ruby, 2021). Themes related to the health crisis were the most frequently reported. This was also seen in a Brazilian study that analyzed dream themes and found a higher proportion of themes around contamination and cleanliness (Mota et al., 2020), and in a Finnish study where participants reported more night‐time awakenings and nightmares as compared to pre‐pandemic times, with over 50% of these nightmares about pandemic‐specific themes, including sickness, physical distancing and family concerns (Pesonen et al., 2020). Among adolescents living in Italy, Croatia and Romania, an increase in nightmares and dreams with pandemic‐related themes were also reported (Guerrero‐Gomez et al., 2021).',\n",
       "    'cite_spans': [{'start': 111,\n",
       "      'end': 115,\n",
       "      'mention': '2021',\n",
       "      'ref_id': 'BIBREF31'},\n",
       "     {'start': 347, 'end': 351, 'mention': '2020', 'ref_id': 'BIBREF20'},\n",
       "     {'start': 625, 'end': 629, 'mention': '2020', 'ref_id': 'BIBREF26'},\n",
       "     {'start': 797, 'end': 801, 'mention': '2021', 'ref_id': 'BIBREF10'}],\n",
       "    'section': 'INTRODUCTION',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'General sleep disturbances during the pandemic have been particularly prevalent among healthcare workers (Wang et al., 2020), whereas other studies have found females in general to be at higher risk (Dal Santo et al., 2021; Kilius et al., 2021; Pinto et al., 2020; Scarpelli et al., 2021). A large study using Fitbit data from approximately 160,000 users across six major US cities found that compared to 2019, sleep duration had increased during the 2020 pandemic (Rezaei & Grandner, 2021). Bedtime also shifted to later and variability in sleep duration decreased. Increased sleep time was also observed in France during the first lockdown, as seen in a survey that covered all regions of the country (N = 3337) (Ruby, 2021).',\n",
       "    'cite_spans': [{'start': 119,\n",
       "      'end': 123,\n",
       "      'mention': '2020',\n",
       "      'ref_id': 'BIBREF38'},\n",
       "     {'start': 218, 'end': 222, 'mention': '2021', 'ref_id': 'BIBREF3'},\n",
       "     {'start': 239, 'end': 243, 'mention': '2021', 'ref_id': 'BIBREF13'},\n",
       "     {'start': 259, 'end': 263, 'mention': '2020', 'ref_id': 'BIBREF27'},\n",
       "     {'start': 283, 'end': 287, 'mention': '2021', 'ref_id': 'BIBREF32'},\n",
       "     {'start': 485, 'end': 489, 'mention': '2021', 'ref_id': 'BIBREF40'},\n",
       "     {'start': 721, 'end': 725, 'mention': '2021', 'ref_id': 'BIBREF31'}],\n",
       "    'section': 'INTRODUCTION',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'In another study comparing pandemic‐related sleep to pre‐pandemic norms, a team from the Netherlands recruited a population consisting of both good and bad sleepers (for which previous data existed) and assessed subjective sleep quality changes during the pandemic. Kocevska and colleagues (2020) found no uniform effect on sleep, with some individuals experiencing improvements as compared to pre‐pandemic times, whereas others noted worse sleep that was often associated with pandemic anxiety. This was also seen in Italy, France and Spain, where worse sleep quality was more frequently reported than improved sleep quality (Alfonsi et al., 2021; Dal Santo et al., 2021; Ruby, 2021).',\n",
       "    'cite_spans': [{'start': 291,\n",
       "      'end': 295,\n",
       "      'mention': '2020',\n",
       "      'ref_id': 'BIBREF14'},\n",
       "     {'start': 643, 'end': 647, 'mention': '2021', 'ref_id': 'BIBREF0'},\n",
       "     {'start': 667, 'end': 671, 'mention': '2021', 'ref_id': 'BIBREF3'},\n",
       "     {'start': 679, 'end': 683, 'mention': '2021', 'ref_id': 'BIBREF31'}],\n",
       "    'section': 'INTRODUCTION',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'More time than usual spent indoors could be responsible for some of the sleep disturbances that have been seen. Morin and colleagues (2020) postulated that not only could stress be responsible, but also disturbed circadian rhythms as a result of confinement. The usual light and social cues used for circadian entrainment are no longer present when individuals are restricted to extended periods of social distancing, at home, indoors. With this lifestyle change has also come increased reliance on the use of screens for work and social connections (Majumdar et al., 2020). Blue‐light‐emitting devices are known to suppress melatonin production and thus disturb sleep (Cajochen et al., 2011). These factors may have contributed to the increase in sleep medication use seen during confinement by Alfonsi and colleagues (2021).',\n",
       "    'cite_spans': [{'start': 134,\n",
       "      'end': 138,\n",
       "      'mention': '2020',\n",
       "      'ref_id': 'BIBREF19'},\n",
       "     {'start': 568, 'end': 572, 'mention': '2020', 'ref_id': 'BIBREF18'},\n",
       "     {'start': 687, 'end': 691, 'mention': '2011', 'ref_id': 'BIBREF2'},\n",
       "     {'start': 820, 'end': 824, 'mention': '2021', 'ref_id': 'BIBREF0'}],\n",
       "    'section': 'INTRODUCTION',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Given the known implications of stress and sleep loss on health and well‐being, and the need for further understanding of the pathology of nightmares, the aim of the present study was to determine whether COVID‐related general, family or media stress, subjective perception of worsened sleep, increased onset insomnia or middle‐of‐the‐night insomnia were associated with specific nightmare themes in a United States sample after seeing similar effects in other parts of the world. We hypothesized that pandemic‐related worsening of sleep quality and pandemic‐related increased stress would be associated with increased frequency of nightmares that would similarly reflect pandemic‐related themes.',\n",
       "    'cite_spans': [],\n",
       "    'section': 'INTRODUCTION',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'These data were collected as part of the Coronavirus and Impact on Dreams (CoVID) study, which was approved by the Institutional Review Board (IRB) of the University of Arizona. Data were collected from June to November 2020. Adults aged 18 and older who were also fluent in English were eligible. Recruitment included flyers posted locally in Tucson, Arizona, as well as social media and online advertisements accessible nationwide. Data were collected in the form of a REDCap survey, for which informed consent was required in order to proceed. Analyses were conducted on all completed surveys (N = 419).',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Data source ::: METHODS',\n",
       "    'ref_spans': []},\n",
       "   {'text': \"Participants were asked to indicate the degree to which they agreed or disagreed with the following statements about COVID‐related stress: “COVID‐19 is increasing my general stress,” “COVID‐19 is increasing stress about my family” and “The media coverage of COVID‐19 has increased my stress.” They were also asked to indicate the degree to which they agreed or disagreed with the following statements about their sleep: “Since quarantine, my sleep has worsened,” “Since quarantine, I'm struggling to fall asleep” and “Since quarantine, I'm waking up more during the night.” These six items, which record general stress, family stress, media stress, worsened sleep, onset insomnia and middle‐of‐the night insomnia, respectively, had the following response options: “Strongly Disagree,” “Disagree,” “Agree” and “Strongly Agree.” These were coded numerically as 0–3.\",\n",
       "    'cite_spans': [],\n",
       "    'section': 'Measures ::: METHODS',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Participants were also asked, “Have you had nightmares about any of the following during quarantine?” They indicated yes or no to the following themes inspired from the French survey (Ruby, 2021): “confinement,” “claustrophobia,” “suffocation,” “oppression,” “drowning,” “failure,” “feeling helpless,” “natural disasters,” “anxiety,” “evil forces,” “war,” “domestic abuse,” “separation from loved ones,” “totalitarian regime,” “being chased,” “dangerous animals,” “sickness,” “death,” “covid‐19 virus” and “end of the world.”',\n",
       "    'cite_spans': [{'start': 190,\n",
       "      'end': 194,\n",
       "      'mention': '2021',\n",
       "      'ref_id': 'BIBREF31'}],\n",
       "    'section': 'Measures ::: METHODS',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Participants completed the Patient Health Questionnaire (PHQ‐9) (Kroenke et al., 2001), which screened for depression, and the Generalized Anxiety Disorder 7‐item instrument (GAD‐7) (Spitzer et al., 2006). Participants also completed the Mannheim Dreams questionnaire (MADRE) (Shredl et al., 2014), which asked about dream and nightmare experiences, including frequency of nightmares.',\n",
       "    'cite_spans': [{'start': 81,\n",
       "      'end': 85,\n",
       "      'mention': '2001',\n",
       "      'ref_id': 'BIBREF15'},\n",
       "     {'start': 199, 'end': 203, 'mention': '2006', 'ref_id': 'BIBREF35'},\n",
       "     {'start': 292, 'end': 296, 'mention': '2014', 'ref_id': 'BIBREF34'}],\n",
       "    'section': 'Measures ::: METHODS',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Additional variables included age, sex and self‐reported race/ethnicity (non‐Hispanic white, Hispanic/Latino, black/African‐American, Indian/Subcontinent, Asian or multiracial/other).',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Measures ::: METHODS',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Logistic regression analyses examined the likelihood of each nightmare as a binary variable, predicted by each of the stress and sleep variables, treated as pseudo‐linear independent variables. All logistic regression analyses were adjusted for age, sex and race/ethnicity. Results are displayed as adjusted odds ratios (ORs) and 95% confidence intervals (CIs), along with z score of the OR and p‐value. Because there were 20 different outcomes, all p‐values were subject to Holm‐Bonferonni adjustment (Holm, 1979). Adjusted p‐values were computed by weighting the observed p‐value by the Holm‐Bonferonni cut‐offs, relative to 0.05. All analyses were performed in STATA 14.2 (STATACORP, College Station, TX), except for Holm‐Bonferonni adjustments, which were computed in Microsoft Excel 365.',\n",
       "    'cite_spans': [{'start': 509,\n",
       "      'end': 513,\n",
       "      'mention': '1979',\n",
       "      'ref_id': 'BIBREF11'}],\n",
       "    'section': 'Statistical analyses ::: METHODS',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Characteristics of the sample are reported in Table 1. A total of N = 419 individuals provided data. The sample was predominantly female and non‐Hispanic white. The mean age was 46 (range, 18–80). The most commonly reported nightmare content was “anxiety” (41.2%), with more than 1/5 respondents reporting nightmares that had themes of helplessness (40.0%), separation from loved ones (28.1%), failure (27.4%), being chased (24.3%) and death (22.1%). COVID‐related stress was common, with about 86.2% endorsing some increase in general stress, 67.6% reporting media‐related stress and 83.8% reporting family‐related stress. Sleep disturbances were also common, with 60.5% reporting that their sleep worsened in general, 43.6% reporting that they had more difficulties with sleep onset insomnia, and 55.2% reporting that they were having more difficulties with middle‐of‐the‐night insomnia.',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Characteristics of the sample ::: RESULTS',\n",
       "    'ref_spans': [{'start': 52,\n",
       "      'end': 53,\n",
       "      'mention': '1',\n",
       "      'ref_id': 'TABREF0'}]},\n",
       "   {'text': 'Results of logistic regression analyses investigating relationships between COVID‐related stress and nightmare content are reported in Table 2. In unadjusted analyses, following p‐value adjustment for multiple comparisons, a greater increase in general stress was associated with an increased likelihood of nightmares about failure, helplessness, anxiety, war, separation from loved ones, totalitarian regimes, sickness, death, COVID‐19 and an apocalypse. After adjustment for demographic covariates, the relationships with failure, death and COVID‐19 were no longer statistically significant in Holm‐Bonferroni‐adjusted analyses. Z‐score plots for each stress and nightmare theme are presented in Figure 1.',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Associations between COVID‐related stress and nightmare content ::: RESULTS',\n",
       "    'ref_spans': [{'start': 705,\n",
       "      'end': 706,\n",
       "      'mention': '1',\n",
       "      'ref_id': 'FIGREF0'},\n",
       "     {'start': 141, 'end': 142, 'mention': '2', 'ref_id': 'TABREF1'}]},\n",
       "   {'text': 'An increase in family stress was associated with an increased likelihood of nightmares about confinement, suffocation, oppression, failure, helplessness, anxiety, evil forces, war, domestic abuse, separation from loves ones, totalitarian regimes, being chased, sickness, death, COVID‐19 and an apocalypse. After adjustment for demographic covariates, the relationships with suffocation, evil forces, domestic abuse, being chased, sickness and COVID‐19 were no longer statistically significant in Holm‐Bonferroni‐adjusted analyses.',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Associations between COVID‐related stress and nightmare content ::: RESULTS',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Media stress was not associated with an increased likelihood of any specific nightmare content.',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Associations between COVID‐related stress and nightmare content ::: RESULTS',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Results of logistic regression analyses investigating relationships between COVID‐related sleep disturbances and nightmare content are reported in Table 3. In unadjusted analyses, following a p‐value adjustment for multiple comparisons, worse sleep was associated with an increased likelihood of nightmares about confinement, oppression, failure, helplessness, natural disasters, anxiety, evil forces, war, domestic abuse, separation from loves ones, totalitarian regimes, sickness, death, COVID‐19 and an apocalypse. After adjustment for demographic covariates, the relationships with evil forces and domestic abuse were no longer statistically significant in Holm‐Bonferroni‐adjusted analyses. Z‐score plots for sleep disturbances and nightmare theme associations are presented in Figure 2.',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Associations between COVID‐related sleep disturbance and nightmare content ::: RESULTS',\n",
       "    'ref_spans': [{'start': 790,\n",
       "      'end': 791,\n",
       "      'mention': '2',\n",
       "      'ref_id': 'FIGREF1'},\n",
       "     {'start': 153, 'end': 154, 'mention': '3', 'ref_id': 'TABREF2'}]},\n",
       "   {'text': 'Early‐onset insomnia was associated with an increased likelihood of nightmares about all topics except dangerous animals. After adjustment for demographic covariates, the relationships with suffocation, drowning, evil forces, being chased, sickness and COVID‐19 were no longer statistically significant in Holm‐Bonferroni‐adjusted analyses.',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Associations between COVID‐related sleep disturbance and nightmare content ::: RESULTS',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Middle‐of‐the‐night insomnia was associated with an increased likelihood of nightmares about confinement, oppression, failure, helplessness, anxiety, war, domestic abuse, separation from loved ones, sickness, death, COVID‐19 and an apocalypse. After adjustment for demographic covariates, the relationships with confinement, COVID‐19 and an apocalypse were no longer statistically significant in Holm‐Bonferroni‐adjusted analyses.',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Associations between COVID‐related sleep disturbance and nightmare content ::: RESULTS',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'To determine the effects of depression and anxiety on nightmare content, logistic regression analyses investigating relationships between PHQ‐9 and GAD‐7 scores and nightmare themes were performed. These are reported in Table 4. In unadjusted analyses, following a p‐value adjustment for multiple comparisons, depression and anxiety were significantly associated with all nightmare themes. This persisted following adjustment for demographic covariates, with the exception of what are presumed to be two spurious results (natural disasters and COVID‐19).',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Associations between depression and anxiety and nightmare content ::: RESULTS',\n",
       "    'ref_spans': [{'start': 226,\n",
       "      'end': 227,\n",
       "      'mention': '4',\n",
       "      'ref_id': 'TABREF3'}]},\n",
       "   {'text': 'Nightmare frequency was assessed using the Mannheim Dream questionnaire (MADRE), with the question: “How often have you experienced nightmares recently (in the past several months)?” The answer options included: several times a week, about once a week, two to three times a month, once a month, two to four times a year, once a year, less than once a year, and never. Data were grouped into: more than once a week, more than one a month, more than one a year, and less than one a year, and assessed as an additional covariate in the models. In almost all cases, the relationship between stressor and nightmare content, or sleep complaint and nightmare content was maintained, indicating there was no influence of nightmare frequency on specific nightmare themes (unreported data).',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Association between nightmare frequency and content ::: RESULTS',\n",
       "    'ref_spans': []},\n",
       "   {'text': \"Although this survey was open to all adults over the age of 18, the specific location of participants was unknown. However, although any location‐specific variability in COVID‐19 related circumstances could not be accounted for, this sample represents a general or collective effect of the pandemic on nightmares within the US. Similarly, the extent to which participants were affected by other potentially stressful sociopolitical circumstances that may have had an impact on nightmares that occurred during the study period remains unknown. Although survey questions included those about dreams and nightmares prior to the COVID‐19 pandemic, previous data for these individuals does not exist, thus preventing accurate comparisons being made in the realms of sleep quality, nightmare content and frequency before and after the pandemic. Also, the difference between a bad dream and a nightmare was not specified in the survey; therefore, it's unclear whether individuals were awoken by these reported nightmares, thus leading to sleep difficulties, or whether they remembered the dream content once they were awake and were thus unable to return to sleep. Regardless, there was a general increase in sleep difficulties that accompanied these negatively toned dreams. Measures of sleep were also limited to very few questions, thus limiting the extent to which disturbances and poor sleep could be determined. Lastly, this survey was advertised largely online and those without internet access or those without social media accounts will have been less likely to have participated. Although online survey distribution is now commonplace, it's important that future studies take this portion of the population into account, so as not to exclude any individuals.\",\n",
       "    'cite_spans': [],\n",
       "    'section': 'Limitations ::: DISCUSSION',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'The mechanisms underpinning the emotion processing involved in dream manifestation ‐ or perhaps the lack thereof ‐ during a stress response, or as seen in sleep loss, are not yet fully understood. However, this study highlights the effects of stress and reported sleep difficulties on specific nightmare themes, particularly with regards to a global pandemic or similar health crisis and the sociopolitical stressors that occurred in parallel within the United States. This may be beneficial for future sleep and mental health interventions.',\n",
       "    'cite_spans': [],\n",
       "    'section': 'CONCLUSIONS',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'There are no conflicts of interest to disclose.',\n",
       "    'cite_spans': [],\n",
       "    'section': 'CONFLICT OF INTEREST',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'The study was conducted by Kathryn E.R. Kennedy, Chloe C.A. Wills and Michael A. Grandner. The manuscript was written by Kathryn E.R. Kennedy and Michael A. Grandner, with edits from Celyne H. Bastien and Perrine Ruby, and a review by William D.S. Killgore.',\n",
       "    'cite_spans': [],\n",
       "    'section': 'AUTHOR CONTRIBUTIONS',\n",
       "    'ref_spans': []}],\n",
       "  'ref_entries': {'TABREF0': {'text': 'TABLE 1: Characteristics of the sample\\n',\n",
       "    'type': 'table'},\n",
       "   'TABREF1': {'text': 'TABLE 2: Associations between COVID‐related stress and nightmare content, unadjusted and adjusted, with standard and Holm‐Bonferroni‐adjusted p values\\n',\n",
       "    'type': 'table'},\n",
       "   'TABREF2': {'text': 'TABLE 3: Associations between COVID‐related sleep disturbance and nightmare content, unadjusted and adjusted, with standard and Holm‐Bonferroni‐adjusted p values\\n',\n",
       "    'type': 'table'},\n",
       "   'TABREF3': {'text': 'TABLE 4: Associations between depression, anxiety, and nightmare content, unadjusted and adjusted, with standard and Holm‐Bonferroni adjusted p values\\n',\n",
       "    'type': 'table'},\n",
       "   'FIGREF0': {'text': 'FIGURE 1: Associations between general, family and media‐related stress and nightmare content',\n",
       "    'type': 'figure'},\n",
       "   'FIGREF1': {'text': 'FIGURE 2: Associations between worse sleep, onset insomnia and middle‐of‐the‐night insomnia and nightmare content',\n",
       "    'type': 'figure'}},\n",
       "  'back_matter': [],\n",
       "  'bib_entries': {'BIBREF0': {'title': 'COVID‐19 lockdown and poor sleep quality: Not the whole story',\n",
       "    'authors': [],\n",
       "    'year': 2021,\n",
       "    'venue': 'Journal of Sleep Research',\n",
       "    'volume': '',\n",
       "    'issn': '',\n",
       "    'pages': None,\n",
       "    'other_ids': {'DOI': ['10.1111/jsr.13368']}},\n",
       "   'BIBREF1': {'title': 'Prevalence of sleep disorders in the Los Angeles metropolitan area',\n",
       "    'authors': [],\n",
       "    'year': 1979,\n",
       "    'venue': 'American Journal of Psychiatry',\n",
       "    'volume': '136',\n",
       "    'issn': '10',\n",
       "    'pages': '1257-1262',\n",
       "    'other_ids': {'DOI': ['10.1176/ajp.136.10.1257']}},\n",
       "   'BIBREF2': {'title': 'Evening exposure to a light‐emitting diodes (LED)‐backlit computer screen affects circadian physiology and cognitive performance',\n",
       "    'authors': [],\n",
       "    'year': 2011,\n",
       "    'venue': 'Journal of Applied Physiology 1985',\n",
       "    'volume': '110',\n",
       "    'issn': '5',\n",
       "    'pages': '1432-1438',\n",
       "    'other_ids': {'DOI': ['10.1152/japplphysiol.00165.2011']}},\n",
       "   'BIBREF3': {'title': 'Early Impact of the COVID‐19 Outbreak on Sleep in a Large Spanish Sample',\n",
       "    'authors': [],\n",
       "    'year': 2021,\n",
       "    'venue': 'Behavioral Sleep Medicine',\n",
       "    'volume': '',\n",
       "    'issn': '',\n",
       "    'pages': '1-16',\n",
       "    'other_ids': {'DOI': ['10.1080/15402002.2021.1890597']}},\n",
       "   'BIBREF4': {'title': 'Presleep suggestion related to a phobic object: successful manipulation of reported dream affect',\n",
       "    'authors': [],\n",
       "    'year': 1991,\n",
       "    'venue': 'The Journal of General Psychology',\n",
       "    'volume': '118',\n",
       "    'issn': '3',\n",
       "    'pages': '185-200',\n",
       "    'other_ids': {'DOI': ['10.1080/00221309.1991.9917780']}},\n",
       "   'BIBREF5': {'title': 'Familial risk for insomnia is associated with abnormal cortisol response to stress',\n",
       "    'authors': [],\n",
       "    'year': 2017,\n",
       "    'venue': 'Sleep',\n",
       "    'volume': '40',\n",
       "    'issn': '10',\n",
       "    'pages': None,\n",
       "    'other_ids': {'DOI': ['10.1093/sleep/zsx143']}},\n",
       "   'BIBREF6': {'title': 'A psychophysiological study of nightmares',\n",
       "    'authors': [],\n",
       "    'year': 1970,\n",
       "    'venue': 'Journal of the American Psychoanalytic Association',\n",
       "    'volume': '18',\n",
       "    'issn': '4',\n",
       "    'pages': '747-782',\n",
       "    'other_ids': {'DOI': ['10.1177/000306517001800401']}},\n",
       "   'BIBREF7': {'title': 'Sleep pathophysiology in posttraumatic stress disorder and idiopathic nightmare sufferers',\n",
       "    'authors': [],\n",
       "    'year': 2003,\n",
       "    'venue': 'Biological Psychiatry',\n",
       "    'volume': '54',\n",
       "    'issn': '10',\n",
       "    'pages': '1092-1098',\n",
       "    'other_ids': {'DOI': ['10.1016/s0006-3223(03)00071-4']}},\n",
       "   'BIBREF8': {'title': 'Pandemic dreams: quantitative and qualitative features of the oneiric activity during the lockdown due to COVID‐19 in Italy',\n",
       "    'authors': [],\n",
       "    'year': 2021,\n",
       "    'venue': 'Sleep Medicine',\n",
       "    'volume': '81',\n",
       "    'issn': '',\n",
       "    'pages': '20-32',\n",
       "    'other_ids': {'DOI': ['10.1016/j.sleep.2021.02.006']}},\n",
       "   'BIBREF9': {'title': 'Autonomic dysregulation and sleep homeostasis in insomnia',\n",
       "    'authors': [],\n",
       "    'year': 2020,\n",
       "    'venue': 'Sleep',\n",
       "    'volume': '44',\n",
       "    'issn': '6',\n",
       "    'pages': '1-13',\n",
       "    'other_ids': {'DOI': ['10.1093/sleep/zsaa274']}},\n",
       "   'BIBREF10': {'title': 'Dreaming in adolescents during the COVID‐19 health crisis: Survey among a sample of European School Students',\n",
       "    'authors': [],\n",
       "    'year': 2021,\n",
       "    'venue': 'Front Psychol',\n",
       "    'volume': '12',\n",
       "    'issn': '',\n",
       "    'pages': None,\n",
       "    'other_ids': {'DOI': ['10.3389/fpsyg.2021.652627']}},\n",
       "   'BIBREF11': {'title': 'A simple sequentially rejective multiple test procedure',\n",
       "    'authors': [],\n",
       "    'year': 1979,\n",
       "    'venue': 'Scandinavian Journal of Statistics',\n",
       "    'volume': '6',\n",
       "    'issn': '2',\n",
       "    'pages': '65-70',\n",
       "    'other_ids': {'DOI': []}},\n",
       "   'BIBREF12': {'title': 'Nightmares: Familial aggregation and association with psychiatric disorders in a nationwide twin cohort',\n",
       "    'authors': [],\n",
       "    'year': 1999,\n",
       "    'venue': 'American Journal of Medical Genetics',\n",
       "    'volume': '88',\n",
       "    'issn': '4',\n",
       "    'pages': '329-336',\n",
       "    'other_ids': {'DOI': ['10.1002/(sici)1096-8628(19990820)88:4<329:aid-ajmg8>3.0.co;2-e']}},\n",
       "   'BIBREF13': {'title': \"Pandemic nightmares: COVID‐19 lockdown associated with increased aggression in female university students' dreams\",\n",
       "    'authors': [],\n",
       "    'year': 2021,\n",
       "    'venue': 'Front Psychol',\n",
       "    'volume': '12',\n",
       "    'issn': '',\n",
       "    'pages': None,\n",
       "    'other_ids': {'DOI': ['10.3389/fpsyg.2021.644636']}},\n",
       "   'BIBREF14': {'title': 'Sleep quality during the COVID‐19 pandemic: Not one size fits all',\n",
       "    'authors': [],\n",
       "    'year': 2020,\n",
       "    'venue': 'Sleep Medicine',\n",
       "    'volume': '76',\n",
       "    'issn': '',\n",
       "    'pages': '86-88',\n",
       "    'other_ids': {'DOI': ['10.1016/j.sleep.2020.09.029']}},\n",
       "   'BIBREF15': {'title': 'The PHQ‐9: Validity of a brief depression severity measure',\n",
       "    'authors': [],\n",
       "    'year': 2001,\n",
       "    'venue': 'Journal of General Internal Medicine',\n",
       "    'volume': '16',\n",
       "    'issn': '9',\n",
       "    'pages': '606-613',\n",
       "    'other_ids': {'DOI': ['10.1046/j.1525-1497.2001.016009606.x']}},\n",
       "   'BIBREF16': {'title': 'Nightmares',\n",
       "    'authors': [],\n",
       "    'year': 1993,\n",
       "    'venue': 'Journal of the National Medical Association',\n",
       "    'volume': '85',\n",
       "    'issn': '3',\n",
       "    'pages': '233-235',\n",
       "    'other_ids': {'DOI': []}},\n",
       "   'BIBREF17': {'title': 'Pandemic dreaming: The effect of COVID‐19 on dream imagery, a pilot study',\n",
       "    'authors': [],\n",
       "    'year': 2020,\n",
       "    'venue': 'Dreaming',\n",
       "    'volume': '30',\n",
       "    'issn': '3',\n",
       "    'pages': '222-234',\n",
       "    'other_ids': {'DOI': ['10.1037/drm0000148']}},\n",
       "   'BIBREF18': {'title': 'COVID‐19 pandemic and lockdown: Cause of sleep disruption, depression, somatic pain, and increased screen exposure of office workers and students of India',\n",
       "    'authors': [],\n",
       "    'year': 2020,\n",
       "    'venue': 'Chronobiology International',\n",
       "    'volume': '37',\n",
       "    'issn': '8',\n",
       "    'pages': '1191-1200',\n",
       "    'other_ids': {'DOI': ['10.1080/07420528.2020.1786107']}},\n",
       "   'BIBREF19': {'title': 'Sleep and circadian rhythm in response to the COVID‐19 pandemic',\n",
       "    'authors': [],\n",
       "    'year': 2020,\n",
       "    'venue': 'Canadian Journal of Public Health',\n",
       "    'volume': '111',\n",
       "    'issn': '5',\n",
       "    'pages': '654-657',\n",
       "    'other_ids': {'DOI': ['10.17269/s41997-020-00382-7']}},\n",
       "   'BIBREF20': {'title': 'Dreaming during the Covid‐19 pandemic: Computational assessment of dream reports reveals mental suffering related to fear of contagion',\n",
       "    'authors': [],\n",
       "    'year': 2020,\n",
       "    'venue': 'PLoS ONE',\n",
       "    'volume': '15',\n",
       "    'issn': '11',\n",
       "    'pages': None,\n",
       "    'other_ids': {'DOI': ['10.1371/journal.pone.0242903']}},\n",
       "   'BIBREF21': {'title': 'Frequent nightmares are associated with blunted cortisol awakening response in women',\n",
       "    'authors': [],\n",
       "    'year': 2015,\n",
       "    'venue': 'Physiology & Behavior',\n",
       "    'volume': '147',\n",
       "    'issn': '',\n",
       "    'pages': '233-237',\n",
       "    'other_ids': {'DOI': ['10.1016/j.physbeh.2015.05.001']}},\n",
       "   'BIBREF22': {'title': 'Nightmares: A new neurocognitive model',\n",
       "    'authors': [],\n",
       "    'year': 2007,\n",
       "    'venue': 'Sleep Medicine Reviews',\n",
       "    'volume': '11',\n",
       "    'issn': '4',\n",
       "    'pages': '295-310',\n",
       "    'other_ids': {'DOI': ['10.1016/j.smrv.2007.03.004']}},\n",
       "   'BIBREF23': {'title': 'Nightmares do result in psychophysiological arousal: A multimeasure ambulatory assessment study',\n",
       "    'authors': [],\n",
       "    'year': 2019,\n",
       "    'venue': 'Psychophysiology',\n",
       "    'volume': '56',\n",
       "    'issn': '7',\n",
       "    'pages': None,\n",
       "    'other_ids': {'DOI': ['10.1111/psyp.13366']}},\n",
       "   'BIBREF24': {'title': 'Impact of the novel coronavirus (COVID‐19) pandemic on sleep',\n",
       "    'authors': [],\n",
       "    'year': 2020,\n",
       "    'venue': 'Journal of Thoracic Disease',\n",
       "    'volume': '12',\n",
       "    'issn': 'Suppl 2',\n",
       "    'pages': 'S163-S175',\n",
       "    'other_ids': {'DOI': ['10.21037/jtd-cus-2020-015']}},\n",
       "   'BIBREF25': {'title': 'Increased heartbeat‐evoked potential during REM sleep in nightmare disorder',\n",
       "    'authors': [],\n",
       "    'year': 2019,\n",
       "    'venue': 'NeuroImage Clinical',\n",
       "    'volume': '22',\n",
       "    'issn': '',\n",
       "    'pages': None,\n",
       "    'other_ids': {'DOI': ['10.1016/j.nicl.2019.101701']}},\n",
       "   'BIBREF26': {'title': 'Pandemic dreams: Network analysis of dream content during the COVID‐19 lockdown',\n",
       "    'authors': [],\n",
       "    'year': 2020,\n",
       "    'venue': 'Front Psychol',\n",
       "    'volume': '11',\n",
       "    'issn': '',\n",
       "    'pages': None,\n",
       "    'other_ids': {'DOI': ['10.3389/fpsyg.2020.573961']}},\n",
       "   'BIBREF27': {'title': 'Sleep quality in times of Covid‐19 pandemic',\n",
       "    'authors': [],\n",
       "    'year': 2020,\n",
       "    'venue': 'Sleep Medicine',\n",
       "    'volume': '74',\n",
       "    'issn': '',\n",
       "    'pages': '81-85',\n",
       "    'other_ids': {'DOI': ['10.1016/j.sleep.2020.07.012']}},\n",
       "   'BIBREF28': {'title': 'Effects of acute sleep deprivation on state anxiety levels: A systematic review and meta‐analysis',\n",
       "    'authors': [],\n",
       "    'year': 2016,\n",
       "    'venue': 'Sleep Medicine',\n",
       "    'volume': '24',\n",
       "    'issn': '',\n",
       "    'pages': '109-118',\n",
       "    'other_ids': {'DOI': ['10.1016/j.sleep.2016.07.019']}},\n",
       "   'BIBREF29': {'title': 'The reinterpretation of dreams: an evolutionary hypothesis of the function of dreaming',\n",
       "    'authors': [],\n",
       "    'year': 2000,\n",
       "    'venue': 'The Behavioral and Brain Sciences',\n",
       "    'volume': '23',\n",
       "    'issn': '6',\n",
       "    'pages': '877-901',\n",
       "    'other_ids': {'DOI': ['10.1017/s0140525x00004015']}},\n",
       "   'BIBREF30': {'title': 'Thematic and content analysis of idiopathic nightmares and bad dreams',\n",
       "    'authors': [],\n",
       "    'year': 2014,\n",
       "    'venue': 'Sleep',\n",
       "    'volume': '37',\n",
       "    'issn': '2',\n",
       "    'pages': '409-417',\n",
       "    'other_ids': {'DOI': ['10.5665/sleep.3426']}},\n",
       "   'BIBREF31': {'title': '',\n",
       "    'authors': [],\n",
       "    'year': 2021,\n",
       "    'venue': 'Rêver pendant le confinement. Ce que le rêve nous apprend sur le vécu des françaises et des français',\n",
       "    'volume': '',\n",
       "    'issn': '',\n",
       "    'pages': None,\n",
       "    'other_ids': {'DOI': []}},\n",
       "   'BIBREF32': {'title': 'Pandemic nightmares: Effects on dream activity of the COVID‐19 lockdown in Italy',\n",
       "    'authors': [],\n",
       "    'year': 2021,\n",
       "    'venue': 'Journal of Sleep Research',\n",
       "    'volume': '',\n",
       "    'issn': '',\n",
       "    'pages': None,\n",
       "    'other_ids': {'DOI': ['10.1111/jsr.13300']}},\n",
       "   'BIBREF33': {'title': \"Not so sweet dreams: Adults' quantity, quality, and disruptions of sleep during the initial stages of the COVID‐19 pandemic\",\n",
       "    'authors': [],\n",
       "    'year': 2021,\n",
       "    'venue': 'Sleep Medicine',\n",
       "    'volume': 'S1389‐9457',\n",
       "    'issn': '21',\n",
       "    'pages': None,\n",
       "    'other_ids': {'DOI': ['10.1016/j.sleep.2021.02.028']}},\n",
       "   'BIBREF34': {'title': 'The Mannheim Dream questionnaire (MADRE): Retest reliability, age and gender effects',\n",
       "    'authors': [],\n",
       "    'year': 2014,\n",
       "    'venue': 'International Journal of Dream Research',\n",
       "    'volume': '7',\n",
       "    'issn': '2',\n",
       "    'pages': '141-147',\n",
       "    'other_ids': {'DOI': []}},\n",
       "   'BIBREF35': {'title': 'A brief measure for assessing generalized anxiety disorder: the GAD‐7',\n",
       "    'authors': [],\n",
       "    'year': 2006,\n",
       "    'venue': 'Archives of Internal Medicine',\n",
       "    'volume': '166',\n",
       "    'issn': '10',\n",
       "    'pages': '1092-1097',\n",
       "    'other_ids': {'DOI': ['10.1001/archinte.166.10.1092']}},\n",
       "   'BIBREF36': {'title': 'Nightmares: From anxiety symptom to sleep disorder',\n",
       "    'authors': [],\n",
       "    'year': 2006,\n",
       "    'venue': 'Sleep Medicine Reviews',\n",
       "    'volume': '10',\n",
       "    'issn': '1',\n",
       "    'pages': '19-31',\n",
       "    'other_ids': {'DOI': ['10.1016/j.smrv.2005.06.001']}},\n",
       "   'BIBREF37': {'title': 'Overnight therapy? The role of sleep in emotional brain processing',\n",
       "    'authors': [],\n",
       "    'year': 2009,\n",
       "    'venue': 'Psychological Bulletin',\n",
       "    'volume': '135',\n",
       "    'issn': '5',\n",
       "    'pages': '731-748',\n",
       "    'other_ids': {'DOI': ['10.1037/a0016570']}},\n",
       "   'BIBREF38': {'title': 'Sleep disturbances among medical workers during the outbreak of COVID‐2019',\n",
       "    'authors': [],\n",
       "    'year': 2020,\n",
       "    'venue': 'Occupational Medicine (Oxford, England)',\n",
       "    'volume': '70',\n",
       "    'issn': '5',\n",
       "    'pages': '364-369',\n",
       "    'other_ids': {'DOI': ['10.1093/occmed/kqaa074']}},\n",
       "   'BIBREF39': {'title': 'Suicidal ideation during the COVID‐19 pandemic: The role of insomnia',\n",
       "    'authors': [],\n",
       "    'year': 2020,\n",
       "    'venue': 'Psychiatry Research',\n",
       "    'volume': '290',\n",
       "    'issn': '',\n",
       "    'pages': None,\n",
       "    'other_ids': {'DOI': ['10.1016/j.psychres.2020.113134']}},\n",
       "   'BIBREF40': {'title': 'Changes in sleep duration, timing, and variability during the COVID‐19 pandemic: Large‐scale Fitbit data from 6 major US cities',\n",
       "    'authors': [],\n",
       "    'year': 2021,\n",
       "    'venue': 'Sleep Health',\n",
       "    'volume': '7',\n",
       "    'issn': '3',\n",
       "    'pages': '303-313',\n",
       "    'other_ids': {'DOI': ['10.1016/j.sleh.2021.02.008']}}}},\n",
       " {'paper_id': 'PMC7859284',\n",
       "  'metadata': {'title': 'Keep Your Friends Close, but Your Enemies Closer: Role of Acid Sphingomyelinase During Infection and Host Response',\n",
       "   'authors': [{'first': 'Ha-Yeun',\n",
       "     'middle': [],\n",
       "     'last': 'Chung',\n",
       "     'suffix': '',\n",
       "     'email': None,\n",
       "     'affiliation': {}},\n",
       "    {'first': 'Ralf',\n",
       "     'middle': ['A.'],\n",
       "     'last': 'Claus',\n",
       "     'suffix': '',\n",
       "     'email': None,\n",
       "     'affiliation': {}}]},\n",
       "  'body_text': [{'text': 'During severe infection and sepsis, a stress-responsive enzyme becomes present in circulation, which is known to be essentially involved in membrane repair, internalization of pathogens, maturation of phagolysosomes, and mitochondrial dysfunction. The function of the circulating enzyme is held responsible for rapid and transient formation of the highly bioactive lipid mediator ceramide from the inert membrane constituent sphingomyelin (SM), which is localized at the outer leaflet of cellular membranes. Under physiological conditions, there is a very consequent segregation of the enzyme from its substrate. But why it is important for a better understanding of the pathophysiology of organ dysfunction development, that there is a resolution of the spatial separation? Is there an action of the enzyme for a remote signaling to regulate tissue damage apart from the infectious focus? In this review, we summarize the functions of acid sphingomyelinase in order to contribute to the question whether acid sphingomyelinase (ASM) is our friend or foe in the course of sepsis and severe infection, and further discuss the significance of both, an intended and an unattended inhibition for interpretation of results from preclinical and clinical studies with septic patients.',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Introduction—Why Is Consideration of ASM Important In The Context of Infection and Host Response?',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'The first clear description of an enzymatic activity cleaving SM into ceramide with an acidic pH optimum was given by Gatt (1). Twenty-five years later, the protein was isolated and purified from human urine and biochemically characterized (2). Surprisingly, the urine obtained from patients with peritonitis was identified as a rich source for purifying human acid sphingomyelinase (3), which was at that time used as a reagent for in vitro experimentation of cellular membranes. Tissue, i.e., brain tissue, was also identified as an appropriate starting material useful for purification procedures (4).',\n",
       "    'cite_spans': [{'start': 124,\n",
       "      'end': 125,\n",
       "      'mention': '1',\n",
       "      'ref_id': 'BIBREF0'},\n",
       "     {'start': 241, 'end': 242, 'mention': '2', 'ref_id': 'BIBREF90'},\n",
       "     {'start': 384, 'end': 385, 'mention': '3', 'ref_id': 'BIBREF101'},\n",
       "     {'start': 601, 'end': 602, 'mention': '4', 'ref_id': 'BIBREF112'}],\n",
       "    'section': 'Introduction—Why Is Consideration of ASM Important In The Context of Infection and Host Response?',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'The plasma membrane with an asymmetric distribution of phospho- and sphingolipids as well as lateral segregation of SM and cholesterol has—beyond separating cellular compartments—an important function with respect to signal transduction and a plethora of other essential cellular processes (5, 6). The outer leaflet of plasma membranes is enriched in SM, phosphatidylcholines, and glycosphingolipids, whereas in the inner leaflet phosphatidylinositoles, phosphatidylserine, phosphatidylethanolamines, and phosphatidic acid are abundant (5, 7). Metabolism of SM is the entry point in a unique and highly interconnected universe of sphingolipids with a plethora of compounds differing in physicochemical properties and diverse functions regarding cellular signaling and membrane organization (8). The first step—hydrolysis of SM to ceramides and phosphatidylcholine—is catalyzed by the pacemaking enzyme sphingomyelinase, of which so far five different isoforms are known (8, 9). These sphingomyelinases can be distinguished according to primary structure, triggering of activity, cation dependence, and subcellular localization (10, 11). In this review, we focus on acid sphingomyelinase, which is primarily localized in lysosomes (12). Other sources of ceramide formation (de novo synthesis, synthesis from sphingosine and fatty acid, as well as hydrolysis of glucosylated or phosphorylated specimen) are playing a minor role during stress response and severe infection (13). A short overview on in vitro determination of ASM activity is given in Box 1.',\n",
       "    'cite_spans': [{'start': 291,\n",
       "      'end': 292,\n",
       "      'mention': '5',\n",
       "      'ref_id': 'BIBREF123'},\n",
       "     {'start': 294, 'end': 295, 'mention': '6', 'ref_id': 'BIBREF134'},\n",
       "     {'start': 537, 'end': 538, 'mention': '5', 'ref_id': 'BIBREF123'},\n",
       "     {'start': 540, 'end': 541, 'mention': '7', 'ref_id': 'BIBREF145'},\n",
       "     {'start': 791, 'end': 792, 'mention': '8', 'ref_id': 'BIBREF156'},\n",
       "     {'start': 971, 'end': 972, 'mention': '8', 'ref_id': 'BIBREF156'},\n",
       "     {'start': 974, 'end': 975, 'mention': '9', 'ref_id': 'BIBREF167'},\n",
       "     {'start': 1128, 'end': 1130, 'mention': '10', 'ref_id': 'BIBREF1'},\n",
       "     {'start': 1132, 'end': 1134, 'mention': '11', 'ref_id': 'BIBREF12'},\n",
       "     {'start': 1231, 'end': 1233, 'mention': '12', 'ref_id': 'BIBREF23'},\n",
       "     {'start': 1471, 'end': 1473, 'mention': '13', 'ref_id': 'BIBREF34'}],\n",
       "    'section': 'ASM Profile ::: ASM is Our Buddy',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Almost 30 years ago (1991), the full sequence of ASM was firstly described (14, 15). The genetic locus was identified on the short arm of chromosome 11 (15), interestingly in close proximity to the locus of other lysosomal proteins such as cathepsin D and acid phosphatase (13). The sequence of ASM is highly conserved among mammals (16) and the ASM locus [systematically sphingomyelin phosphodiesterase 1 (SMPD1)] is undergoing epigenetic regulation by paternal imprinting (17). During protein synthesis, ASM undergoes extensive posttranslational modification. In this process, glycosylation at all of the six potential sites is of major importance to ensure correct folding, sorting, and/or proper stability within the proteolytic milieu of the lysosome (18, 19). By mannose-6-phosphate-receptor shuttling, the protein is transported via the endosomal system to its final destination, the lysosome (20).',\n",
       "    'cite_spans': [{'start': 76,\n",
       "      'end': 78,\n",
       "      'mention': '14',\n",
       "      'ref_id': 'BIBREF45'},\n",
       "     {'start': 80, 'end': 82, 'mention': '15', 'ref_id': 'BIBREF56'},\n",
       "     {'start': 153, 'end': 155, 'mention': '15', 'ref_id': 'BIBREF56'},\n",
       "     {'start': 274, 'end': 276, 'mention': '13', 'ref_id': 'BIBREF34'},\n",
       "     {'start': 334, 'end': 336, 'mention': '16', 'ref_id': 'BIBREF67'},\n",
       "     {'start': 475, 'end': 477, 'mention': '17', 'ref_id': 'BIBREF78'},\n",
       "     {'start': 757, 'end': 759, 'mention': '18', 'ref_id': 'BIBREF88'},\n",
       "     {'start': 761, 'end': 763, 'mention': '19', 'ref_id': 'BIBREF89'},\n",
       "     {'start': 901, 'end': 903, 'mention': '20', 'ref_id': 'BIBREF91'}],\n",
       "    'section': 'ASM Profile ::: ASM is Our Buddy',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Along the primary subcellular localization, the purified protein favors an optimum pH around 5.0, but sphingolytic activity is retained also at neutral pH (21): regarding parameter of enzymatic activity, despite the pH shift up to 7.45, the maximum turnover velocity (vmax) remains constant (22, 23). The decrease in affinity to the substrate (Km) is of no relevance due to the enormous excess of SM at the outer leaflet of cell membranes (24, 25). The persistence of enzymatic activity at neutral pH values is of great importance as discussed later.',\n",
       "    'cite_spans': [{'start': 156,\n",
       "      'end': 158,\n",
       "      'mention': '21',\n",
       "      'ref_id': 'BIBREF92'},\n",
       "     {'start': 292, 'end': 294, 'mention': '22', 'ref_id': 'BIBREF93'},\n",
       "     {'start': 296, 'end': 298, 'mention': '23', 'ref_id': 'BIBREF94'},\n",
       "     {'start': 440, 'end': 442, 'mention': '24', 'ref_id': 'BIBREF95'},\n",
       "     {'start': 444, 'end': 446, 'mention': '25', 'ref_id': 'BIBREF96'}],\n",
       "    'section': 'ASM Profile ::: ASM is Our Buddy',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'In vitro experiments showed us that enzyme activity is also dependent on lipid environment (26) and addition of a detergent in order to overcome dependence from activation by specific proteins (26). Sensitivity to reducing agents such as dithiothreitol is underlining the relevance of disulfide bridges within the mature protein structure for hydrolyzing activity (27, 28).',\n",
       "    'cite_spans': [{'start': 92,\n",
       "      'end': 94,\n",
       "      'mention': '26',\n",
       "      'ref_id': 'BIBREF97'},\n",
       "     {'start': 194, 'end': 196, 'mention': '26', 'ref_id': 'BIBREF97'},\n",
       "     {'start': 365, 'end': 367, 'mention': '27', 'ref_id': 'BIBREF98'},\n",
       "     {'start': 369, 'end': 371, 'mention': '28', 'ref_id': 'BIBREF99'}],\n",
       "    'section': 'ASM Profile ::: ASM is Our Buddy',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Resolving the crystal structure of mammalian ASM (with 88% identity to the human protein) confirmed that ASM-mediated hydrolysis of SM is functioning in a canonical mechanism, where phosphoesterases are utilizing a nucleophilic attack of a zinc (Zn++)-activated water molecule and protonation of the leaving group for release of phosphocholine and ceramide (29). Two saposin domains are relevant for determination and stabilization of either a closed or open conformation of the enzyme. In the latter one, the enzyme is able to bind and dock to membranes, and extract SM therefrom for subsequent hydrolysis (29). Direct inhibitors of the enzyme (i.e., bisphosphonic acid derivatives) are competing with Zn++ binding within the active center (29). A short overview on milestones in translational research regarding ASM activity is given in Table 1.',\n",
       "    'cite_spans': [{'start': 358,\n",
       "      'end': 360,\n",
       "      'mention': '29',\n",
       "      'ref_id': 'BIBREF100'},\n",
       "     {'start': 608, 'end': 610, 'mention': '29', 'ref_id': 'BIBREF100'},\n",
       "     {'start': 742, 'end': 744, 'mention': '29', 'ref_id': 'BIBREF100'}],\n",
       "    'section': 'ASM Profile ::: ASM is Our Buddy',\n",
       "    'ref_spans': [{'start': 839,\n",
       "      'end': 846,\n",
       "      'mention': 'Table 1',\n",
       "      'ref_id': 'TABREF0'}]},\n",
       "   {'text': 'Under physiological conditions, ASM is fulfilling essential house-keeping functions in the lysosomes, whereas genetic deficiency leads to extensive accumulation and deposition of SM resulting in organ abnormalities as described in Niemann-Pick disease (NBD), types A and B (30). The moment of glory has come to ASM as soon as response to external or internal signals of stress is much needed. Since ceramide generation is the common final pathway of most stressors, the panel of ASM stimulators in a large variety of cell types goes far beyond those previously described for any other molecular switch of the SM pathway and are summarized in Table 2. Activation of the ASM-sensitive pathway leads to a rapid and transient translocation of the enzyme toward the cell membrane ranging from seconds to hours (60, 61).',\n",
       "    'cite_spans': [{'start': 274,\n",
       "      'end': 276,\n",
       "      'mention': '30',\n",
       "      'ref_id': 'BIBREF102'},\n",
       "     {'start': 806, 'end': 808, 'mention': '60', 'ref_id': 'BIBREF135'},\n",
       "     {'start': 810, 'end': 812, 'mention': '61', 'ref_id': 'BIBREF136'}],\n",
       "    'section': 'ASM Profile ::: ASM is Our Buddy',\n",
       "    'ref_spans': [{'start': 642,\n",
       "      'end': 649,\n",
       "      'mention': 'Table 2',\n",
       "      'ref_id': 'TABREF1'}]},\n",
       "   {'text': 'In order to highlight the importance of ceramide generation in the course of a severe systemic disease, it is noteworthy that ASM-deficient fibroblasts or mice are resistant to radiation-induced cell death (57). In addition, specific ceramide-binding antibodies rescued mice from lethal radiation gastrointestinal syndrome by preventing signaling platform formation (see below) and inhibition of endothelial cell death (62).',\n",
       "    'cite_spans': [{'start': 207,\n",
       "      'end': 209,\n",
       "      'mention': '57',\n",
       "      'ref_id': 'BIBREF131'},\n",
       "     {'start': 420, 'end': 422, 'mention': '62', 'ref_id': 'BIBREF137'}],\n",
       "    'section': 'ASM Profile ::: ASM is Our Buddy',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'ASM is essential for proper fusion of late phagosomes with lysosomes, which is crucial for efficient transfer of lysosomal antibacterial hydrolases into phagosomes (63, 64). A significant role of ASM in the phagolysosomal compartment for the defense against infection with intracellular pathogens was shown by a dramatically increased susceptibility to Listeria monocytogenes in ASM-deficient mice (ASMKO). Although ASM-deficient immune cells showed intact production of reactive nitrogen intermediates and oxidative burst, they are completely incapable of restricting and controlling the intracellular growth of L. monocytogenes in vitro (65). Similar findings were obtained from mouse peritoneal macrophages infected with the obligate intracellular protozoan, Leishmania donovani. Increase of intracellular ceramide was not only a consequence of ASM-triggered activity but also from de novo synthesis, which resulted in upregulation of Ca++-independent atypical protein kinase C (PKC)-ζ. Surprisingly, suppression of formation of reactive nitrogen species (i.e., nitric oxide) facilitated the survival of leishmanial parasites in the intramacrophageal milieu (66).',\n",
       "    'cite_spans': [{'start': 165,\n",
       "      'end': 167,\n",
       "      'mention': '63',\n",
       "      'ref_id': 'BIBREF138'},\n",
       "     {'start': 169, 'end': 171, 'mention': '64', 'ref_id': 'BIBREF139'},\n",
       "     {'start': 640, 'end': 642, 'mention': '65', 'ref_id': 'BIBREF140'},\n",
       "     {'start': 1162, 'end': 1164, 'mention': '66', 'ref_id': 'BIBREF141'}],\n",
       "    'section': 'Maturation of Phagolysosome, Translocation, and Role in Raft Modeling ::: ASM is Our Buddy',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Accumulation of reactive oxygen species (ROS), as a consequence of altered redox status followed by ASM activation, ceramide generation, and subsequent clustering of CD95 in ceramide-enriched lipid rafts is a common and early event in neutrophil apoptosis, which are abundant, and short-lived leukocytes. Their death by apoptosis is central to hemostasis and the resolution of inflammation (67).',\n",
       "    'cite_spans': [{'start': 391,\n",
       "      'end': 393,\n",
       "      'mention': '67',\n",
       "      'ref_id': 'BIBREF142'}],\n",
       "    'section': 'Maturation of Phagolysosome, Translocation, and Role in Raft Modeling ::: ASM is Our Buddy',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'In 1996, Tabas et al. described an additional, plasma-secreted, circulating product of the sphingomyelin phosphodiesterase 1 (SMPD1) gene with a similar glycosylation pattern, but increased dependency and susceptibility to Zn++ ions (31, 68). Differential protein trafficking was held responsible for the regularly observed activity increase in men, mice, and cell culture experiments upon stimulation, but the underlying mechanisms remain unknown. There is an ongoing debate on the origin of the ASM isoform circulating in plasma, since the mechanisms for a differentiated intracellular trafficking upon stimulation are hard to explain. Phosphorylation of serine residue 508 (S508) by PKC-δ upon stimulation with phorbol ester or UV light was considered to be essential for activation and translocation (35). But to the best of our knowledge, there is no evidence of phosphorylated ASM in disease models or clinical samples.',\n",
       "    'cite_spans': [{'start': 234,\n",
       "      'end': 236,\n",
       "      'mention': '31',\n",
       "      'ref_id': 'BIBREF103'},\n",
       "     {'start': 238, 'end': 240, 'mention': '68', 'ref_id': 'BIBREF143'},\n",
       "     {'start': 805, 'end': 807, 'mention': '35', 'ref_id': 'BIBREF107'}],\n",
       "    'section': 'Extralysosomal Activity—Circulation in Plasma? ::: ASM is Our Buddy',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'However, recent studies with the protozoan parasite Trypanosoma cruzi revealed that conventional lysosomes are regularly fusing with the plasma membrane in response to increased intracellular Ca++ concentration with subsequent triggering of exocytosis (69) and release of the intralysosomal content to the extracellular space, eventually also into circulation. As a result, exocytosed ASM is capable to act at the outer leaflet of the membrane. This mechanism is thought to define the role of extracellular ASM as well as to represent the major source of extracellular form of the protein (38). The findings, that a plethora of harmful, stress/injury-triggering events induced lysosomal exocytosis including interaction with pathogens (59, 70, 71) offers a plausible perspective of the possible origin of extracellular and circulating ASM activity without any need for postulating differential trafficking (38). An overview on ASM release as a feature of stress response is given in Figure 1.',\n",
       "    'cite_spans': [{'start': 253,\n",
       "      'end': 255,\n",
       "      'mention': '69',\n",
       "      'ref_id': 'BIBREF144'},\n",
       "     {'start': 590, 'end': 592, 'mention': '38', 'ref_id': 'BIBREF110'},\n",
       "     {'start': 736, 'end': 738, 'mention': '59', 'ref_id': 'BIBREF133'},\n",
       "     {'start': 740, 'end': 742, 'mention': '70', 'ref_id': 'BIBREF146'},\n",
       "     {'start': 744, 'end': 746, 'mention': '71', 'ref_id': 'BIBREF147'},\n",
       "     {'start': 907, 'end': 909, 'mention': '38', 'ref_id': 'BIBREF110'}],\n",
       "    'section': 'Extralysosomal Activity—Circulation in Plasma? ::: ASM is Our Buddy',\n",
       "    'ref_spans': [{'start': 983,\n",
       "      'end': 991,\n",
       "      'mention': 'Figure 1',\n",
       "      'ref_id': 'FIGREF0'}]},\n",
       "   {'text': 'Exposition of immune cells to ROS resulted also in a rapid and transient, Ca++-dependent translocation of ASM to the outer leaflet of cellular membranes—mediated by exocytosis of lysosomes—and formation of ceramide-enriched platforms (59). On the other hand, these microdomains are required for Pseudomonas aeruginosa-induced activation of NADPH oxidase and production of ROS, demonstrating a positive feedback mechanism for amplification of ASM-mediated redox signaling (43).',\n",
       "    'cite_spans': [{'start': 235,\n",
       "      'end': 237,\n",
       "      'mention': '59',\n",
       "      'ref_id': 'BIBREF133'},\n",
       "     {'start': 472, 'end': 474, 'mention': '43', 'ref_id': 'BIBREF116'}],\n",
       "    'section': 'Extralysosomal Activity—Circulation in Plasma? ::: ASM is Our Buddy',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'On a molecular level, the generation of ceramide is an integral part of intrinsic repair mechanisms following perforation of the plasmalemma by pathogenic pore-forming toxins, whereby lysosomes fuse with the plasma membrane. Hereby, lysosomes externalize their contents including acid sphingomyelinase and facilitate exposure to the abundant SM at the outer membrane bilayer (70, 72). Subsequent formation of ceramide-enriched, topically restricted domains in the outer leaflet of the lipid bilayer is an essential step contributing to tighter packing of the membrane, forwarding a negative curvature and inward vesiculation of the damaged area. At the end, the resulting internal degradation contributes to cellular integrity and survival (72, 73), e.g., after exposition of cells toward listeriolysin O or pneumolysin (74).',\n",
       "    'cite_spans': [{'start': 376,\n",
       "      'end': 378,\n",
       "      'mention': '70',\n",
       "      'ref_id': 'BIBREF146'},\n",
       "     {'start': 380, 'end': 382, 'mention': '72', 'ref_id': 'BIBREF148'},\n",
       "     {'start': 741, 'end': 743, 'mention': '72', 'ref_id': 'BIBREF148'},\n",
       "     {'start': 745, 'end': 747, 'mention': '73', 'ref_id': 'BIBREF149'},\n",
       "     {'start': 821, 'end': 823, 'mention': '74', 'ref_id': 'BIBREF150'}],\n",
       "    'section': 'Extralysosomal Activity—Circulation in Plasma? ::: ASM is Our Buddy',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'In cultured immune cells, exposure to endotoxin led to activation of ASM, generation of ceramide, phosphorylation of PKC-ζ, assembly of Toll-like receptor 4 (TLR4) within lipid rafts, activation of the stress-responsive kinases, and release of tumor necrosis factor-α (TNF-α). These pathogenetic mechanisms could be abrogated by CD14 blockade or inhibition of ASM but reversed by treatment with the central effector molecule ceramide (51). In addition to other proteins associated with the lipid raft, ASM is contributing to TLR4 signaling triggered by endotoxin and non-microbial endogenous ligands (75) (Figure 1).',\n",
       "    'cite_spans': [{'start': 435,\n",
       "      'end': 437,\n",
       "      'mention': '51',\n",
       "      'ref_id': 'BIBREF125'},\n",
       "     {'start': 601, 'end': 603, 'mention': '75', 'ref_id': 'BIBREF151'}],\n",
       "    'section': 'Microdomain Formation, Protein Organization, and Ceramide Signaling ::: ASM is Our Buddy',\n",
       "    'ref_spans': [{'start': 606,\n",
       "      'end': 614,\n",
       "      'mention': 'Figure 1',\n",
       "      'ref_id': 'FIGREF0'}]},\n",
       "   {'text': 'Moreover, ASM is involved in most effective host membrane remodeling during enteropathogenic infection with Shigella spp. resulting in decreased binding of pathogens to epithelial cells and therefore, impeding abovementioned or other pathogens from reinfection, which was proposed as a novel stress-responsive cell-autonomous defense mechanism (76).',\n",
       "    'cite_spans': [{'start': 345,\n",
       "      'end': 347,\n",
       "      'mention': '76',\n",
       "      'ref_id': 'BIBREF152'}],\n",
       "    'section': 'Microdomain Formation, Protein Organization, and Ceramide Signaling ::: ASM is Our Buddy',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'In concert with the endogenous danger signal adenosine triphosphate (ATP), ASM is involved in secretion of membrane TNF-α within microvesicles bypassing conventional pathways. These cytokine-carrying microvesicles are biologically more potent than soluble TNF-α in vivo, evolving significant lung inflammation in mice, which might have crucial implications for the biological activity of this prototypically proinflammatory cytokine (77).',\n",
       "    'cite_spans': [{'start': 434,\n",
       "      'end': 436,\n",
       "      'mention': '77',\n",
       "      'ref_id': 'BIBREF153'}],\n",
       "    'section': 'Microdomain Formation, Protein Organization, and Ceramide Signaling ::: ASM is Our Buddy',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Beyond the membrane reorganizing capacities (78), ceramides also act as second messengers transducing cellular signals (79). These functions widely differ among the diverse cell types, ranging from induction of senescence to apoptosis. As an example, the role of ceramide generation and the function of generated ceramides in mitochondria were extensively studied (80): organelle-specific accumulation of ceramide is critically involved in progression of mitochondrial apoptosis and mitophagy, defining ceramides as a bona fide transducer of mitochondrial (dys-)function [excellently reviewed in (80) and references cited therein].',\n",
       "    'cite_spans': [{'start': 45,\n",
       "      'end': 47,\n",
       "      'mention': '78',\n",
       "      'ref_id': 'BIBREF154'},\n",
       "     {'start': 120, 'end': 122, 'mention': '79', 'ref_id': 'BIBREF155'},\n",
       "     {'start': 365, 'end': 367, 'mention': '80', 'ref_id': 'BIBREF157'},\n",
       "     {'start': 597, 'end': 599, 'mention': '80', 'ref_id': 'BIBREF157'}],\n",
       "    'section': 'Ceramide as Second Messenger ::: ASM is Our Buddy',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'In the next paragraphs, consequences of ASM depletion in the course of local or systemic infections with the presentation of interesting phenotypes will be discussed. In 1995, the generation of ASM-deficient mice was of great value for studying the pathogenesis and treatment not only of type A/B-Niemann-Pick disease (see below) but also for investigations into the role of ASM in ceramide signaling, induction of apoptosis, and ceramide-induced tissue damage (33).',\n",
       "    'cite_spans': [{'start': 462,\n",
       "      'end': 464,\n",
       "      'mention': '33',\n",
       "      'ref_id': 'BIBREF105'}],\n",
       "    'section': 'Ceramide as Second Messenger ::: ASM is Our Buddy',\n",
       "    'ref_spans': []},\n",
       "   {'text': \"Mice, genetically lacking ASM (33), showed an exaggerated response to polymicrobial sepsis with an increased bacterial burden, an enhanced phagocytotic activity, a more pronounced cytokine storm and decreased survival rate (81). Moreover, on a functional level, leukocyte-endothelial interaction was found diminished in ASMKO animals corresponding to a distinct leukocytes' phenotype with respect to rolling and sticking as well as expression of cellular surface proteins (81). A similar phenotype was found in cultivated lung epithelial cells with controlled ASM activity, where increased neutrophil recruitment, elevated levels of cytokine mRNA, and a pro-oxidative shift could be observed (82).\",\n",
       "    'cite_spans': [{'start': 31,\n",
       "      'end': 33,\n",
       "      'mention': '33',\n",
       "      'ref_id': 'BIBREF105'},\n",
       "     {'start': 224, 'end': 226, 'mention': '81', 'ref_id': 'BIBREF158'},\n",
       "     {'start': 473, 'end': 475, 'mention': '81', 'ref_id': 'BIBREF158'},\n",
       "     {'start': 693, 'end': 695, 'mention': '82', 'ref_id': 'BIBREF159'}],\n",
       "    'section': 'Hyperresponsiveness ::: ASM is Our Buddy',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Moreover, the availability of ASMKO mice provides the opportunity of a better understanding of ceramide generation for immune response on a molecular level. In a fundamental experimental setting, injection of endotoxin and its putative effector TNF-α, into mice induced disseminated apoptosis in endothelium of intestine, lung, fat tissue, and thymus accompanied with cytokine release and ceramide increase. This endothelial cell death was ASM dependent, since ASMKO mice were protected against endothelial apoptosis and animal death (83).',\n",
       "    'cite_spans': [{'start': 535,\n",
       "      'end': 537,\n",
       "      'mention': '83',\n",
       "      'ref_id': 'BIBREF160'}],\n",
       "    'section': 'Hyperresponsiveness ::: ASM is Our Buddy',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'In mice and men, complete loss of function of ASM resulted in a diminished CD1d-restricted antigen presentation of invariant natural killer cells (iNKT), decreased levels of this cell population and resistance to iNKT cell-mediated inflammatory conditions, supporting the concept of a tight link between cellular sphingolipid metabolism and immunity (84).',\n",
       "    'cite_spans': [{'start': 351,\n",
       "      'end': 353,\n",
       "      'mention': '84',\n",
       "      'ref_id': 'BIBREF161'}],\n",
       "    'section': 'Hyperresponsiveness ::: ASM is Our Buddy',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Niemann-Pick disease (types A and B) is an autosomal recessive lysosomal storage disorder caused by biallelic mutations in the SMPD1 gene resulting in a severe human disease state characterized by deficient ASM activity (85). A recent study reported around 185 mutations with ASM-deficient NPD worldwide (86), while the detection of new mutations is not yet completed (87). The majority of mutations are predicted to affect proper folding, stability, as well as membrane binding of the enzyme (29). Type B patients are characterized by hepatosplenomegaly and progressive alterations of the respiratory system, but the central nervous system is usually less affected, which is more profound in type A, resulting in early death (~2 years of age) (85). Lung involvement is the most important prognostic factor in NPD-B, with recurrent respiratory infections starting in infancy being the major cause of morbidity and mortality (82, 88, 89). In lung epithelial cells, decreasing ASM activity by 50% leads to an increased neutrophil recruitment via elevated levels of cytokine expression, both at baseline and in response to bacterial stimulation. Instead of preventing the host defense responses, decreased ASM activity results in an inflammatory response even in the absence of infection supporting the hypothesis of a chronic inflammatory state impairing host defense mechanisms (82). Despite the low incidence of progressive pulmonary disease in a cohort of more than 100 patients diagnosed with NPD-B, pneumonia was the leading cause of death of juvenile patients (<21 years) (90, 91). On the one hand, pathophysiology of the pulmonary disease is presumably related to the accumulation of SM in alveolar macrophages, on the other hand, inflammation, abnormal surfactant catabolism, as well as composition contributing to lung abnormalities was shown in ASMKO mice (92, 93). In parallel, endogenous lipid pneumonia, interstitial fibrosis, and accumulation of foamy macrophages were found in human lung biopsies (94) supporting the hypothesis that the lung is a primarily affected organ of NPD-B contributing to morbidity and mortality (90, 95).',\n",
       "    'cite_spans': [{'start': 221,\n",
       "      'end': 223,\n",
       "      'mention': '85',\n",
       "      'ref_id': 'BIBREF162'},\n",
       "     {'start': 305, 'end': 307, 'mention': '86', 'ref_id': 'BIBREF163'},\n",
       "     {'start': 369, 'end': 371, 'mention': '87', 'ref_id': 'BIBREF164'},\n",
       "     {'start': 494, 'end': 496, 'mention': '29', 'ref_id': 'BIBREF100'},\n",
       "     {'start': 745, 'end': 747, 'mention': '85', 'ref_id': 'BIBREF162'},\n",
       "     {'start': 925, 'end': 927, 'mention': '82', 'ref_id': 'BIBREF159'},\n",
       "     {'start': 929, 'end': 931, 'mention': '88', 'ref_id': 'BIBREF165'},\n",
       "     {'start': 933, 'end': 935, 'mention': '89', 'ref_id': 'BIBREF166'},\n",
       "     {'start': 1378, 'end': 1380, 'mention': '82', 'ref_id': 'BIBREF159'},\n",
       "     {'start': 1577, 'end': 1579, 'mention': '90', 'ref_id': 'BIBREF168'},\n",
       "     {'start': 1581, 'end': 1583, 'mention': '91', 'ref_id': 'BIBREF169'},\n",
       "     {'start': 1865, 'end': 1867, 'mention': '92', 'ref_id': 'BIBREF170'},\n",
       "     {'start': 1869, 'end': 1871, 'mention': '93', 'ref_id': 'BIBREF171'},\n",
       "     {'start': 2011, 'end': 2013, 'mention': '94', 'ref_id': 'BIBREF172'},\n",
       "     {'start': 2135, 'end': 2137, 'mention': '90', 'ref_id': 'BIBREF168'},\n",
       "     {'start': 2139, 'end': 2141, 'mention': '95', 'ref_id': 'BIBREF173'}],\n",
       "    'section': 'Pneumonia in ASM-Deficient Patients ::: ASM is Our Buddy',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'In a brief summary of this section, ASM is a highly conserved stress-responsive enzyme, activity of which is triggered by a variety of harmful events including infection and inflammation. As a key consequence of activation, there is a disorganization of the previously strict segregation of the enzyme (located in the lysosome) and the corresponding substrate (SM in the outer leaflet of cellular membranes). Besides switching the current pH status by two orders of magnitudes, the enzyme is capable of rapid and transient ceramide formation upon activation. The resulting self-aggregation of ceramide molecules is reorganizing cellular membranes. Now it is time to put this critical event of signal amplification as a general mechanism into the scene of stress response, membrane repair, oxidative stress, proper maturation of phagolysosomes, and regulation of host defense against invading pathogens. As our buddy—keeping us well and fine by its integration in imperative actions of life—the enzyme and its regulation of translocation and activity received also value for further elucidation with respect to pathophysiology and pathogenesis of a series of diseases.',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Pneumonia in ASM-Deficient Patients ::: ASM is Our Buddy',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Non-human sphingomyelinases are essential factors for virulence of extracellular, facultative, or obligate intracellular pathogens. These enzymes contribute to phagosomal escape or phagosomal maturation avoidance and even immune response evasion (96). Whether the activity profile of these prokaryotic proteins contribute to the analyzed hydrolysis rate of SM to ceramide in conventional assays in samples obtained from patients with blood stream infection (Box 1) is still discussed controversially. Some prominent and representative mechanistic approaches are shown here in an exemplary manner.',\n",
       "    'cite_spans': [{'start': 247,\n",
       "      'end': 249,\n",
       "      'mention': '96',\n",
       "      'ref_id': 'BIBREF174'}],\n",
       "    'section': 'Invasion of Pathogens ::: ASM is A Dubious Friend',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Infections by Staphylococcus aureus are a major clinical problem ranging from mild infections (skin and soft-tissue) to severe and even lethal infections (e.g., pneumonia, endocarditis, sepsis, osteomyelitis, etc.). S. aureus stimulates ASM via CD44-triggered release of ROS, resulting in ceramide release, clustering of CD44 in ceramide-enriched membrane platforms, co-activation of GTPases, and translocation of linker proteins with subsequent rapid rearrangement of the cytoskeleton. In the absence of either CD44 or ASM, reduced internalization of macrophages is counteracted by a reduced killing capacity (44).',\n",
       "    'cite_spans': [{'start': 611,\n",
       "      'end': 613,\n",
       "      'mention': '44',\n",
       "      'ref_id': 'BIBREF117'}],\n",
       "    'section': 'Invasion of Pathogens ::: ASM is A Dubious Friend',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'A major toxin of S. aureus (α-toxin) caused in bone marrow-derived macrophages ASM-dependent ceramide formation, release of cathepsin B and D from lysosomes, inflammasome activation, and induction of pro-inflammatory cytokines, which could be abrogated by pharmacological ASM-inhibition (45). In in vitro experiments with endothelial cells, ASM activation by α-toxin was linked to degradation of tight junctions, which could be blocked by pharmacological inhibition. However, most importantly, in in vivo experiments, genetic deficiency prevented severe degradation of tight junctions in the lung and edema formation (46). Combination of antibiotic treatment and ASM inhibition are proposed to exhibit synergistic and super-additive effects (47).',\n",
       "    'cite_spans': [{'start': 288,\n",
       "      'end': 290,\n",
       "      'mention': '45',\n",
       "      'ref_id': 'BIBREF118'},\n",
       "     {'start': 618, 'end': 620, 'mention': '46', 'ref_id': 'BIBREF119'},\n",
       "     {'start': 742, 'end': 744, 'mention': '47', 'ref_id': 'BIBREF120'}],\n",
       "    'section': 'Invasion of Pathogens ::: ASM is A Dubious Friend',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Inflammasomes are important for host defense against invading pathogens; ASM activation is critically involved in the activation of endothelial inflammasomes including recruitment of adapter proteins and caspases (97–99) and subsequent oxidative signaling by lipid raft-associated redox platforms, release of cytokines, activation of stress kinases, and altering tight junctions in epithelial cells (45).',\n",
       "    'cite_spans': [{'start': 214,\n",
       "      'end': 216,\n",
       "      'mention': '97',\n",
       "      'ref_id': 'BIBREF175'},\n",
       "     {'start': 217, 'end': 219, 'mention': '99', 'ref_id': 'BIBREF177'},\n",
       "     {'start': 400, 'end': 402, 'mention': '45', 'ref_id': 'BIBREF118'}],\n",
       "    'section': 'Invasion of Pathogens ::: ASM is A Dubious Friend',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'For exposition of proteins, non-enveloped viruses undergo partial uncoating in order to get access to the cytoplasm by membrane lysis. Cellular ASM is a critical player in this process, since ASM is induced and hijacked by mimicking wound removal processes facilitating the adenovirus further membrane disruption and infection. In addition, stimulation of Ca++ influx and lysosomal exocytosis are key steps for efficient membrane penetration of the virus (71). Most recently, influenza A virus infection was found to be associated with suppression of ASM activity in cultured alveolar epithelial cells, whereby depletion of SM content either in the epithelial membrane or in the virus envelope impaired virus infection and reduced virus entry as well as reduced virus infectivity and impaired its attachment and internalization, respectively. Inhibition of ASM by desipramine did not affect influenza virus infection (100), which is in line with the observation that ceramide generated by de novo synthesis might play an antiviral role (101).',\n",
       "    'cite_spans': [{'start': 456,\n",
       "      'end': 458,\n",
       "      'mention': '71',\n",
       "      'ref_id': 'BIBREF147'},\n",
       "     {'start': 918, 'end': 921, 'mention': '100', 'ref_id': 'BIBREF2'},\n",
       "     {'start': 1037, 'end': 1040, 'mention': '101', 'ref_id': 'BIBREF3'}],\n",
       "    'section': 'Invasion of Pathogens ::: ASM is A Dubious Friend',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'For meningococcal internalization into brain endothelial cells, transient ASM activation and ceramide release are also determinative factors for invasiveness among a defined set of pathogenic isolates of Neisseria meningitidis (102).',\n",
       "    'cite_spans': [{'start': 228,\n",
       "      'end': 231,\n",
       "      'mention': '102',\n",
       "      'ref_id': 'BIBREF4'}],\n",
       "    'section': 'Invasion of Pathogens ::: ASM is A Dubious Friend',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'In the pathogenesis of cystic fibrosis, abrogation of ceramide accumulation by inhaled functional inhibitor of ASM (FIASMA, see below) restored normal ceramide concentrations in murine bronchial epithelial cells, reduced age-dependent pulmonary inflammation and deposits of DNA in bronchi, as well as prevented infection with P. aeruginosa (103, 104). ASM activation (by endotoxin) and subsequent ceramide formation play a pivotal role in Escherichia coli-induced apoptosis of immature dendritic cells, a phenomenon contributing to sepsis-induced immunosuppression (105). In liver specimen, inhibition of activity in endotoxin challenged mice correlated with a reduced rate of hepatocellular apoptosis (34).',\n",
       "    'cite_spans': [{'start': 341,\n",
       "      'end': 344,\n",
       "      'mention': '103',\n",
       "      'ref_id': 'BIBREF5'},\n",
       "     {'start': 346, 'end': 349, 'mention': '104', 'ref_id': 'BIBREF6'},\n",
       "     {'start': 566, 'end': 569, 'mention': '105', 'ref_id': 'BIBREF7'},\n",
       "     {'start': 703, 'end': 705, 'mention': '34', 'ref_id': 'BIBREF106'}],\n",
       "    'section': 'Invasion of Pathogens ::: ASM is A Dubious Friend',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'It is also known that ceramide-containing microparticles in packed red blood cells contribute to adverse effects following transfusion, which was abrogated by treatment with a FIASMA during storage time (106).',\n",
       "    'cite_spans': [{'start': 204,\n",
       "      'end': 207,\n",
       "      'mention': '106',\n",
       "      'ref_id': 'BIBREF8'}],\n",
       "    'section': 'Invasion of Pathogens ::: ASM is A Dubious Friend',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'ASM activation is a critical factor for redirection of TNF-α trafficking, thus the cytokine is embedded in microvesicles bypassing conventional pathways in a highly potent manner. Rerouting has crucial implications for the activity profile of the pacemaker cytokine of inflammation, inducing a significant TNF-dependent inflammation status and allowing long-range TNF signaling to target cells more effectively than soluble TNF, which is of particular interest therapeutically targeting TNF in acute inflammatory diseases (77).',\n",
       "    'cite_spans': [{'start': 523,\n",
       "      'end': 525,\n",
       "      'mention': '77',\n",
       "      'ref_id': 'BIBREF153'}],\n",
       "    'section': 'Invasion of Pathogens ::: ASM is A Dubious Friend',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Endotoxin challenge in mice resulted in a mild, 2-fold increase of ASM plasma activity, which was accompanied by release of cytokines (107). These data were confirmed by a similar observation of an increase of ceramide content in lipoproteins paralleled by an increased activity of circulating ASM (108).',\n",
       "    'cite_spans': [{'start': 135,\n",
       "      'end': 138,\n",
       "      'mention': '107',\n",
       "      'ref_id': 'BIBREF9'},\n",
       "     {'start': 299, 'end': 302, 'mention': '108', 'ref_id': 'BIBREF10'}],\n",
       "    'section': 'Marker and Mediator in Sepsis and Pneumonia ::: ASM is A Dubious Friend',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Intratracheal administration of an ASM inhibitor in a model of acute lung injury improved lung function and decreased pulmonary inflammation (109). In critically ill preterm infants with acute lung injury, beyond other markers and mediators, ASM activity was found to be increased in tracheal aspirates (110). Inhibition of NF-κB function attenuated pulmonary inflammation of acute respiratory distress syndrome in a neonatal piglet model with decreased leukocyte concentrations in bronchoalveolar lavage, reduced ASM activity, and subsequently decreased ceramide levels (111). This emphasizes the pivotal role of sphingolipid signaling controlling pulmonary edema formation and lung function.',\n",
       "    'cite_spans': [{'start': 142,\n",
       "      'end': 145,\n",
       "      'mention': '109',\n",
       "      'ref_id': 'BIBREF11'},\n",
       "     {'start': 304, 'end': 307, 'mention': '110', 'ref_id': 'BIBREF13'},\n",
       "     {'start': 572, 'end': 575, 'mention': '111', 'ref_id': 'BIBREF14'}],\n",
       "    'section': 'Marker and Mediator in Sepsis and Pneumonia ::: ASM is A Dubious Friend',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'In patients with community-acquired pneumonia (CAP), a plasma decrease of SM was found to be closely associated with an increase in ceramides (16:0, 18:0, 24:1), but normalized toward clinical remission (112). Furthermore, the sphingolytic activity of plasma-secreted ASM was nearly 3-fold increased with same tendency for normalization. A similar course was also observed with respect to gene expression rate of SMPD1 in circulating leukocytes, supporting the concept of a disease-relevant regulation of ASM expression in CAP at both, protein and mRNA level. These observations might qualify ASM as a potential target for host-directed treatments to reduce end-organ damage in pneumonia (112).',\n",
       "    'cite_spans': [{'start': 204,\n",
       "      'end': 207,\n",
       "      'mention': '112',\n",
       "      'ref_id': 'BIBREF15'},\n",
       "     {'start': 689, 'end': 692, 'mention': '112', 'ref_id': 'BIBREF15'}],\n",
       "    'section': 'Marker and Mediator in Sepsis and Pneumonia ::: ASM is A Dubious Friend',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Cultivated endothelial cells are affected by serum obtained from patients with sepsis, resulting in clustering of receptors relevant for signal transduction and suppression of a stress-sensitive transcript marker of these cells (i.e., ADAMTS13), which is abrogated by direct and indirect inhibition of ASM activity (113). Both, plasma activity and amount of ASM were found to be increased in septic patients dependent on clinical severity (34, 113). Thus, ASM is involved in the dysregulation of ceramide metabolism in endothelial cells leading to macrodomain formation, cytotoxicity, and downregulation of ADAMTS13 expression (113), which is held to function as an adverse effect to endothelial dysfunction and microthrombus formation in sepsis (114). These results obtained in in vitro experimentation were recently confirmed in a monocentric clinical study, where a plasma decrease of the endothelium-stabilizing mediator sphingosine-1-phosphate (S1P) was strongly negatively associated with an increase in ceramide levels (115). Moreover, the association with severity of clinical course could be outlined by a highly powerful value of an integrative analysis of the S1P/Cer ratio for prediction of unfavorable outcome, superior to established severity scores (SOFA) and HLA-DR expression on circulating monocytes (115).',\n",
       "    'cite_spans': [{'start': 316,\n",
       "      'end': 319,\n",
       "      'mention': '113',\n",
       "      'ref_id': 'BIBREF16'},\n",
       "     {'start': 440, 'end': 442, 'mention': '34', 'ref_id': 'BIBREF106'},\n",
       "     {'start': 444, 'end': 447, 'mention': '113', 'ref_id': 'BIBREF16'},\n",
       "     {'start': 628, 'end': 631, 'mention': '113', 'ref_id': 'BIBREF16'},\n",
       "     {'start': 747, 'end': 750, 'mention': '114', 'ref_id': 'BIBREF17'},\n",
       "     {'start': 1027, 'end': 1030, 'mention': '115', 'ref_id': 'BIBREF18'},\n",
       "     {'start': 1319, 'end': 1322, 'mention': '115', 'ref_id': 'BIBREF18'}],\n",
       "    'section': 'Endothelial Integrity ::: ASM is A Dubious Friend',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Beside predominant localization in lysosomes especially of monocytic, hepatic, and endothelial cells, and delocalization of the protein to the outer leaflet of cellular membranes in response to multiple stimuli including pathogens (116), encoding mRNASMPD1 is undergoing alternative splicing as an independent matter of stress response. A series of SMPD1 mRNA splice isoforms are described to date, but only ASM-1 as the full-length transcript, Ref_mRNA NM_000543 has been shown to be translated into a catalytically active protein (14, 117, 118). It might be speculated, that the extensive variability is a marker of negative regulation with highest variability in healthy controls but decreasing in a stress condition such as severe infection by skipping of exon 3 and/or elongation of exon 2 (119). Thus, an association of specific pattern of alternatively spliced SMPD1 transcripts with disease severity (healthy and non-infectious patients undergoing intensive care as controls vs. sepsis) was observed (119). At the end, alternative splicing of SMPD1 might act in a dominant negative manner upon overexpression making alternative splicing a promising target in regulation of ASM activity (118, 119). Interestingly, a similar phenomenon was observed in patients with major depression, a disease, where despite clear associations of ASM activity with the severity of the disease (120) the regulatory mechanisms and cause-effect links are not well-understood (121). Strikingly, alternative splicing of SMPD1 was also found to be reduced in depressed patients, and most interestingly, normalized upon subchronical treatment with FIASMA in both, patients and healthy volunteers (118, 122).',\n",
       "    'cite_spans': [{'start': 232,\n",
       "      'end': 235,\n",
       "      'mention': '116',\n",
       "      'ref_id': 'BIBREF19'},\n",
       "     {'start': 533, 'end': 535, 'mention': '14', 'ref_id': 'BIBREF45'},\n",
       "     {'start': 537, 'end': 540, 'mention': '117', 'ref_id': 'BIBREF20'},\n",
       "     {'start': 542, 'end': 545, 'mention': '118', 'ref_id': 'BIBREF21'},\n",
       "     {'start': 796, 'end': 799, 'mention': '119', 'ref_id': 'BIBREF22'},\n",
       "     {'start': 1009, 'end': 1012, 'mention': '119', 'ref_id': 'BIBREF22'},\n",
       "     {'start': 1195, 'end': 1198, 'mention': '118', 'ref_id': 'BIBREF21'},\n",
       "     {'start': 1200, 'end': 1203, 'mention': '119', 'ref_id': 'BIBREF22'},\n",
       "     {'start': 1384, 'end': 1387, 'mention': '120', 'ref_id': 'BIBREF24'},\n",
       "     {'start': 1463, 'end': 1466, 'mention': '121', 'ref_id': 'BIBREF25'},\n",
       "     {'start': 1680, 'end': 1683, 'mention': '118', 'ref_id': 'BIBREF21'},\n",
       "     {'start': 1685, 'end': 1688, 'mention': '122', 'ref_id': 'BIBREF26'}],\n",
       "    'section': 'Role of Alternative Splicing and SNP in Sepsis and Depression ::: ASM is A Dubious Friend',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'There are a small number of reports on polymorphisms of the SMPD1 gene locus: V36A, A487V, and G508R as well as hexanucleotide repeat in the signaling peptide (123–127). In contrast to the variety of missense mutations, there is only a minor effect of these sequence variations on overall activity and function of the enzyme, but they might increase the susceptibility for common diseases such as allergy (125). The G508A transition—exchange of an uncharged with a charged amino acid—is discussed to be significant for recognition of a potential phosphorylation site, which is relevant for the control of protein activation and secretion (35, 52). In line with this hypothesis, G508A is associated with plasma-secreted activity in a gene-dosage-dependent manner (125), since subjects homozygous for the minor A allele displayed half of the plasma activity compared with the major G allele. Whether this observation on a molecular level might contribute to control the susceptibility to infections is still a matter of debate, but as discussed below, a decreased ASM activity is associated with lower respiratory tract infections (90, 91).',\n",
       "    'cite_spans': [{'start': 160,\n",
       "      'end': 163,\n",
       "      'mention': '123',\n",
       "      'ref_id': 'BIBREF27'},\n",
       "     {'start': 164, 'end': 167, 'mention': '127', 'ref_id': 'BIBREF31'},\n",
       "     {'start': 406, 'end': 409, 'mention': '125', 'ref_id': 'BIBREF29'},\n",
       "     {'start': 639, 'end': 641, 'mention': '35', 'ref_id': 'BIBREF107'},\n",
       "     {'start': 643, 'end': 645, 'mention': '52', 'ref_id': 'BIBREF126'},\n",
       "     {'start': 763, 'end': 766, 'mention': '125', 'ref_id': 'BIBREF29'},\n",
       "     {'start': 1130, 'end': 1132, 'mention': '90', 'ref_id': 'BIBREF168'},\n",
       "     {'start': 1134, 'end': 1136, 'mention': '91', 'ref_id': 'BIBREF169'}],\n",
       "    'section': 'Role of Alternative Splicing and SNP in Sepsis and Depression ::: ASM is A Dubious Friend',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'In brief, ASM is also held responsible for internalization of pathogens (bacteria and viruses). In acute and chronic infection, inhibition of ASM improved outcome in (pre-)clinical studies in patients with cystic fibrosis and CAP. ASM inhibition also diminished inflammation-responsive fibrogenesis following sepsis in a preclinical study. A multilevel regulation with association to favorable outcome was observed in patients undergoing CAP. Due to the facts that (i) the impact of single nucleotide polymorphisms and alternative splicing of ASM with respect to susceptibility and progression of infection is not fully understood and (ii) pharmacological inhibition of the enzyme resulted in improved outcome from chronic infection, the role of ASM should not be evaluated as exclusively favorable without any restriction. Our friend is becoming dubious and needs more critical consideration.',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Role of Alternative Splicing and SNP in Sepsis and Depression ::: ASM is A Dubious Friend',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'In patients with hyperbilirubinemia, as often observed in the acute phase of severe infection due to sepsis-induced cholestasis and also a long-term consequence of survivors (136, 137), high levels of conjugated bilirubin may also lead to progressive sclerosing cholangitis (138) and are able to stimulate suicidal death of human erythrocytes. As an underlying mechanism, bilirubin triggered rapid Ca++ influx resulting in the release of ASM, formation of ceramide, and subsequent translocation of phosphatidylserine to the erythrocyte surface (139), a phenomenon, which is also compatible with the anemia status of these patients exerting an increased mortality rate (140).',\n",
       "    'cite_spans': [{'start': 175,\n",
       "      'end': 178,\n",
       "      'mention': '136',\n",
       "      'ref_id': 'BIBREF41'},\n",
       "     {'start': 180, 'end': 183, 'mention': '137', 'ref_id': 'BIBREF42'},\n",
       "     {'start': 275, 'end': 278, 'mention': '138', 'ref_id': 'BIBREF43'},\n",
       "     {'start': 545, 'end': 548, 'mention': '139', 'ref_id': 'BIBREF44'},\n",
       "     {'start': 669, 'end': 672, 'mention': '140', 'ref_id': 'BIBREF46'}],\n",
       "    'section': 'Eryptosis ::: But ASM is Also Worrying',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Ceramide accumulation over time, generated by ASM in stored and aged platelets, caused lung injury in endotoxin-challenged mice, examined by neutrophil accumulation, endothelial barrier dysfunction, and histological evidence of tissue injury (141). Interestingly, this adverse effect of pulmonary complications following transfusion could be overcome by ASM inhibition (141).',\n",
       "    'cite_spans': [{'start': 243,\n",
       "      'end': 246,\n",
       "      'mention': '141',\n",
       "      'ref_id': 'BIBREF47'},\n",
       "     {'start': 370, 'end': 373, 'mention': '141', 'ref_id': 'BIBREF47'}],\n",
       "    'section': 'Platelets ::: But ASM is Also Worrying',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'A broad panel of cationic amphiphilic compounds is known to inhibit the activity of ASM by lysosomotropism due to their unique physicochemical properties, which was firstly observed by Albouz et al. (142). Interaction with the membrane-embedding N-terminal saposin domain of ASM caused detachment from the inner lysosomal membrane and a consecutive proteolysis of the enzyme (143, 144). As a result, there is a significant decrease in sphingolytic activity, therefore these compounds are termed as FIASMA (36). The compounds differ markedly in molecular structure. A prediction of inhibitory capacity is available by a structure-property-activity relation (SPAR) model in order to specify the structural and physicochemical characteristics including variables referring to pKa, logP, as well as a factor depicting the steric hindrance of the most basic nitrogen atom of the compound modulating the free presentation of a protonated nitrogen atom at the inner lysosomal surface (145). It is noteworthy that these compounds are licensed for medical use in humans, are minimally toxic, and in use for a broad range of clinical indications, including the treatment of intensive care patients. There is a long list of FIASMA of ASM including amitriptyline, imipramine, desipramine, doxepine, fluoxetine, maprotiline, nortriptyline, paroxetine, sertraline, suloctidil, terfenadine, and famotidine, to mention a few (145) (Figure 1).',\n",
       "    'cite_spans': [{'start': 200,\n",
       "      'end': 203,\n",
       "      'mention': '142',\n",
       "      'ref_id': 'BIBREF48'},\n",
       "     {'start': 376, 'end': 379, 'mention': '143', 'ref_id': 'BIBREF49'},\n",
       "     {'start': 381, 'end': 384, 'mention': '144', 'ref_id': 'BIBREF50'},\n",
       "     {'start': 506, 'end': 508, 'mention': '36', 'ref_id': 'BIBREF108'},\n",
       "     {'start': 978, 'end': 981, 'mention': '145', 'ref_id': 'BIBREF51'},\n",
       "     {'start': 1410, 'end': 1413, 'mention': '145', 'ref_id': 'BIBREF51'}],\n",
       "    'section': 'Mechanisms and Effects of ASM Inhibition ::: But ASM is Also Worrying',\n",
       "    'ref_spans': [{'start': 1416,\n",
       "      'end': 1424,\n",
       "      'mention': 'Figure 1',\n",
       "      'ref_id': 'FIGREF0'}]},\n",
       "   {'text': 'Furthermore, evaluating lysosomotropic and ASM-inhibiting activities in appropriate cell culture models are an applicable approach of newly designed substances to identify novel compounds with anti-apoptotic and anti-inflammatory capacity, which results ultimately in a decreased response of prototypic inflammatory mediators. At the end, in new candidate drugs, based on established SPAR models, physicochemical and biological properties will be selected and identified to enrich the pool of compounds, which might be beneficial for the treatment of the adverse effects of ASM upon activation (146).',\n",
       "    'cite_spans': [{'start': 595,\n",
       "      'end': 598,\n",
       "      'mention': '146',\n",
       "      'ref_id': 'BIBREF52'}],\n",
       "    'section': 'Mechanisms and Effects of ASM Inhibition ::: But ASM is Also Worrying',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'In the next paragraph, there is a short overview on the proposed beneficial effects of ASM inhibition in a series of conditions associated with development of organ failure and long-term effects of sepsis sequelae, classified by the affected tissue.',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Mechanisms and Effects of ASM Inhibition ::: But ASM is Also Worrying',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Pulmonary outcome following endotoxin challenge in mice was improved by ASM inhibition, resulting in attenuating alveolar collapse (157). Inhibition of ASM was identified as a possible target in acute lung injury and pulmonary edema, induced by administration of platelet-activating factor and endotoxin (158). Fluoxetine and desipramine reduced in ovalbumin-sensitized rats the number of migrated immune cells into bronchalveolar lavage fluid but did not exert anti-inflammatory activity by attenuation of bronchial hyperreactivity (134).',\n",
       "    'cite_spans': [{'start': 132,\n",
       "      'end': 135,\n",
       "      'mention': '157',\n",
       "      'ref_id': 'BIBREF64'},\n",
       "     {'start': 305, 'end': 308, 'mention': '158', 'ref_id': 'BIBREF65'},\n",
       "     {'start': 534, 'end': 537, 'mention': '134', 'ref_id': 'BIBREF39'}],\n",
       "    'section': 'Lung ::: Muscles, Diaphragm—Heart, and Cardiovascular System ::: But ASM is Also Worrying',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Long-term sepsis survivors might develop hepatocellular/hepatobiliary injury and fibrosis (159–162). ASM, also an important regulator of hepatocyte apoptosis and hepatic stellate cell (HSC) activation (163), is linked to the promotion of liver dysfunction in the acute phase as well as to fibrogenesis in the long term. In both, the acute and the postacute phase, pharmacological inhibition of ASM displayed a beneficial effect on oxidative stress levels, hepatobiliary function, macrophage infiltration, hepatic stellate activation, and overall survival (156). ASM inhibition exhibited a protective effect on liver function in the acute phase, and the reduction of HSC activation diminished development of sepsis-associated liver fibrosis in the postacute phase of sepsis (156). In this context, dysregulation of hepatic biotransformation capacity, especially of the cytochrome P450 (CYP) system, represents an important distress factor during host response (164–166). Thus, these enzymes are estimated to be responsible for metabolizing >75% of drugs which are in daily clinical use. Pharmacological inhibition of ASM has an important impact on expression and activity of different hepatic CYP enzymes using an animal model of polymicrobial sepsis in the acute as well as in the postsepsis phase (167).',\n",
       "    'cite_spans': [{'start': 91,\n",
       "      'end': 94,\n",
       "      'mention': '159',\n",
       "      'ref_id': 'BIBREF66'},\n",
       "     {'start': 95, 'end': 98, 'mention': '162', 'ref_id': 'BIBREF70'},\n",
       "     {'start': 202, 'end': 205, 'mention': '163', 'ref_id': 'BIBREF71'},\n",
       "     {'start': 556, 'end': 559, 'mention': '156', 'ref_id': 'BIBREF63'},\n",
       "     {'start': 774, 'end': 777, 'mention': '156', 'ref_id': 'BIBREF63'},\n",
       "     {'start': 960, 'end': 963, 'mention': '164', 'ref_id': 'BIBREF72'},\n",
       "     {'start': 964, 'end': 967, 'mention': '166', 'ref_id': 'BIBREF74'},\n",
       "     {'start': 1299, 'end': 1302, 'mention': '167', 'ref_id': 'BIBREF75'}],\n",
       "    'section': 'Liver Tissue—Long-Term Effects on Tissue Function and Fibrosis Following Sepsis ::: Muscles, Diaphragm—Heart, and Cardiovascular System ::: But ASM is Also Worrying',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'In murine models of peritonitis and endotoxemia following LPS challenge, amitriptyline-treated mice were protected from overwhelming cytokine release (KC, MCP-1) and from pulmonary edema as well as exhibited improved survival. Anti-inflammatory effect of amitriptyline treatment is reflected by increased IL-10 levels and decreased accumulation of immune cells at the site of infection (135).',\n",
       "    'cite_spans': [{'start': 387,\n",
       "      'end': 390,\n",
       "      'mention': '135',\n",
       "      'ref_id': 'BIBREF40'}],\n",
       "    'section': 'Liver Tissue—Long-Term Effects on Tissue Function and Fibrosis Following Sepsis ::: Muscles, Diaphragm—Heart, and Cardiovascular System ::: But ASM is Also Worrying',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'In all studies enrolling patients with severe infection, sepsis and multiple organ failure as well as in all reports modeling the disease continuum ex vivo or in vivo, we found a clear association of ASM activity with morbidity and unfavorable outcome. These observations are independent from the underlying disease such as peritonitis, pneumonia, and HHL. On the other hand, inhibition of ASM activity is capable to prevent destructive events of overwhelming immune activation in all affected tissues and circulating cells, be they nucleated or not. Here, we come to the point for further consideration of the presumed beneficial effects of ASM inhibition in daily clinical care, because a broad panel of drugs is exhibiting ASM inhibition.',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Liver Tissue—Long-Term Effects on Tissue Function and Fibrosis Following Sepsis ::: Muscles, Diaphragm—Heart, and Cardiovascular System ::: But ASM is Also Worrying',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'FIASMA are a class of drugs, which are widely used for (often chronic) treatment of a number of symptoms such as major depression, neuropathic pain, fibromyalgia, etc., to mention a few (168). From that list, major depression was recently ranked as the third leading burden of non-fatal diseases worldwide with a prevalence of >10% in all analyzed regions and with an increasing incidence to be first during the next decade (169, 170). In the Global Burden of Disease survey for 2017, more than 264 million cases were reported worldwide (169).',\n",
       "    'cite_spans': [{'start': 187,\n",
       "      'end': 190,\n",
       "      'mention': '168',\n",
       "      'ref_id': 'BIBREF76'},\n",
       "     {'start': 425, 'end': 428, 'mention': '169', 'ref_id': 'BIBREF77'},\n",
       "     {'start': 430, 'end': 433, 'mention': '170', 'ref_id': 'BIBREF79'},\n",
       "     {'start': 538, 'end': 541, 'mention': '169', 'ref_id': 'BIBREF77'}],\n",
       "    'section': 'FIASMA—From Unattended ASM Inhibition at ICU to an Intended Use ::: Conclusions and Further Perspectives',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'In Germany, the 12-month prevalence of major depression is 12% in adults, of whom the majority is treated with antidepressant drugs (171).',\n",
       "    'cite_spans': [{'start': 133,\n",
       "      'end': 136,\n",
       "      'mention': '171',\n",
       "      'ref_id': 'BIBREF80'}],\n",
       "    'section': 'FIASMA—From Unattended ASM Inhibition at ICU to an Intended Use ::: Conclusions and Further Perspectives',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'In cultured PBMC from healthy volunteers treated either with imipramine or amitriptyline in a therapeutical dosage, activity of ASM is rapidly reduced to levels around 30% of original activity over a period of 3 weeks. Interestingly, removal of the drugs resulted in a gradual and prolonged, but complete normalization of activity over a period of 5–6 days (172). Considering this scenario combined with the facts that (i) daily use medication is often or regularly spared on ICU admission and (ii) that drugs initially used at the newly admitted ICU patient might also exert an inhibitory capacity on ASM, it seems quite possible that the septic patients at least in the early days following admission might be subdivided in separate groups: one with decreased ASM activity due to antecedent treatment with FIASMA due to other indication and gradual normalization of ASM activity, one with inhibition of ASM activity only just at ICU submission, and one without any interference with ASM activity. In addition, it might be further speculated that the presented ASM activity in circulation is also superimposed by the conserved mechanisms of stress response as discussed in detail previously.',\n",
       "    'cite_spans': [{'start': 358,\n",
       "      'end': 361,\n",
       "      'mention': '172',\n",
       "      'ref_id': 'BIBREF81'}],\n",
       "    'section': 'FIASMA—From Unattended ASM Inhibition at ICU to an Intended Use ::: Conclusions and Further Perspectives',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'This scenario in mind, there are some principal opportunities, risks, as well as consequences examining host response and its unintended, but presumptive treatment by FIASMA.',\n",
       "    'cite_spans': [],\n",
       "    'section': 'FIASMA—From Unattended ASM Inhibition at ICU to an Intended Use ::: Conclusions and Further Perspectives',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Repurposing of established drugs to treat both, common, or rare diseases is becoming an increasingly attractive and fast-track approach because it involves the use of compounds with known pharmacokinetic and safety profiles, with potentially lower overall development costs and shorter development timelines due to existing approval by the regulatory authorities (175). In the case of ASM, it is of remarkable importance since there is a long list of potential candidates available (36), and both, the structure-activity relationship (145) as well as the underlying mechanism of effective inhibition are known (144). Also, there are promising results from preclinical and clinical studies as discussed in this review, and there are some more outcomes using an explorative design for identification of beneficial effect of ASM inhibition.',\n",
       "    'cite_spans': [{'start': 364,\n",
       "      'end': 367,\n",
       "      'mention': '175',\n",
       "      'ref_id': 'BIBREF84'},\n",
       "     {'start': 483, 'end': 485, 'mention': '36', 'ref_id': 'BIBREF108'},\n",
       "     {'start': 535, 'end': 538, 'mention': '145', 'ref_id': 'BIBREF51'},\n",
       "     {'start': 611, 'end': 614, 'mention': '144', 'ref_id': 'BIBREF50'}],\n",
       "    'section': 'Drug Repurposing ::: Conclusions and Further Perspectives',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Out of around 800 unique three-drug combinations, two sets were identified to effectively inhibit Ebola virus entry into human cells and were further validated for inhibition of live Ebola virus infection—at least two drugs of the triple exhibiting effective ASM inhibitory capacity (176).',\n",
       "    'cite_spans': [{'start': 284,\n",
       "      'end': 287,\n",
       "      'mention': '176',\n",
       "      'ref_id': 'BIBREF85'}],\n",
       "    'section': 'Drug Repurposing ::: Conclusions and Further Perspectives',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'There is also an excellent review [Beckmann et al., (177) and references cited therein], critically outlining the effectiveness of amitriptyline in a series of serious conditions such as cancer, infection, and metabolic and neurological diseases, all of them assessed as ASM-related diseases. For this drug, potential new applications for therapeutical treatment are demonstrated which might also be considered a general opportunity, since amitriptyline is proposed to function pars pro toto for this group of drugs exhibiting inhibitory capacity for ASM. Beside other drugs, these studies revealed that amitriptyline is a promising candidate for further consideration for the treatment of infectious diseases and overwhelming host response. However, adverse effects of a missing residual activity as shown by incompetence for phagocytosis and increased bacterial burden were also observed (65, 81). On the other hand, there is a clear association of ASM activity with the severity of sepsis and unfavorable outcome (34, 113, 128). It has to be mentioned that in heterogeneous mice by FIASMA treatment, a temporary status similar to complete loss of function was shown, underlining the effectiveness of functional ASM inhibition (167). A residual activity of 15% is insufficient to prevent clinical features of Niemann-Pick diseases over time (17).',\n",
       "    'cite_spans': [{'start': 53,\n",
       "      'end': 56,\n",
       "      'mention': '177',\n",
       "      'ref_id': 'BIBREF86'},\n",
       "     {'start': 891, 'end': 893, 'mention': '65', 'ref_id': 'BIBREF140'},\n",
       "     {'start': 895, 'end': 897, 'mention': '81', 'ref_id': 'BIBREF158'},\n",
       "     {'start': 1017, 'end': 1019, 'mention': '34', 'ref_id': 'BIBREF106'},\n",
       "     {'start': 1021, 'end': 1024, 'mention': '113', 'ref_id': 'BIBREF16'},\n",
       "     {'start': 1026, 'end': 1029, 'mention': '128', 'ref_id': 'BIBREF32'},\n",
       "     {'start': 1230, 'end': 1233, 'mention': '167', 'ref_id': 'BIBREF75'},\n",
       "     {'start': 1344, 'end': 1346, 'mention': '17', 'ref_id': 'BIBREF78'}],\n",
       "    'section': 'Drug Repurposing ::: Conclusions and Further Perspectives',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'It is of major interest that fluoxetine, a widely used antidepressant drug, efficiently inhibited the entry and propagation of SARS-CoV-2 in the cell culture model without cytotoxic effects and also exerted potent antiviral activity against two currently circulating influenza A virus subtypes, an effect which was also observed upon treatment with the FIASMAs amiodarone and imipramine (178).',\n",
       "    'cite_spans': [{'start': 388,\n",
       "      'end': 391,\n",
       "      'mention': '178',\n",
       "      'ref_id': 'BIBREF87'}],\n",
       "    'section': 'Drug Repurposing ::: Conclusions and Further Perspectives',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'The recently proposed concept of a stress/injury-induced lysosomal exocytosis (59) as the major source of extracellularly circulating ASM (38) is in line (i) with a restoration of dependency for Zn++ ions, since due to rapid displacement of these ions after reaching the extracellular space, an additional regulating factor participates in the resolution of ASM activity beyond the outfall of the lysosomal content, and (ii) the effectiveness of activity decreases in circulation upon treatment with FIASMA, resulting in intralysosomal proteolysis of the mature ASM protein and subsequent release of inactive protein fragments without sphingolytic activity, and (iii) missing evidence of phosphorylated ASM in circulation of a patient undergoing stress response. However, the validation of this concept in septic patients still needs further examination, e.g., by comparison of the fragmentation and phosphorylation pattern of ASM isolated from both compartments, lysosomes and plasma, obtained from patients undergoing treatment with FIASMA. Another important point with respect to the dosage of FIASMA for treatment of host response is the fact of similarity to that of the original indication (often major depression) due to a very similar mode of action regarding ceramide generation.',\n",
       "    'cite_spans': [{'start': 79,\n",
       "      'end': 81,\n",
       "      'mention': '59',\n",
       "      'ref_id': 'BIBREF133'},\n",
       "     {'start': 139, 'end': 141, 'mention': '38', 'ref_id': 'BIBREF110'}],\n",
       "    'section': 'Drug Repurposing ::: Conclusions and Further Perspectives',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'During an episode of sepsis, a broad panel of cell, tissue, and organ response is controlled by stress-induced ceramide generation; there is a broad understanding of potentially harmful effects of ceramide generation during sepsis and there is a broad panel of well-established and approved drugs with effectiveness for ASM inhibition (Box 2), at the end encouraging systematic studies for detailed examination of an unattended or an intended inhibition of ASM during sepsis to improve patients outcome.',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Résumé and Take Home Messages ::: Conclusions and Further Perspectives',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'The objective of this narrative review is to evaluate the changes of sphingomyelinase activity during infection and host response and the discussion of translation into the field of translational sepsis research including development of new strategies for diagnosis and treatment. A search in the main biomedical databases (PubMed, Medline, Scopus, and Web of science) was conducted for a 20-year period ending in July 2020, focused on primary research articles in the field of interest. Keyword search for abstracts and titles included (“sphingomyelinase” OR “SMPD1”) AND (“sepsis” OR “inflammation” OR “infection”). The search identified 723 references, which were selected by particular importance for this review. The prescreened references were completed by other publications related to the issue. We apologize if a valuable work of any appreciated colleagues could not be included due to space limitations and the narrow scope of this review.',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Methods ::: Conclusions and Further Perspectives',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'RC and H-YC drafted the manuscript. Both authors revised the final version of the manuscript.',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Author Contributions',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Conflict of Interest',\n",
       "    'ref_spans': []}],\n",
       "  'ref_entries': {'TABREF0': {'text': 'Table 1: Milestones for ASM in translational sepsis research.\\nDescription of milestones, which are mostly relevant for a better understanding of the role of ASM during host response, development of organ failure, and proposed treatment thereof.',\n",
       "    'type': 'table'},\n",
       "   'TABREF1': {'text': 'Table 2: Stressors triggering ASM activity and translocation (selection).\\nOutline of stressors and harmful events resulting in triggering extracellular ASM activity by translocation and exocytosis of the lysosome with decompartimentalization and amplification of biological effects of ASM at the outer leaflet of cellular membranes (selection).',\n",
       "    'type': 'table'},\n",
       "   'FIGREF0': {'text': 'Figure 1: Release of acid sphingomyelinase (ASM) in the course of stress response and mode of action of its inhibition. Exposition of a cell membrane to external harmful stress events such as endogenous or exogenous stimuli (bacterial endotoxin, pro-inflammatory cytokines, pore-forming toxins, Table 2) is followed by intracellular Ca++ influx, triggering the exocytosis of lysosomes, where ASM was bound to the inner lysosomal membrane by SAP domain. In the extracellular space, ASM mediates hydrolysis of SM (abundantly embedded into the outer leaflet of the membrane), generates ceramide, facilitating remodeling, and repair of the membrane (restoring integrity), as well as pathogen entry. As a hallmark of ceramide-induced signal transduction, due to the trend for self-aggregation and formation of ceramide-enriched microdomains, subunits of receptor proteins are reorganized to functionally active receptor complexes such as TLR4, TNFR, etc. As a result, an increase in signaling quality and intensity is observed, controlling an adequate cellular response to external harmful stimuli. On the right panel, the mode of action of cationic amphiphilic substances is illustrated: in an uncharged form at physiological pH value, the compounds diffuse across the cellular membrane through the cytoplasma into the lysosome, where the weak basic nitrogen atom of the compound is protonated because of the acid pH value of the lysosome. The protonated compound interacts with the sapsonin domain of ASM, detaching them from the membrane, then undergoing proteolytic inactivation. Following stimulation and release, the inactivated ASM is unable to contribute to ceramide generation at the outer leaflet of the membrane. Due to similar physicochemical properties, a long list of cationic amphiphilic substances with a broad range of clinical indications, but most of them used in daily care as antidepressive drugs, are found to function as functional inhibitors of acid sphingomyelinase (FIASMA) and to effectively control stress-induced ceramide generation. Most of the available FIASMAs are licensed for medical use in humans, are minimally toxic, and may therefore be applied for disease states associated with increased activity of ASM.',\n",
       "    'type': 'figure'},\n",
       "   'FIGREF1': {'text': 'Figure 2: Properties of ASM inhibition in preclinical sepsis research. Administration of the inhibitor either prior (pretreatment) or following septic insult (curative). For details, see text.',\n",
       "    'type': 'figure'}},\n",
       "  'back_matter': [],\n",
       "  'bib_entries': {'BIBREF0': {'title': 'Enzymic hydrolysis and synthesis of ceramides',\n",
       "    'authors': [{'first': 'S', 'middle': [], 'last': 'Gatt', 'suffix': ''}],\n",
       "    'year': 1963,\n",
       "    'venue': 'J Biol Chem.',\n",
       "    'volume': '238',\n",
       "    'issn': '',\n",
       "    'pages': '3131-3',\n",
       "    'other_ids': {'DOI': []}},\n",
       "   'BIBREF1': {'title': 'Sphingomyelinases: enzymology and membrane activity',\n",
       "    'authors': [{'first': 'FM', 'middle': [], 'last': 'Goni', 'suffix': ''},\n",
       "     {'first': 'A', 'middle': [], 'last': 'Alonso', 'suffix': ''}],\n",
       "    'year': 2002,\n",
       "    'venue': 'FEBS Lett.',\n",
       "    'volume': '531',\n",
       "    'issn': '',\n",
       "    'pages': '38-46',\n",
       "    'other_ids': {'DOI': ['10.1016/S0014-5793(02)03482-8']}},\n",
       "   'BIBREF2': {'title': 'Depletion of host and viral sphingomyelin impairs influenza virus infection',\n",
       "    'authors': [{'first': 'A', 'middle': [], 'last': 'Audi', 'suffix': ''},\n",
       "     {'first': 'N', 'middle': [], 'last': 'Soudani', 'suffix': ''},\n",
       "     {'first': 'G', 'middle': [], 'last': 'Dbaibo', 'suffix': ''},\n",
       "     {'first': 'H', 'middle': [], 'last': 'Zaraket', 'suffix': ''}],\n",
       "    'year': 2020,\n",
       "    'venue': 'Front Microbiol.',\n",
       "    'volume': '11',\n",
       "    'issn': '',\n",
       "    'pages': None,\n",
       "    'other_ids': {'DOI': ['10.3389/fmicb.2020.00612']}},\n",
       "   'BIBREF3': {'title': 'Ceramide suppresses influenza a virus replication in vitro',\n",
       "    'authors': [{'first': 'N', 'middle': [], 'last': 'Soudani', 'suffix': ''},\n",
       "     {'first': 'R', 'middle': [], 'last': 'Hage-Sleiman', 'suffix': ''},\n",
       "     {'first': 'W', 'middle': [], 'last': 'Karam', 'suffix': ''},\n",
       "     {'first': 'G', 'middle': [], 'last': 'Dbaibo', 'suffix': ''},\n",
       "     {'first': 'H', 'middle': [], 'last': 'Zaraket', 'suffix': ''}],\n",
       "    'year': 2019,\n",
       "    'venue': 'J Virol.',\n",
       "    'volume': '93',\n",
       "    'issn': '',\n",
       "    'pages': 'e00053-19',\n",
       "    'other_ids': {'DOI': ['10.1128/JVI.00053-19']}},\n",
       "   'BIBREF4': {'title': 'Differential activation of acid sphingomyelinase and ceramide release determines invasiveness of Neisseria meningitidis into brain endothelial cells',\n",
       "    'authors': [{'first': 'A', 'middle': [], 'last': 'Simonis', 'suffix': ''},\n",
       "     {'first': 'S', 'middle': [], 'last': 'Hebling', 'suffix': ''},\n",
       "     {'first': 'E', 'middle': [], 'last': 'Gulbins', 'suffix': ''},\n",
       "     {'first': 'S', 'middle': [], 'last': 'Schneider-Schaulies', 'suffix': ''},\n",
       "     {'first': 'A', 'middle': [], 'last': 'Schubert-Unkmeir', 'suffix': ''}],\n",
       "    'year': 2014,\n",
       "    'venue': 'PLoS Pathog.',\n",
       "    'volume': '10',\n",
       "    'issn': '',\n",
       "    'pages': None,\n",
       "    'other_ids': {'DOI': ['10.1371/journal.ppat.1004160']}},\n",
       "   'BIBREF5': {'title': 'Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis',\n",
       "    'authors': [{'first': 'V',\n",
       "      'middle': [],\n",
       "      'last': 'Teichgraber',\n",
       "      'suffix': ''},\n",
       "     {'first': 'M', 'middle': [], 'last': 'Ulrich', 'suffix': ''},\n",
       "     {'first': 'N', 'middle': [], 'last': 'Endlich', 'suffix': ''},\n",
       "     {'first': 'J', 'middle': [], 'last': 'Riethmuller', 'suffix': ''},\n",
       "     {'first': 'B', 'middle': [], 'last': 'Wilker', 'suffix': ''},\n",
       "     {'first': 'Oliveira-Munding',\n",
       "      'middle': ['CC'],\n",
       "      'last': 'De',\n",
       "      'suffix': ''}],\n",
       "    'year': 2008,\n",
       "    'venue': 'Nat Med.',\n",
       "    'volume': '14',\n",
       "    'issn': '',\n",
       "    'pages': '382-91',\n",
       "    'other_ids': {'DOI': ['10.1038/nm1748']}},\n",
       "   'BIBREF6': {'title': 'Acid sphingomyelinase inhibitors normalize pulmonary ceramide and inflammation in cystic fibrosis',\n",
       "    'authors': [{'first': 'KA', 'middle': [], 'last': 'Becker', 'suffix': ''},\n",
       "     {'first': 'J', 'middle': [], 'last': 'Riethmuller', 'suffix': ''},\n",
       "     {'first': 'A', 'middle': [], 'last': 'Luth', 'suffix': ''},\n",
       "     {'first': 'G', 'middle': [], 'last': 'Doring', 'suffix': ''},\n",
       "     {'first': 'B', 'middle': [], 'last': 'Kleuser', 'suffix': ''},\n",
       "     {'first': 'E', 'middle': [], 'last': 'Gulbins', 'suffix': ''}],\n",
       "    'year': 2010,\n",
       "    'venue': 'Am J Respir Cell Mol Biol.',\n",
       "    'volume': '42',\n",
       "    'issn': '',\n",
       "    'pages': '716-24',\n",
       "    'other_ids': {'DOI': ['10.1165/rcmb.2009-0174OC']}},\n",
       "   'BIBREF7': {'title': \"Activation of acid sphingomyelinase and its inhibition by the nitric oxide/cyclic guanosine 3',5'-monophosphate pathway: key events in Escherichia coli-elicited apoptosis of dendritic cells\",\n",
       "    'authors': [{'first': 'S', 'middle': [], 'last': 'Falcone', 'suffix': ''},\n",
       "     {'first': 'C', 'middle': [], 'last': 'Perrotta', 'suffix': ''},\n",
       "     {'first': 'C', 'middle': [], 'last': 'De Palma', 'suffix': ''},\n",
       "     {'first': 'A', 'middle': [], 'last': 'Pisconti', 'suffix': ''},\n",
       "     {'first': 'C', 'middle': [], 'last': 'Sciorati', 'suffix': ''},\n",
       "     {'first': 'A', 'middle': [], 'last': 'Capobianco', 'suffix': ''}],\n",
       "    'year': 2004,\n",
       "    'venue': 'J Immunol.',\n",
       "    'volume': '173',\n",
       "    'issn': '',\n",
       "    'pages': '4452-63',\n",
       "    'other_ids': {'DOI': ['10.4049/jimmunol.173.7.4452']}},\n",
       "   'BIBREF8': {'title': 'Acid sphingomyelinase inhibition in stored erythrocytes reduces transfusion-associated lung inflammation',\n",
       "    'authors': [{'first': 'RS', 'middle': [], 'last': 'Hoehn', 'suffix': ''},\n",
       "     {'first': 'PL', 'middle': [], 'last': 'Jernigan', 'suffix': ''},\n",
       "     {'first': 'L', 'middle': [], 'last': 'Japtok', 'suffix': ''},\n",
       "     {'first': 'AL', 'middle': [], 'last': 'Chang', 'suffix': ''},\n",
       "     {'first': 'EF', 'middle': [], 'last': 'Midura', 'suffix': ''},\n",
       "     {'first': 'CC', 'middle': [], 'last': 'Caldwell', 'suffix': ''}],\n",
       "    'year': 2017,\n",
       "    'venue': 'Ann Surg.',\n",
       "    'volume': '265',\n",
       "    'issn': '',\n",
       "    'pages': '218-26',\n",
       "    'other_ids': {'DOI': ['10.1097/SLA.0000000000001648']}},\n",
       "   'BIBREF9': {'title': 'Acute systemic inflammation up-regulates secretory sphingomyelinase in vivo: a possible link between inflammatory cytokines and atherogenesis',\n",
       "    'authors': [{'first': 'ML', 'middle': [], 'last': 'Wong', 'suffix': ''},\n",
       "     {'first': 'B', 'middle': [], 'last': 'Xie', 'suffix': ''},\n",
       "     {'first': 'N', 'middle': [], 'last': 'Beatini', 'suffix': ''},\n",
       "     {'first': 'P', 'middle': [], 'last': 'Phu', 'suffix': ''},\n",
       "     {'first': 'S', 'middle': [], 'last': 'Marathe', 'suffix': ''},\n",
       "     {'first': 'A', 'middle': [], 'last': 'Johns', 'suffix': ''}],\n",
       "    'year': 2000,\n",
       "    'venue': 'Proc Natl Acad Sci USA.',\n",
       "    'volume': '97',\n",
       "    'issn': '',\n",
       "    'pages': '8681-6',\n",
       "    'other_ids': {'DOI': ['10.1073/pnas.150098097']}},\n",
       "   'BIBREF10': {'title': 'Elevation of ceramide in serum lipoproteins during acute phase response in humans and mice: role of serine-palmitoyl transferase',\n",
       "    'authors': [{'first': 'S', 'middle': [], 'last': 'Lightle', 'suffix': ''},\n",
       "     {'first': 'R', 'middle': [], 'last': 'Tosheva', 'suffix': ''},\n",
       "     {'first': 'A', 'middle': [], 'last': 'Lee', 'suffix': ''},\n",
       "     {'first': 'J', 'middle': [], 'last': 'Queen-Baker', 'suffix': ''},\n",
       "     {'first': 'B', 'middle': [], 'last': 'Boyanovsky', 'suffix': ''},\n",
       "     {'first': 'S', 'middle': [], 'last': 'Shedlofsky', 'suffix': ''}],\n",
       "    'year': 2003,\n",
       "    'venue': 'Arch Biochem Biophys.',\n",
       "    'volume': '419',\n",
       "    'issn': '',\n",
       "    'pages': '120-8',\n",
       "    'other_ids': {'DOI': ['10.1016/j.abb.2003.08.031']}},\n",
       "   'BIBREF11': {'title': 'Improved pulmonary function by acid sphingomyelinase inhibition in a newborn piglet lavage model',\n",
       "    'authors': [{'first': 'P',\n",
       "      'middle': [],\n",
       "      'last': 'von Bismarck',\n",
       "      'suffix': ''},\n",
       "     {'first': 'CF', 'middle': [], 'last': 'Wistadt', 'suffix': ''},\n",
       "     {'first': 'K', 'middle': [], 'last': 'Klemm', 'suffix': ''},\n",
       "     {'first': 'S', 'middle': [], 'last': 'Winoto-Morbach', 'suffix': ''},\n",
       "     {'first': 'U', 'middle': [], 'last': 'Uhlig', 'suffix': ''},\n",
       "     {'first': 'S', 'middle': [], 'last': 'Schutze', 'suffix': ''}],\n",
       "    'year': 2008,\n",
       "    'venue': 'Am J Respir Crit Care Med.',\n",
       "    'volume': '177',\n",
       "    'issn': '',\n",
       "    'pages': '1233-41',\n",
       "    'other_ids': {'DOI': ['10.1164/rccm.200705-752OC']}},\n",
       "   'BIBREF12': {'title': 'Acid and neutral sphingomyelinases: roles and mechanisms of regulation',\n",
       "    'authors': [{'first': 'N',\n",
       "      'middle': [],\n",
       "      'last': 'Marchesini',\n",
       "      'suffix': ''},\n",
       "     {'first': 'YA', 'middle': [], 'last': 'Hannun', 'suffix': ''}],\n",
       "    'year': 2004,\n",
       "    'venue': 'Biochem Cell Biol.',\n",
       "    'volume': '82',\n",
       "    'issn': '',\n",
       "    'pages': '27-44',\n",
       "    'other_ids': {'DOI': ['10.1139/o03-091']}},\n",
       "   'BIBREF13': {'title': 'Inflammatory mediators in tracheal aspirates of preterm infants participating in a randomized trial of inhaled nitric oxide',\n",
       "    'authors': [{'first': 'M', 'middle': [], 'last': 'Laube', 'suffix': ''},\n",
       "     {'first': 'E', 'middle': [], 'last': 'Amann', 'suffix': ''},\n",
       "     {'first': 'U', 'middle': [], 'last': 'Uhlig', 'suffix': ''},\n",
       "     {'first': 'Y', 'middle': [], 'last': 'Yang', 'suffix': ''},\n",
       "     {'first': 'HW', 'middle': [], 'last': 'Fuchs', 'suffix': ''},\n",
       "     {'first': 'M', 'middle': [], 'last': 'Zemlin', 'suffix': ''}],\n",
       "    'year': 2017,\n",
       "    'venue': 'PLoS ONE.',\n",
       "    'volume': '12',\n",
       "    'issn': '',\n",
       "    'pages': None,\n",
       "    'other_ids': {'DOI': ['10.1371/journal.pone.0169352']}},\n",
       "   'BIBREF14': {'title': 'Surfactant “fortification” by topical inhibition of nuclear factor-kappaB activity in a newborn piglet lavage model',\n",
       "    'authors': [{'first': 'P',\n",
       "      'middle': [],\n",
       "      'last': 'von Bismarck',\n",
       "      'suffix': ''},\n",
       "     {'first': 'K', 'middle': [], 'last': 'Klemm', 'suffix': ''},\n",
       "     {'first': 'CF', 'middle': [], 'last': 'Wistadt', 'suffix': ''},\n",
       "     {'first': 'S', 'middle': [], 'last': 'Winoto-Morbach', 'suffix': ''},\n",
       "     {'first': 'U', 'middle': [], 'last': 'Uhlig', 'suffix': ''},\n",
       "     {'first': 'S', 'middle': [], 'last': 'Schutze', 'suffix': ''}],\n",
       "    'year': 2007,\n",
       "    'venue': 'Crit Care Med.',\n",
       "    'volume': '35',\n",
       "    'issn': '',\n",
       "    'pages': '2309-18',\n",
       "    'other_ids': {'DOI': ['10.1097/01.CCM.0000281472.47067.45']}},\n",
       "   'BIBREF15': {'title': 'Decreased plasma phospholipid concentrations and increased acid sphingomyelinase activity are accurate biomarkers for community-acquired pneumonia',\n",
       "    'authors': [{'first': 'H', 'middle': [], 'last': 'Arshad', 'suffix': ''},\n",
       "     {'first': 'JCL', 'middle': [], 'last': 'Alfonso', 'suffix': ''},\n",
       "     {'first': 'R', 'middle': [], 'last': 'Franke', 'suffix': ''},\n",
       "     {'first': 'K', 'middle': [], 'last': 'Michaelis', 'suffix': ''},\n",
       "     {'first': 'L', 'middle': [], 'last': 'Araujo', 'suffix': ''},\n",
       "     {'first': 'A', 'middle': [], 'last': 'Habib', 'suffix': ''}],\n",
       "    'year': 2019,\n",
       "    'venue': 'J Transl Med.',\n",
       "    'volume': '17',\n",
       "    'issn': '',\n",
       "    'pages': None,\n",
       "    'other_ids': {'DOI': ['10.1186/s12967-019-2112-z']}},\n",
       "   'BIBREF16': {'title': 'Acid sphingomyelinase promotes endothelial stress response in systemic inflammation and sepsis',\n",
       "    'authors': [{'first': 'HY', 'middle': [], 'last': 'Chung', 'suffix': ''},\n",
       "     {'first': 'DC', 'middle': [], 'last': 'Hupe', 'suffix': ''},\n",
       "     {'first': 'GP', 'middle': [], 'last': 'Otto', 'suffix': ''},\n",
       "     {'first': 'M', 'middle': [], 'last': 'Sprenger', 'suffix': ''},\n",
       "     {'first': 'AC', 'middle': [], 'last': 'Bunck', 'suffix': ''},\n",
       "     {'first': 'MJ', 'middle': [], 'last': 'Dorer', 'suffix': ''}],\n",
       "    'year': 2016,\n",
       "    'venue': 'Mol Med.',\n",
       "    'volume': '22',\n",
       "    'issn': '',\n",
       "    'pages': '412-23',\n",
       "    'other_ids': {'DOI': ['10.2119/molmed.2016.00140']}},\n",
       "   'BIBREF17': {'title': 'ADAMTS13 activity is decreased in a septic porcine model',\n",
       "    'authors': [{'first': 'CL',\n",
       "      'middle': [],\n",
       "      'last': 'Bockmeyer',\n",
       "      'suffix': ''},\n",
       "     {'first': 'PA', 'middle': [], 'last': 'Reuken', 'suffix': ''},\n",
       "     {'first': 'TP', 'middle': [], 'last': 'Simon', 'suffix': ''},\n",
       "     {'first': 'U', 'middle': [], 'last': 'Budde', 'suffix': ''},\n",
       "     {'first': 'W', 'middle': [], 'last': 'Losche', 'suffix': ''},\n",
       "     {'first': 'M', 'middle': [], 'last': 'Bauer', 'suffix': ''}],\n",
       "    'year': 2011,\n",
       "    'venue': '',\n",
       "    'volume': '105',\n",
       "    'issn': '',\n",
       "    'pages': '145-53',\n",
       "    'other_ids': {'DOI': ['10.1160/TH10-03-0153']}},\n",
       "   'BIBREF18': {'title': 'Inverse correlation between plasma sphingosine-1-phosphate and ceramide concentrations in septic patients and their utility in predicting mortality',\n",
       "    'authors': [{'first': 'X', 'middle': [], 'last': 'Wu', 'suffix': ''},\n",
       "     {'first': 'J', 'middle': [], 'last': 'Hou', 'suffix': ''},\n",
       "     {'first': 'H', 'middle': [], 'last': 'Li', 'suffix': ''},\n",
       "     {'first': 'G', 'middle': [], 'last': 'Xie', 'suffix': ''},\n",
       "     {'first': 'X', 'middle': [], 'last': 'Zhang', 'suffix': ''},\n",
       "     {'first': 'J', 'middle': [], 'last': 'Zheng', 'suffix': ''}],\n",
       "    'year': 2019,\n",
       "    'venue': 'Shock.',\n",
       "    'volume': '51',\n",
       "    'issn': '',\n",
       "    'pages': '718-24',\n",
       "    'other_ids': {'DOI': ['10.1097/SHK.0000000000001229']}},\n",
       "   'BIBREF19': {'title': 'Roles and regulation of secretory and lysosomal acid sphingomyelinase',\n",
       "    'authors': [{'first': 'RW', 'middle': [], 'last': 'Jenkins', 'suffix': ''},\n",
       "     {'first': 'D', 'middle': [], 'last': 'Canals', 'suffix': ''},\n",
       "     {'first': 'YA', 'middle': [], 'last': 'Hannun', 'suffix': ''}],\n",
       "    'year': 2009,\n",
       "    'venue': 'Cell Signal.',\n",
       "    'volume': '21',\n",
       "    'issn': '',\n",
       "    'pages': '836-46',\n",
       "    'other_ids': {'DOI': ['10.1016/j.cellsig.2009.01.026']}},\n",
       "   'BIBREF20': {'title': 'Isolation of cDNA clones encoding human acid sphingomyelinase: occurrence of alternatively processed transcripts',\n",
       "    'authors': [{'first': 'LE',\n",
       "      'middle': [],\n",
       "      'last': 'Quintern',\n",
       "      'suffix': ''},\n",
       "     {'first': 'EH', 'middle': [], 'last': 'Schuchman', 'suffix': ''},\n",
       "     {'first': 'O', 'middle': [], 'last': 'Levran', 'suffix': ''},\n",
       "     {'first': 'M', 'middle': [], 'last': 'Suchi', 'suffix': ''},\n",
       "     {'first': 'K', 'middle': [], 'last': 'Ferlinz', 'suffix': ''},\n",
       "     {'first': 'H', 'middle': [], 'last': 'Reinke', 'suffix': ''}],\n",
       "    'year': 1989,\n",
       "    'venue': 'EMBO J',\n",
       "    'volume': '8',\n",
       "    'issn': '',\n",
       "    'pages': '2469-73',\n",
       "    'other_ids': {'DOI': ['10.1002/j.1460-2075.1989.tb08382.x']}},\n",
       "   'BIBREF21': {'title': 'Functional implications of novel human acid sphingomyelinase splice variants',\n",
       "    'authors': [{'first': 'C', 'middle': [], 'last': 'Rhein', 'suffix': ''},\n",
       "     {'first': 'P', 'middle': [], 'last': 'Tripal', 'suffix': ''},\n",
       "     {'first': 'A', 'middle': [], 'last': 'Seebahn', 'suffix': ''},\n",
       "     {'first': 'A', 'middle': [], 'last': 'Konrad', 'suffix': ''},\n",
       "     {'first': 'M', 'middle': [], 'last': 'Kramer', 'suffix': ''},\n",
       "     {'first': 'C', 'middle': [], 'last': 'Nagel', 'suffix': ''}],\n",
       "    'year': 2012,\n",
       "    'venue': 'PLoS ONE.',\n",
       "    'volume': '7',\n",
       "    'issn': '',\n",
       "    'pages': None,\n",
       "    'other_ids': {'DOI': ['10.1371/journal.pone.0035467']}},\n",
       "   'BIBREF22': {'title': 'Alternative splicing of SMPD1 in sepsis',\n",
       "    'authors': [{'first': 'M', 'middle': [], 'last': 'Kramer', 'suffix': ''},\n",
       "     {'first': 'S', 'middle': [], 'last': 'Quickert', 'suffix': ''},\n",
       "     {'first': 'C', 'middle': [], 'last': 'Sponholz', 'suffix': ''},\n",
       "     {'first': 'U', 'middle': [], 'last': 'Menzel', 'suffix': ''},\n",
       "     {'first': 'K', 'middle': [], 'last': 'Huse', 'suffix': ''},\n",
       "     {'first': 'M', 'middle': [], 'last': 'Platzer', 'suffix': ''}],\n",
       "    'year': 2015,\n",
       "    'venue': 'PLoS ONE.',\n",
       "    'volume': '10',\n",
       "    'issn': '',\n",
       "    'pages': None,\n",
       "    'other_ids': {'DOI': ['10.1371/journal.pone.0124503']}},\n",
       "   'BIBREF23': {'title': 'Acid sphingomyelinase',\n",
       "    'authors': [{'first': 'B', 'middle': [], 'last': 'Henry', 'suffix': ''},\n",
       "     {'first': 'R', 'middle': [], 'last': 'Ziobro', 'suffix': ''},\n",
       "     {'first': 'KA', 'middle': [], 'last': 'Becker', 'suffix': ''},\n",
       "     {'first': 'R', 'middle': [], 'last': 'Kolesnick', 'suffix': ''},\n",
       "     {'first': 'E', 'middle': [], 'last': 'Gulbins', 'suffix': ''}],\n",
       "    'year': 2013,\n",
       "    'venue': 'Handb Exp Pharmacol.',\n",
       "    'volume': '215',\n",
       "    'issn': '',\n",
       "    'pages': '77-88',\n",
       "    'other_ids': {'DOI': ['10.1007/978-3-7091-1368-4_4']}},\n",
       "   'BIBREF24': {'title': 'Acid sphingomyelinase-ceramide system mediates effects of antidepressant drugs',\n",
       "    'authors': [{'first': 'E', 'middle': [], 'last': 'Gulbins', 'suffix': ''},\n",
       "     {'first': 'M', 'middle': [], 'last': 'Palmada', 'suffix': ''},\n",
       "     {'first': 'M', 'middle': [], 'last': 'Reichel', 'suffix': ''},\n",
       "     {'first': 'A', 'middle': [], 'last': 'Luth', 'suffix': ''},\n",
       "     {'first': 'C', 'middle': [], 'last': 'Bohmer', 'suffix': ''},\n",
       "     {'first': 'D', 'middle': [], 'last': 'Amato', 'suffix': ''}],\n",
       "    'year': 2013,\n",
       "    'venue': 'Nat Med.',\n",
       "    'volume': '19',\n",
       "    'issn': '',\n",
       "    'pages': '934-8',\n",
       "    'other_ids': {'DOI': ['10.1038/nm.3214']}},\n",
       "   'BIBREF25': {'title': 'Secretory acid sphingomyelinase in the serum of medicated patients predicts the prospective course of depression',\n",
       "    'authors': [{'first': 'C', 'middle': [], 'last': 'Muhle', 'suffix': ''},\n",
       "     {'first': 'CJ', 'middle': [], 'last': 'Wagner', 'suffix': ''},\n",
       "     {'first': 'K', 'middle': [], 'last': 'Farber', 'suffix': ''},\n",
       "     {'first': 'T', 'middle': [], 'last': 'Richter-Schmidinger', 'suffix': ''},\n",
       "     {'first': 'E', 'middle': [], 'last': 'Gulbins', 'suffix': ''},\n",
       "     {'first': 'B', 'middle': [], 'last': 'Lenz', 'suffix': ''}],\n",
       "    'year': 2019,\n",
       "    'venue': 'J Clin Med.',\n",
       "    'volume': '8',\n",
       "    'issn': '',\n",
       "    'pages': None,\n",
       "    'other_ids': {'DOI': ['10.3390/jcm8060846']}},\n",
       "   'BIBREF26': {'title': 'Alternative splicing of SMPD1 coding for acid sphingomyelinase in major depression',\n",
       "    'authors': [{'first': 'C', 'middle': [], 'last': 'Rhein', 'suffix': ''},\n",
       "     {'first': 'M', 'middle': [], 'last': 'Reichel', 'suffix': ''},\n",
       "     {'first': 'M', 'middle': [], 'last': 'Kramer', 'suffix': ''},\n",
       "     {'first': 'A', 'middle': [], 'last': 'Rotter', 'suffix': ''},\n",
       "     {'first': 'B', 'middle': [], 'last': 'Lenz', 'suffix': ''},\n",
       "     {'first': 'C', 'middle': [], 'last': 'Muhle', 'suffix': ''}],\n",
       "    'year': 2017,\n",
       "    'venue': 'J Affect Disord.',\n",
       "    'volume': '209',\n",
       "    'issn': '',\n",
       "    'pages': '10-5',\n",
       "    'other_ids': {'DOI': ['10.1016/j.jad.2016.09.019']}},\n",
       "   'BIBREF27': {'title': 'A novel polymorphism in the human acid sphingomyelinase gene due to size variation of the signal peptide region',\n",
       "    'authors': [{'first': 'Q', 'middle': [], 'last': 'Wan', 'suffix': ''},\n",
       "     {'first': 'EH', 'middle': [], 'last': 'Schuchman', 'suffix': ''}],\n",
       "    'year': 1995,\n",
       "    'venue': 'Biochim Biophys Acta.',\n",
       "    'volume': '1270',\n",
       "    'issn': '',\n",
       "    'pages': '207-10',\n",
       "    'other_ids': {'DOI': ['10.1016/0925-4439(95)00050-E']}},\n",
       "   'BIBREF28': {'title': 'The acid sphingomyelinase sequence variant p.A487V is not associated with decreased levels of enzymatic activity',\n",
       "    'authors': [{'first': 'C', 'middle': [], 'last': 'Rhein', 'suffix': ''},\n",
       "     {'first': 'J', 'middle': [], 'last': 'Naumann', 'suffix': ''},\n",
       "     {'first': 'C', 'middle': [], 'last': 'Muhle', 'suffix': ''},\n",
       "     {'first': 'P', 'middle': [], 'last': 'Zill', 'suffix': ''},\n",
       "     {'first': 'M', 'middle': [], 'last': 'Adli', 'suffix': ''},\n",
       "     {'first': 'U', 'middle': [], 'last': 'Hegerl', 'suffix': ''}],\n",
       "    'year': 2013,\n",
       "    'venue': 'JIMD Rep.',\n",
       "    'volume': '8',\n",
       "    'issn': '',\n",
       "    'pages': '1-6',\n",
       "    'other_ids': {'DOI': ['10.1007/8904_2012_147']}},\n",
       "   'BIBREF29': {'title': 'The common acid sphingomyelinase polymorphism p.G508R is associated with self-reported allergy',\n",
       "    'authors': [{'first': 'M', 'middle': [], 'last': 'Reichel', 'suffix': ''},\n",
       "     {'first': 'T', 'middle': [], 'last': 'Richter-Schmidinger', 'suffix': ''},\n",
       "     {'first': 'C', 'middle': [], 'last': 'Muhle', 'suffix': ''},\n",
       "     {'first': 'C', 'middle': [], 'last': 'Rhein', 'suffix': ''},\n",
       "     {'first': 'P', 'middle': [], 'last': 'Alexopoulos', 'suffix': ''},\n",
       "     {'first': 'SG', 'middle': [], 'last': 'Schwab', 'suffix': ''}],\n",
       "    'year': 2014,\n",
       "    'venue': 'Cell Physiol Biochem.',\n",
       "    'volume': '34',\n",
       "    'issn': '',\n",
       "    'pages': '82-91',\n",
       "    'other_ids': {'DOI': ['10.1159/000362986']}},\n",
       "   'BIBREF30': {'title': 'Secretion of acid sphingomyelinase is affected by its polymorphic signal peptide',\n",
       "    'authors': [{'first': 'C', 'middle': [], 'last': 'Rhein', 'suffix': ''},\n",
       "     {'first': 'M', 'middle': [], 'last': 'Reichel', 'suffix': ''},\n",
       "     {'first': 'C', 'middle': [], 'last': 'Muhle', 'suffix': ''},\n",
       "     {'first': 'A', 'middle': [], 'last': 'Rotter', 'suffix': ''},\n",
       "     {'first': 'SG', 'middle': [], 'last': 'Schwab', 'suffix': ''},\n",
       "     {'first': 'J', 'middle': [], 'last': 'Kornhuber', 'suffix': ''}],\n",
       "    'year': 2014,\n",
       "    'venue': 'Cell Physiol Biochem.',\n",
       "    'volume': '34',\n",
       "    'issn': '',\n",
       "    'pages': '1385-401',\n",
       "    'other_ids': {'DOI': ['10.1159/000366345']}},\n",
       "   'BIBREF31': {'title': 'Alleged detrimental mutations in the smpd1 gene in patients with niemann-pick disease',\n",
       "    'authors': [{'first': 'C', 'middle': [], 'last': 'Rhein', 'suffix': ''},\n",
       "     {'first': 'C', 'middle': [], 'last': 'Muhle', 'suffix': ''},\n",
       "     {'first': 'J', 'middle': [], 'last': 'Kornhuber', 'suffix': ''},\n",
       "     {'first': 'M', 'middle': [], 'last': 'Reichel', 'suffix': ''}],\n",
       "    'year': 2015,\n",
       "    'venue': 'Int J Mol Sci.',\n",
       "    'volume': '16',\n",
       "    'issn': '',\n",
       "    'pages': '13649-52',\n",
       "    'other_ids': {'DOI': ['10.3390/ijms160613649']}},\n",
       "   'BIBREF32': {'title': 'Acid sphingomyelinase serum activity predicts mortality in intensive care unit patients after systemic inflammation: a prospective cohort study',\n",
       "    'authors': [{'first': 'M', 'middle': [], 'last': 'Kott', 'suffix': ''},\n",
       "     {'first': 'G', 'middle': [], 'last': 'Elke', 'suffix': ''},\n",
       "     {'first': 'M', 'middle': [], 'last': 'Reinicke', 'suffix': ''},\n",
       "     {'first': 'S', 'middle': [], 'last': 'Winoto-Morbach', 'suffix': ''},\n",
       "     {'first': 'D', 'middle': [], 'last': 'Schadler', 'suffix': ''},\n",
       "     {'first': 'G', 'middle': [], 'last': 'Zick', 'suffix': ''}],\n",
       "    'year': 2014,\n",
       "    'venue': 'PLoS ONE.',\n",
       "    'volume': '9',\n",
       "    'issn': '',\n",
       "    'pages': None,\n",
       "    'other_ids': {'DOI': ['10.1371/journal.pone.0112323']}},\n",
       "   'BIBREF33': {'title': 'Secretory sphingomyelinase (S-SMase) activity is elevated in patients with rheumatoid arthritis',\n",
       "    'authors': [{'first': 'BY', 'middle': [], 'last': 'Hanaoka', 'suffix': ''},\n",
       "     {'first': 'MJ', 'middle': [], 'last': 'Ormseth', 'suffix': ''},\n",
       "     {'first': 'C', 'middle': [], 'last': 'Michael Stein', 'suffix': ''},\n",
       "     {'first': 'D', 'middle': [], 'last': 'Banerjee', 'suffix': ''},\n",
       "     {'first': 'M',\n",
       "      'middle': [],\n",
       "      'last': 'Nikolova-Karakashian',\n",
       "      'suffix': ''},\n",
       "     {'first': 'LJ', 'middle': [], 'last': 'Crofford', 'suffix': ''}],\n",
       "    'year': 2018,\n",
       "    'venue': 'Clin Rheumatol.',\n",
       "    'volume': '37',\n",
       "    'issn': '',\n",
       "    'pages': '1395-9',\n",
       "    'other_ids': {'DOI': ['10.1007/s10067-017-3824-1']}},\n",
       "   'BIBREF34': {'title': 'The acid sphingomyelinase/ceramide pathway: biomedical significance and mechanisms of regulation',\n",
       "    'authors': [{'first': 'YH', 'middle': [], 'last': 'Zeidan', 'suffix': ''},\n",
       "     {'first': 'YA', 'middle': [], 'last': 'Hannun', 'suffix': ''}],\n",
       "    'year': 2010,\n",
       "    'venue': 'Curr Mol Med.',\n",
       "    'volume': '10',\n",
       "    'issn': '',\n",
       "    'pages': '454-66',\n",
       "    'other_ids': {'DOI': ['10.2174/156652410791608225']}},\n",
       "   'BIBREF35': {'title': 'Acid sphingomyelinase activity is elevated in the serum of rheumatoid arthritis patients, suppressed by anti-TNF-alpha treatment',\n",
       "    'authors': [{'first': 'HY', 'middle': [], 'last': 'Chung', 'suffix': ''},\n",
       "     {'first': 'J', 'middle': [], 'last': 'Wickel', 'suffix': ''},\n",
       "     {'first': 'B', 'middle': [], 'last': 'Stuhlmuller', 'suffix': ''},\n",
       "     {'first': 'RW', 'middle': [], 'last': 'Kinne', 'suffix': ''},\n",
       "     {'first': 'RA', 'middle': [], 'last': 'Claus', 'suffix': ''}],\n",
       "    'year': 2019,\n",
       "    'venue': 'Clin Exp Rheumatol.',\n",
       "    'volume': '37',\n",
       "    'issn': 'Suppl',\n",
       "    'pages': '18-9',\n",
       "    'other_ids': {'DOI': []}},\n",
       "   'BIBREF36': {'title': 'Ceramide concentrations in septic patients: a possible marker of multiple organ dysfunction syndrome',\n",
       "    'authors': [{'first': 'G', 'middle': [], 'last': 'Delogu', 'suffix': ''},\n",
       "     {'first': 'G', 'middle': [], 'last': 'Famularo', 'suffix': ''},\n",
       "     {'first': 'F', 'middle': [], 'last': 'Amati', 'suffix': ''},\n",
       "     {'first': 'L', 'middle': [], 'last': 'Signore', 'suffix': ''},\n",
       "     {'first': 'A', 'middle': [], 'last': 'Antonucci', 'suffix': ''},\n",
       "     {'first': 'V', 'middle': [], 'last': 'Trinchieri', 'suffix': ''}],\n",
       "    'year': 1999,\n",
       "    'venue': 'Crit Care Med.',\n",
       "    'volume': '27',\n",
       "    'issn': '',\n",
       "    'pages': '2413-7',\n",
       "    'other_ids': {'DOI': ['10.1097/00003246-199911000-00015']}},\n",
       "   'BIBREF37': {'title': 'Evaluation of the role of secretory sphingomyelinase and bioactive sphingolipids as biomarkers in hemophagocytic lymphohistiocytosis',\n",
       "    'authors': [{'first': 'RW', 'middle': [], 'last': 'Jenkins', 'suffix': ''},\n",
       "     {'first': 'CJ', 'middle': [], 'last': 'Clarke', 'suffix': ''},\n",
       "     {'first': 'JTJr', 'middle': [], 'last': 'Lucas', 'suffix': ''},\n",
       "     {'first': 'M', 'middle': [], 'last': 'Shabbir', 'suffix': ''},\n",
       "     {'first': 'BX', 'middle': [], 'last': 'Wu', 'suffix': ''},\n",
       "     {'first': 'F', 'middle': [], 'last': 'Simbari', 'suffix': ''}],\n",
       "    'year': 2013,\n",
       "    'venue': 'Am J Hematol.',\n",
       "    'volume': '88',\n",
       "    'issn': '',\n",
       "    'pages': 'E265-72',\n",
       "    'other_ids': {'DOI': ['10.1002/ajh.23535']}},\n",
       "   'BIBREF38': {'title': 'Elevated sphingomyelinase and hypercytokinemia in hemophagocytic lymphohistiocytosis',\n",
       "    'authors': [{'first': 'T',\n",
       "      'middle': [],\n",
       "      'last': 'Takahashi',\n",
       "      'suffix': ''},\n",
       "     {'first': 'T', 'middle': [], 'last': 'Abe', 'suffix': ''},\n",
       "     {'first': 'T', 'middle': [], 'last': 'Sato', 'suffix': ''},\n",
       "     {'first': 'K', 'middle': [], 'last': 'Miura', 'suffix': ''},\n",
       "     {'first': 'I', 'middle': [], 'last': 'Takahashi', 'suffix': ''},\n",
       "     {'first': 'M', 'middle': [], 'last': 'Yano', 'suffix': ''}],\n",
       "    'year': 2002,\n",
       "    'venue': 'J Pediatr Hematol Oncol.',\n",
       "    'volume': '24',\n",
       "    'issn': '',\n",
       "    'pages': '401-4',\n",
       "    'other_ids': {'DOI': ['10.1097/00043426-200206000-00016']}},\n",
       "   'BIBREF39': {'title': 'Anti-inflammatory properties of desipramine and fluoxetine',\n",
       "    'authors': [{'first': 'C',\n",
       "      'middle': [],\n",
       "      'last': 'Roumestan',\n",
       "      'suffix': ''},\n",
       "     {'first': 'A', 'middle': [], 'last': 'Michel', 'suffix': ''},\n",
       "     {'first': 'F', 'middle': [], 'last': 'Bichon', 'suffix': ''},\n",
       "     {'first': 'K', 'middle': [], 'last': 'Portet', 'suffix': ''},\n",
       "     {'first': 'M', 'middle': [], 'last': 'Detoc', 'suffix': ''},\n",
       "     {'first': 'C', 'middle': [], 'last': 'Henriquet', 'suffix': ''}],\n",
       "    'year': 2007,\n",
       "    'venue': 'Respir Res.',\n",
       "    'volume': '8',\n",
       "    'issn': '',\n",
       "    'pages': None,\n",
       "    'other_ids': {'DOI': ['10.1186/1465-9921-8-35']}},\n",
       "   'BIBREF40': {'title': 'Amitriptyline reduces inflammation and mortality in a murine model of sepsis',\n",
       "    'authors': [{'first': 'BT', 'middle': [], 'last': 'Xia', 'suffix': ''},\n",
       "     {'first': 'N', 'middle': [], 'last': 'Beckmann', 'suffix': ''},\n",
       "     {'first': 'LK', 'middle': [], 'last': 'Winer', 'suffix': ''},\n",
       "     {'first': 'AM', 'middle': [], 'last': 'Pugh', 'suffix': ''},\n",
       "     {'first': 'TA', 'middle': [], 'last': 'Pritts', 'suffix': ''},\n",
       "     {'first': 'V', 'middle': [], 'last': 'Nomellini', 'suffix': ''}],\n",
       "    'year': 2019,\n",
       "    'venue': 'Cell Physiol Biochem.',\n",
       "    'volume': '52',\n",
       "    'issn': '',\n",
       "    'pages': '565-79',\n",
       "    'other_ids': {'DOI': ['10.33594/000000040']}},\n",
       "   'BIBREF41': {'title': 'Serum bilirubin levels on ICU admission are associated with ARDS development and mortality in sepsis',\n",
       "    'authors': [{'first': 'R', 'middle': [], 'last': 'Zhai', 'suffix': ''},\n",
       "     {'first': 'CC', 'middle': [], 'last': 'Sheu', 'suffix': ''},\n",
       "     {'first': 'L', 'middle': [], 'last': 'Su', 'suffix': ''},\n",
       "     {'first': 'MN', 'middle': [], 'last': 'Gong', 'suffix': ''},\n",
       "     {'first': 'P', 'middle': [], 'last': 'Tejera', 'suffix': ''},\n",
       "     {'first': 'F', 'middle': [], 'last': 'Chen', 'suffix': ''}],\n",
       "    'year': 2009,\n",
       "    'venue': 'Thorax.',\n",
       "    'volume': '64',\n",
       "    'issn': '',\n",
       "    'pages': '784-90',\n",
       "    'other_ids': {'DOI': ['10.1136/thx.2009.113464']}},\n",
       "   'BIBREF42': {'title': 'Liver dysfunction and phosphatidylinositol-3-kinase signalling in early sepsis: experimental studies in rodent models of peritonitis',\n",
       "    'authors': [{'first': 'P',\n",
       "      'middle': [],\n",
       "      'last': 'Recknagel',\n",
       "      'suffix': ''},\n",
       "     {'first': 'FA', 'middle': [], 'last': 'Gonnert', 'suffix': ''},\n",
       "     {'first': 'M', 'middle': [], 'last': 'Westermann', 'suffix': ''},\n",
       "     {'first': 'S', 'middle': [], 'last': 'Lambeck', 'suffix': ''},\n",
       "     {'first': 'A', 'middle': [], 'last': 'Lupp', 'suffix': ''},\n",
       "     {'first': 'A', 'middle': [], 'last': 'Rudiger', 'suffix': ''}],\n",
       "    'year': 2012,\n",
       "    'venue': 'PLoS Med.',\n",
       "    'volume': '9',\n",
       "    'issn': '',\n",
       "    'pages': None,\n",
       "    'other_ids': {'DOI': ['10.1371/journal.pmed.1001338']}},\n",
       "   'BIBREF43': {'title': 'Poor outcome in progressive sclerosing cholangitis after septic shock',\n",
       "    'authors': [{'first': 'H', 'middle': [], 'last': 'Kulaksiz', 'suffix': ''},\n",
       "     {'first': 'D', 'middle': [], 'last': 'Heuberger', 'suffix': ''},\n",
       "     {'first': 'S', 'middle': [], 'last': 'Engler', 'suffix': ''},\n",
       "     {'first': 'A', 'middle': [], 'last': 'Stiehl', 'suffix': ''}],\n",
       "    'year': 2008,\n",
       "    'venue': 'Endoscopy.',\n",
       "    'volume': '40',\n",
       "    'issn': '',\n",
       "    'pages': '214-8',\n",
       "    'other_ids': {'DOI': ['10.1055/s-2007-967024']}},\n",
       "   'BIBREF44': {'title': 'Conjugated bilirubin triggers anemia by inducing erythrocyte death',\n",
       "    'authors': [{'first': 'E', 'middle': [], 'last': 'Lang', 'suffix': ''},\n",
       "     {'first': 'S', 'middle': [], 'last': 'Gatidis', 'suffix': ''},\n",
       "     {'first': 'NF', 'middle': [], 'last': 'Freise', 'suffix': ''},\n",
       "     {'first': 'H', 'middle': [], 'last': 'Bock', 'suffix': ''},\n",
       "     {'first': 'R', 'middle': [], 'last': 'Kubitz', 'suffix': ''},\n",
       "     {'first': 'C', 'middle': [], 'last': 'Lauermann', 'suffix': ''}],\n",
       "    'year': 2015,\n",
       "    'venue': 'Hepatology.',\n",
       "    'volume': '61',\n",
       "    'issn': '',\n",
       "    'pages': '275-84',\n",
       "    'other_ids': {'DOI': ['10.1002/hep.27338']}},\n",
       "   'BIBREF45': {'title': 'Human acid sphingomyelinase. isolation, nucleotide sequence and expression of the full-length and alternatively spliced cDNAs',\n",
       "    'authors': [{'first': 'EH',\n",
       "      'middle': [],\n",
       "      'last': 'Schuchman',\n",
       "      'suffix': ''},\n",
       "     {'first': 'M', 'middle': [], 'last': 'Suchi', 'suffix': ''},\n",
       "     {'first': 'T', 'middle': [], 'last': 'Takahashi', 'suffix': ''},\n",
       "     {'first': 'K', 'middle': [], 'last': 'Sandhoff', 'suffix': ''},\n",
       "     {'first': 'RJ', 'middle': [], 'last': 'Desnick', 'suffix': ''}],\n",
       "    'year': 1991,\n",
       "    'venue': 'J Biol Chem.',\n",
       "    'volume': '266',\n",
       "    'issn': '',\n",
       "    'pages': '8531-9',\n",
       "    'other_ids': {'DOI': []}},\n",
       "   'BIBREF46': {'title': 'The prevalence of anemia and its association with 90-day mortality in hospitalized community-acquired pneumonia',\n",
       "    'authors': [{'first': 'MC', 'middle': [], 'last': 'Reade', 'suffix': ''},\n",
       "     {'first': 'L', 'middle': [], 'last': 'Weissfeld', 'suffix': ''},\n",
       "     {'first': 'DC', 'middle': [], 'last': 'Angus', 'suffix': ''},\n",
       "     {'first': 'JA', 'middle': [], 'last': 'Kellum', 'suffix': ''},\n",
       "     {'first': 'EB', 'middle': [], 'last': 'Milbrandt', 'suffix': ''}],\n",
       "    'year': 2010,\n",
       "    'venue': 'BMC Pulm Med.',\n",
       "    'volume': '10',\n",
       "    'issn': '',\n",
       "    'pages': None,\n",
       "    'other_ids': {'DOI': ['10.1186/1471-2466-10-15']}},\n",
       "   'BIBREF47': {'title': 'Acid sphingomyelinase mediates murine acute lung injury following transfusion of aged platelets',\n",
       "    'authors': [{'first': 'MJ', 'middle': [], 'last': 'McVey', 'suffix': ''},\n",
       "     {'first': 'M', 'middle': [], 'last': 'Kim', 'suffix': ''},\n",
       "     {'first': 'A', 'middle': [], 'last': 'Tabuchi', 'suffix': ''},\n",
       "     {'first': 'V', 'middle': [], 'last': 'Srbely', 'suffix': ''},\n",
       "     {'first': 'L', 'middle': [], 'last': 'Japtok', 'suffix': ''},\n",
       "     {'first': 'C', 'middle': [], 'last': 'Arenz', 'suffix': ''}],\n",
       "    'year': 2017,\n",
       "    'venue': '',\n",
       "    'volume': '312',\n",
       "    'issn': '',\n",
       "    'pages': 'L625-37',\n",
       "    'other_ids': {'DOI': ['10.1152/ajplung.00317.2016']}},\n",
       "   'BIBREF48': {'title': 'Tricyclic antidepressants induce sphingomyelinase deficiency in fibroblast and neuroblastoma cell cultures',\n",
       "    'authors': [{'first': 'S', 'middle': [], 'last': 'Albouz', 'suffix': ''},\n",
       "     {'first': 'JJ', 'middle': [], 'last': 'Hauw', 'suffix': ''},\n",
       "     {'first': 'Y', 'middle': [], 'last': 'Berwald-Netter', 'suffix': ''},\n",
       "     {'first': 'JM', 'middle': [], 'last': 'Boutry', 'suffix': ''},\n",
       "     {'first': 'R', 'middle': [], 'last': 'Bourdon', 'suffix': ''},\n",
       "     {'first': 'N', 'middle': [], 'last': 'Baumann', 'suffix': ''}],\n",
       "    'year': 1981,\n",
       "    'venue': 'Biomedicine.',\n",
       "    'volume': '35',\n",
       "    'issn': '',\n",
       "    'pages': '218-20',\n",
       "    'other_ids': {'DOI': []}},\n",
       "   'BIBREF49': {'title': 'The tricyclic antidepressant desipramine causes proteolytic degradation of lysosomal sphingomyelinase in human fibroblasts',\n",
       "    'authors': [{'first': 'R', 'middle': [], 'last': 'Hurwitz', 'suffix': ''},\n",
       "     {'first': 'K', 'middle': [], 'last': 'Ferlinz', 'suffix': ''},\n",
       "     {'first': 'K', 'middle': [], 'last': 'Sandhoff', 'suffix': ''}],\n",
       "    'year': 1994,\n",
       "    'venue': 'Biol Chem Hoppe Seyler.',\n",
       "    'volume': '375',\n",
       "    'issn': '',\n",
       "    'pages': '447-50',\n",
       "    'other_ids': {'DOI': ['10.1515/bchm3.1994.375.7.447']}},\n",
       "   'BIBREF50': {'title': 'Interactions of acid sphingomyelinase and lipid bilayers in the presence of the tricyclic antidepressant desipramine',\n",
       "    'authors': [{'first': 'M', 'middle': [], 'last': 'Kolzer', 'suffix': ''},\n",
       "     {'first': 'N', 'middle': [], 'last': 'Werth', 'suffix': ''},\n",
       "     {'first': 'K', 'middle': [], 'last': 'Sandhoff', 'suffix': ''}],\n",
       "    'year': 2004,\n",
       "    'venue': 'FEBS Lett.',\n",
       "    'volume': '559',\n",
       "    'issn': '',\n",
       "    'pages': '96-8',\n",
       "    'other_ids': {'DOI': ['10.1016/S0014-5793(04)00033-X']}},\n",
       "   'BIBREF51': {'title': 'Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model',\n",
       "    'authors': [{'first': 'J',\n",
       "      'middle': [],\n",
       "      'last': 'Kornhuber',\n",
       "      'suffix': ''},\n",
       "     {'first': 'P', 'middle': [], 'last': 'Tripal', 'suffix': ''},\n",
       "     {'first': 'M', 'middle': [], 'last': 'Reichel', 'suffix': ''},\n",
       "     {'first': 'L', 'middle': [], 'last': 'Terfloth', 'suffix': ''},\n",
       "     {'first': 'S', 'middle': [], 'last': 'Bleich', 'suffix': ''},\n",
       "     {'first': 'J', 'middle': [], 'last': 'Wiltfang', 'suffix': ''}],\n",
       "    'year': 2008,\n",
       "    'venue': 'J Med Chem.',\n",
       "    'volume': '51',\n",
       "    'issn': '',\n",
       "    'pages': '219-37',\n",
       "    'other_ids': {'DOI': ['10.1021/jm070524a']}},\n",
       "   'BIBREF52': {'title': 'NB 06: from a simple lysosomotropic aSMase inhibitor to tools for elucidating the role of lysosomes in signaling apoptosis and LPS-induced inflammation',\n",
       "    'authors': [{'first': 'M', 'middle': [], 'last': 'Blaess', 'suffix': ''},\n",
       "     {'first': 'N', 'middle': [], 'last': 'Bibak', 'suffix': ''},\n",
       "     {'first': 'RA', 'middle': [], 'last': 'Claus', 'suffix': ''},\n",
       "     {'first': 'M', 'middle': [], 'last': 'Kohl', 'suffix': ''},\n",
       "     {'first': 'GA', 'middle': [], 'last': 'Bonaterra', 'suffix': ''},\n",
       "     {'first': 'R', 'middle': [], 'last': 'Kinscherf', 'suffix': ''}],\n",
       "    'year': 2018,\n",
       "    'venue': 'Eur J Med Chem.',\n",
       "    'volume': '153',\n",
       "    'issn': '',\n",
       "    'pages': '73-104',\n",
       "    'other_ids': {'DOI': ['10.1016/j.ejmech.2017.09.021']}},\n",
       "   'BIBREF53': {'title': 'Adjustment of dysregulated ceramide metabolism in a murine model of sepsis-induced cardiac dysfunction',\n",
       "    'authors': [{'first': 'HY', 'middle': [], 'last': 'Chung', 'suffix': ''},\n",
       "     {'first': 'AS', 'middle': [], 'last': 'Kollmey', 'suffix': ''},\n",
       "     {'first': 'A', 'middle': [], 'last': 'Schrepper', 'suffix': ''},\n",
       "     {'first': 'M', 'middle': [], 'last': 'Kohl', 'suffix': ''},\n",
       "     {'first': 'MF', 'middle': [], 'last': 'Blass', 'suffix': ''},\n",
       "     {'first': 'SN', 'middle': [], 'last': 'Stehr', 'suffix': ''}],\n",
       "    'year': 2017,\n",
       "    'venue': 'Int J Mol Sci',\n",
       "    'volume': '18',\n",
       "    'issn': '',\n",
       "    'pages': None,\n",
       "    'other_ids': {'DOI': ['10.3390/ijms18040839']}},\n",
       "   'BIBREF54': {'title': 'Sphingomyelinase stimulates oxidant signaling to weaken skeletal muscle and promote fatigue',\n",
       "    'authors': [{'first': 'LF',\n",
       "      'middle': [],\n",
       "      'last': 'Ferreira',\n",
       "      'suffix': ''},\n",
       "     {'first': 'JS', 'middle': [], 'last': 'Moylan', 'suffix': ''},\n",
       "     {'first': 'LA', 'middle': [], 'last': 'Gilliam', 'suffix': ''},\n",
       "     {'first': 'JD', 'middle': [], 'last': 'Smith', 'suffix': ''},\n",
       "     {'first': 'M',\n",
       "      'middle': [],\n",
       "      'last': 'Nikolova-Karakashian',\n",
       "      'suffix': ''},\n",
       "     {'first': 'MB', 'middle': [], 'last': 'Reid', 'suffix': ''}],\n",
       "    'year': 2010,\n",
       "    'venue': 'Am J Physiol Cell Physiol.',\n",
       "    'volume': '299',\n",
       "    'issn': '',\n",
       "    'pages': 'C552-60',\n",
       "    'other_ids': {'DOI': ['10.1152/ajpcell.00065.2010']}},\n",
       "   'BIBREF55': {'title': 'Sphingomyelinase depresses force and calcium sensitivity of the contractile apparatus in mouse diaphragm muscle fibers',\n",
       "    'authors': [{'first': 'LF',\n",
       "      'middle': [],\n",
       "      'last': 'Ferreira',\n",
       "      'suffix': ''},\n",
       "     {'first': 'JS', 'middle': [], 'last': 'Moylan', 'suffix': ''},\n",
       "     {'first': 'S', 'middle': [], 'last': 'Stasko', 'suffix': ''},\n",
       "     {'first': 'JD', 'middle': [], 'last': 'Smith', 'suffix': ''},\n",
       "     {'first': 'KS', 'middle': [], 'last': 'Campbell', 'suffix': ''}],\n",
       "    'year': 2012,\n",
       "    'venue': 'J Appl Physiol 1985',\n",
       "    'volume': '112',\n",
       "    'issn': '',\n",
       "    'pages': '1538-45',\n",
       "    'other_ids': {'DOI': ['10.1152/japplphysiol.01269.2011']}},\n",
       "   'BIBREF56': {'title': 'Structural organization and complete nucleotide sequence of the gene encoding human acid sphingomyelinase (SMPD1)',\n",
       "    'authors': [{'first': 'EH',\n",
       "      'middle': [],\n",
       "      'last': 'Schuchman',\n",
       "      'suffix': ''},\n",
       "     {'first': 'O', 'middle': [], 'last': 'Levran', 'suffix': ''},\n",
       "     {'first': 'LV', 'middle': [], 'last': 'Pereira', 'suffix': ''},\n",
       "     {'first': 'RJ', 'middle': [], 'last': 'Desnick', 'suffix': ''}],\n",
       "    'year': 1992,\n",
       "    'venue': 'Genomics.',\n",
       "    'volume': '12',\n",
       "    'issn': '',\n",
       "    'pages': '197-205',\n",
       "    'other_ids': {'DOI': ['10.1016/0888-7543(92)90366-Z']}},\n",
       "   'BIBREF57': {'title': 'Diaphragm dysfunction caused by sphingomyelinase requires the p47(phox) subunit of NADPH oxidase',\n",
       "    'authors': [{'first': 'ER', 'middle': [], 'last': 'Bost', 'suffix': ''},\n",
       "     {'first': 'GS', 'middle': [], 'last': 'Frye', 'suffix': ''},\n",
       "     {'first': 'B', 'middle': [], 'last': 'Ahn', 'suffix': ''},\n",
       "     {'first': 'LF', 'middle': [], 'last': 'Ferreira', 'suffix': ''}],\n",
       "    'year': 2015,\n",
       "    'venue': 'Respir Physiol Neurobiol.',\n",
       "    'volume': '205',\n",
       "    'issn': '',\n",
       "    'pages': '47-52',\n",
       "    'other_ids': {'DOI': ['10.1016/j.resp.2014.10.011']}},\n",
       "   'BIBREF58': {'title': 'Acid sphingomyelinase inhibitors, imipramine and zoledronic acid, increase skeletal muscle tissue sensitivity to insulin action at old age',\n",
       "    'authors': [{'first': 'LK',\n",
       "      'middle': [],\n",
       "      'last': 'Hassouneh',\n",
       "      'suffix': ''},\n",
       "     {'first': 'OA', 'middle': [], 'last': 'Timofiychuk', 'suffix': ''},\n",
       "     {'first': 'NA', 'middle': [], 'last': 'Babenko', 'suffix': ''}],\n",
       "    'year': 2018,\n",
       "    'venue': 'Gen Physiol Biophys.',\n",
       "    'volume': '37',\n",
       "    'issn': '',\n",
       "    'pages': '163-74',\n",
       "    'other_ids': {'DOI': ['10.4149/gpb_2017020']}},\n",
       "   'BIBREF59': {'title': 'The role of sphingosine-1-phosphate in skeletal muscle: physiology, mechanisms, and clinical perspectives',\n",
       "    'authors': [{'first': 'AV',\n",
       "      'middle': [],\n",
       "      'last': 'Cordeiro',\n",
       "      'suffix': ''},\n",
       "     {'first': 'VRR', 'middle': [], 'last': 'Silva', 'suffix': ''},\n",
       "     {'first': 'JR', 'middle': [], 'last': 'Pauli', 'suffix': ''},\n",
       "     {'first': 'ASR', 'middle': [], 'last': 'da Silva', 'suffix': ''},\n",
       "     {'first': 'DE', 'middle': [], 'last': 'Cintra', 'suffix': ''},\n",
       "     {'first': 'LP', 'middle': [], 'last': 'Moura', 'suffix': ''}],\n",
       "    'year': 2019,\n",
       "    'venue': 'J Cell Physiol.',\n",
       "    'volume': '234',\n",
       "    'issn': '',\n",
       "    'pages': '10047-59',\n",
       "    'other_ids': {'DOI': ['10.1002/jcp.27870']}},\n",
       "   'BIBREF60': {'title': 'Reevaluation of lung injury in TNF-induced shock: the role of the acid sphingomyelinase',\n",
       "    'authors': [{'first': 'LK', 'middle': [], 'last': 'Reiss', 'suffix': ''},\n",
       "     {'first': 'U', 'middle': [], 'last': 'Raffetseder', 'suffix': ''},\n",
       "     {'first': 'L', 'middle': [], 'last': 'Gibbert', 'suffix': ''},\n",
       "     {'first': 'HK', 'middle': [], 'last': 'Drescher', 'suffix': ''},\n",
       "     {'first': 'KL', 'middle': [], 'last': 'Streetz', 'suffix': ''},\n",
       "     {'first': 'A', 'middle': [], 'last': 'Schwarz', 'suffix': ''}],\n",
       "    'year': 2020,\n",
       "    'venue': 'Mediators Inflamm.',\n",
       "    'volume': '2020',\n",
       "    'issn': '',\n",
       "    'pages': None,\n",
       "    'other_ids': {'DOI': ['10.1155/2020/3650508']}},\n",
       "   'BIBREF61': {'title': 'Laboratory models of sepsis and septic shock',\n",
       "    'authors': [{'first': 'MP', 'middle': [], 'last': 'Fink', 'suffix': ''},\n",
       "     {'first': 'SO', 'middle': [], 'last': 'Heard', 'suffix': ''}],\n",
       "    'year': 1990,\n",
       "    'venue': 'J Surg Res.',\n",
       "    'volume': '49',\n",
       "    'issn': '',\n",
       "    'pages': '186-96',\n",
       "    'other_ids': {'DOI': ['10.1016/0022-4804(90)90260-9']}},\n",
       "   'BIBREF62': {'title': \"Activation of endothelial nitric-oxide synthase by tumor necrosis factor-alpha: a novel pathway involving sequential activation of neutral sphingomyelinase, phosphatidylinositol-3' kinase, and Akt\",\n",
       "    'authors': [{'first': 'R',\n",
       "      'middle': [],\n",
       "      'last': 'Barsacchi',\n",
       "      'suffix': ''},\n",
       "     {'first': 'C', 'middle': [], 'last': 'Perrotta', 'suffix': ''},\n",
       "     {'first': 'S', 'middle': [], 'last': 'Bulotta', 'suffix': ''},\n",
       "     {'first': 'S', 'middle': [], 'last': 'Moncada', 'suffix': ''},\n",
       "     {'first': 'N', 'middle': [], 'last': 'Borgese', 'suffix': ''},\n",
       "     {'first': 'E', 'middle': [], 'last': 'Clementi', 'suffix': ''}],\n",
       "    'year': 2003,\n",
       "    'venue': 'Mol Pharmacol.',\n",
       "    'volume': '63',\n",
       "    'issn': '',\n",
       "    'pages': '886-95',\n",
       "    'other_ids': {'DOI': ['10.1124/mol.63.4.886']}},\n",
       "   'BIBREF63': {'title': 'Acid sphingomyelinase inhibition prevents development of sepsis sequelae in the murine liver',\n",
       "    'authors': [{'first': 'HY', 'middle': [], 'last': 'Chung', 'suffix': ''},\n",
       "     {'first': 'CJ', 'middle': [], 'last': 'Witt', 'suffix': ''},\n",
       "     {'first': 'N', 'middle': [], 'last': 'Jbeily', 'suffix': ''},\n",
       "     {'first': 'J', 'middle': [], 'last': 'Hurtado-Oliveros', 'suffix': ''},\n",
       "     {'first': 'B', 'middle': [], 'last': 'Giszas', 'suffix': ''},\n",
       "     {'first': 'A', 'middle': [], 'last': 'Lupp', 'suffix': ''}],\n",
       "    'year': 2017,\n",
       "    'venue': 'Sci Rep',\n",
       "    'volume': '7',\n",
       "    'issn': '',\n",
       "    'pages': None,\n",
       "    'other_ids': {'DOI': ['10.1038/s41598-017-11837-2']}},\n",
       "   'BIBREF64': {'title': 'The role of sphingolipid metabolism disruption on lipopolysaccharide-induced lung injury in mice',\n",
       "    'authors': [{'first': 'RT', 'middle': [], 'last': 'Okuro', 'suffix': ''},\n",
       "     {'first': 'MN', 'middle': [], 'last': 'Machado', 'suffix': ''},\n",
       "     {'first': 'NV', 'middle': [], 'last': 'Casquilho', 'suffix': ''},\n",
       "     {'first': 'A', 'middle': [], 'last': 'Jardim-Neto', 'suffix': ''},\n",
       "     {'first': 'A', 'middle': [], 'last': 'Roncally-Carvalho', 'suffix': ''},\n",
       "     {'first': 'GC', 'middle': [], 'last': 'Atella', 'suffix': ''}],\n",
       "    'year': 2018,\n",
       "    'venue': 'Pulm Pharmacol Ther.',\n",
       "    'volume': '50',\n",
       "    'issn': '',\n",
       "    'pages': '100-10',\n",
       "    'other_ids': {'DOI': ['10.1016/j.pupt.2018.04.008']}},\n",
       "   'BIBREF65': {'title': 'PAF-mediated pulmonary edema: a new role for acid sphingomyelinase and ceramide',\n",
       "    'authors': [{'first': 'R', 'middle': [], 'last': 'Goggel', 'suffix': ''},\n",
       "     {'first': 'S', 'middle': [], 'last': 'Winoto-Morbach', 'suffix': ''},\n",
       "     {'first': 'G', 'middle': [], 'last': 'Vielhaber', 'suffix': ''},\n",
       "     {'first': 'Y', 'middle': [], 'last': 'Imai', 'suffix': ''},\n",
       "     {'first': 'K', 'middle': [], 'last': 'Lindner', 'suffix': ''},\n",
       "     {'first': 'L', 'middle': [], 'last': 'Brade', 'suffix': ''}],\n",
       "    'year': 2004,\n",
       "    'venue': 'Nat Med.',\n",
       "    'volume': '10',\n",
       "    'issn': '',\n",
       "    'pages': '155-60',\n",
       "    'other_ids': {'DOI': ['10.1038/nm977']}},\n",
       "   'BIBREF66': {'title': 'Increased liver stiffness denotes hepatic dysfunction and mortality risk in critically ill non-cirrhotic patients at a medical ICU',\n",
       "    'authors': [{'first': 'A', 'middle': [], 'last': 'Koch', 'suffix': ''},\n",
       "     {'first': 'A', 'middle': [], 'last': 'Horn', 'suffix': ''},\n",
       "     {'first': 'H', 'middle': [], 'last': 'Duckers', 'suffix': ''},\n",
       "     {'first': 'E', 'middle': [], 'last': 'Yagmur', 'suffix': ''},\n",
       "     {'first': 'E', 'middle': [], 'last': 'Sanson', 'suffix': ''},\n",
       "     {'first': 'J', 'middle': [], 'last': 'Bruensing', 'suffix': ''}],\n",
       "    'year': 2011,\n",
       "    'venue': 'Crit Care.',\n",
       "    'volume': '15',\n",
       "    'issn': '',\n",
       "    'pages': None,\n",
       "    'other_ids': {'DOI': ['10.1186/cc10543']}},\n",
       "   'BIBREF67': {'title': 'Molecular cloning of the acid sphingomyelinase of the mouse and the organization and complete nucleotide sequence of the gene',\n",
       "    'authors': [{'first': 'D',\n",
       "      'middle': [],\n",
       "      'last': 'Newrzella',\n",
       "      'suffix': ''},\n",
       "     {'first': 'W', 'middle': [], 'last': 'Stoffel', 'suffix': ''}],\n",
       "    'year': 1992,\n",
       "    'venue': 'Biol Chem Hoppe Seyler.',\n",
       "    'volume': '373',\n",
       "    'issn': '',\n",
       "    'pages': '1233-8',\n",
       "    'other_ids': {'DOI': ['10.1515/bchm3.1992.373.2.1233']}},\n",
       "   'BIBREF68': {'title': 'Clinical review: the liver in sepsis',\n",
       "    'authors': [{'first': 'N', 'middle': [], 'last': 'Nesseler', 'suffix': ''},\n",
       "     {'first': 'Y', 'middle': [], 'last': 'Launey', 'suffix': ''},\n",
       "     {'first': 'C', 'middle': [], 'last': 'Aninat', 'suffix': ''},\n",
       "     {'first': 'F', 'middle': [], 'last': 'Morel', 'suffix': ''},\n",
       "     {'first': 'Y', 'middle': [], 'last': 'Malledant', 'suffix': ''},\n",
       "     {'first': 'P', 'middle': [], 'last': 'Seguin', 'suffix': ''}],\n",
       "    'year': 2012,\n",
       "    'venue': 'Crit Care.',\n",
       "    'volume': '16',\n",
       "    'issn': '',\n",
       "    'pages': None,\n",
       "    'other_ids': {'DOI': ['10.1186/cc11381']}},\n",
       "   'BIBREF69': {'title': 'Liver - guardian, modifier and target of sepsis',\n",
       "    'authors': [{'first': 'P', 'middle': [], 'last': 'Strnad', 'suffix': ''},\n",
       "     {'first': 'F', 'middle': [], 'last': 'Tacke', 'suffix': ''},\n",
       "     {'first': 'A', 'middle': [], 'last': 'Koch', 'suffix': ''},\n",
       "     {'first': 'C', 'middle': [], 'last': 'Trautwein', 'suffix': ''}],\n",
       "    'year': 2017,\n",
       "    'venue': 'Nat Rev Gastroenterol Hepatol.',\n",
       "    'volume': '14',\n",
       "    'issn': '',\n",
       "    'pages': '55-66',\n",
       "    'other_ids': {'DOI': ['10.1038/nrgastro.2016.168']}},\n",
       "   'BIBREF70': {'title': 'Liver injury and failure in critical illness',\n",
       "    'authors': [{'first': 'T',\n",
       "      'middle': [],\n",
       "      'last': 'Horvatits',\n",
       "      'suffix': ''},\n",
       "     {'first': 'A', 'middle': [], 'last': 'Drolz', 'suffix': ''},\n",
       "     {'first': 'M', 'middle': [], 'last': 'Trauner', 'suffix': ''},\n",
       "     {'first': 'V', 'middle': [], 'last': 'Fuhrmann', 'suffix': ''}],\n",
       "    'year': 2019,\n",
       "    'venue': 'Hepatology.',\n",
       "    'volume': '70',\n",
       "    'issn': '',\n",
       "    'pages': '2204-15',\n",
       "    'other_ids': {'DOI': ['10.1002/hep.30824']}},\n",
       "   'BIBREF71': {'title': 'Inhibition of acidic sphingomyelinase reduces established hepatic fibrosis in mice',\n",
       "    'authors': [{'first': 'RC',\n",
       "      'middle': [],\n",
       "      'last': 'Quillin',\n",
       "      'suffix': 'III'},\n",
       "     {'first': 'GC', 'middle': [], 'last': 'Wilson', 'suffix': ''},\n",
       "     {'first': 'H', 'middle': [], 'last': 'Nojima', 'suffix': ''},\n",
       "     {'first': 'CM', 'middle': [], 'last': 'Freeman', 'suffix': ''},\n",
       "     {'first': 'J', 'middle': [], 'last': 'Wang', 'suffix': ''},\n",
       "     {'first': 'RM', 'middle': [], 'last': 'Schuster', 'suffix': ''}],\n",
       "    'year': 2015,\n",
       "    'venue': 'Hepatol Res.',\n",
       "    'volume': '45',\n",
       "    'issn': '',\n",
       "    'pages': '305-14',\n",
       "    'other_ids': {'DOI': ['10.1111/hepr.12352']}},\n",
       "   'BIBREF72': {'title': 'Cytochrome P-450 activity is differentially altered in severely injured patients',\n",
       "    'authors': [{'first': 'BG',\n",
       "      'middle': [],\n",
       "      'last': 'Harbrecht',\n",
       "      'suffix': ''},\n",
       "     {'first': 'RF', 'middle': [], 'last': 'Frye', 'suffix': ''},\n",
       "     {'first': 'MS', 'middle': [], 'last': 'Zenati', 'suffix': ''},\n",
       "     {'first': 'RA', 'middle': [], 'last': 'Branch', 'suffix': ''},\n",
       "     {'first': 'AB', 'middle': [], 'last': 'Peitzman', 'suffix': ''}],\n",
       "    'year': 2005,\n",
       "    'venue': 'Crit Care Med.',\n",
       "    'volume': '33',\n",
       "    'issn': '',\n",
       "    'pages': '541-6',\n",
       "    'other_ids': {'DOI': ['10.1097/01.CCM.0000155989.54344.E0']}},\n",
       "   'BIBREF73': {'title': 'A preliminary study of atorvastatin plasma concentrations in critically ill patients with sepsis',\n",
       "    'authors': [{'first': 'PS', 'middle': [], 'last': 'Kruger', 'suffix': ''},\n",
       "     {'first': 'NM', 'middle': [], 'last': 'Freir', 'suffix': ''},\n",
       "     {'first': 'B', 'middle': [], 'last': 'Venkatesh', 'suffix': ''},\n",
       "     {'first': 'TA', 'middle': [], 'last': 'Robertson', 'suffix': ''},\n",
       "     {'first': 'MS', 'middle': [], 'last': 'Roberts', 'suffix': ''},\n",
       "     {'first': 'M', 'middle': [], 'last': 'Jones', 'suffix': ''}],\n",
       "    'year': 2009,\n",
       "    'venue': 'Intensive Care Med.',\n",
       "    'volume': '35',\n",
       "    'issn': '',\n",
       "    'pages': '717-21',\n",
       "    'other_ids': {'DOI': ['10.1007/s00134-008-1358-3']}},\n",
       "   'BIBREF74': {'title': 'Inflammation-induced phenoconversion of polymorphic drug metabolizing enzymes: hypothesis with implications for personalized medicine',\n",
       "    'authors': [{'first': 'RR', 'middle': [], 'last': 'Shah', 'suffix': ''},\n",
       "     {'first': 'RL', 'middle': [], 'last': 'Smith', 'suffix': ''}],\n",
       "    'year': 2015,\n",
       "    'venue': 'Drug Metab Dispos.',\n",
       "    'volume': '43',\n",
       "    'issn': '',\n",
       "    'pages': '400-10',\n",
       "    'other_ids': {'DOI': ['10.1124/dmd.114.061093']}},\n",
       "   'BIBREF75': {'title': 'Acid sphingomyelinase inhibition stabilizes hepatic ceramide content and improves hepatic biotransformation capacity in a murine model of polymicrobial sepsis',\n",
       "    'authors': [{'first': 'HY', 'middle': [], 'last': 'Chung', 'suffix': ''},\n",
       "     {'first': 'CJ', 'middle': [], 'last': 'Witt', 'suffix': ''},\n",
       "     {'first': 'J', 'middle': [], 'last': 'Hurtado-Oliveros', 'suffix': ''},\n",
       "     {'first': 'J', 'middle': [], 'last': 'Wickel', 'suffix': ''},\n",
       "     {'first': 'MH', 'middle': [], 'last': 'Graler', 'suffix': ''},\n",
       "     {'first': 'A', 'middle': [], 'last': 'Lupp', 'suffix': ''}],\n",
       "    'year': 2018,\n",
       "    'venue': 'Int J Mol Sci.',\n",
       "    'volume': '19',\n",
       "    'issn': '',\n",
       "    'pages': None,\n",
       "    'other_ids': {'DOI': ['10.3390/ijms19103163']}},\n",
       "   'BIBREF76': {'title': 'Treatment of fibromyalgia syndrome with antidepressants: a meta-analysis',\n",
       "    'authors': [{'first': 'W', 'middle': [], 'last': 'Hauser', 'suffix': ''},\n",
       "     {'first': 'K', 'middle': [], 'last': 'Bernardy', 'suffix': ''},\n",
       "     {'first': 'N', 'middle': [], 'last': 'Uceyler', 'suffix': ''},\n",
       "     {'first': 'C', 'middle': [], 'last': 'Sommer', 'suffix': ''}],\n",
       "    'year': 2009,\n",
       "    'venue': 'JAMA.',\n",
       "    'volume': '301',\n",
       "    'issn': '',\n",
       "    'pages': '198-209',\n",
       "    'other_ids': {'DOI': ['10.1001/jama.2008.944']}},\n",
       "   'BIBREF77': {'title': 'Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study 2017',\n",
       "    'authors': [{'first': 'GBD',\n",
       "      'middle': [],\n",
       "      'last': 'Disease',\n",
       "      'suffix': ''},\n",
       "     {'first': 'I', 'middle': [], 'last': 'Injury', 'suffix': ''},\n",
       "     {'first': 'C', 'middle': [], 'last': 'Prevalence', 'suffix': ''}],\n",
       "    'year': 2018,\n",
       "    'venue': 'Lancet.',\n",
       "    'volume': '392',\n",
       "    'issn': '',\n",
       "    'pages': '1789-858',\n",
       "    'other_ids': {'DOI': ['10.1016/S0140-6736(18)32279-7']}},\n",
       "   'BIBREF78': {'title': 'Imprinting at the SMPD1 locus: implications for acid sphingomyelinase-deficient Niemann-Pick disease',\n",
       "    'authors': [{'first': 'CM',\n",
       "      'middle': [],\n",
       "      'last': 'Simonaro',\n",
       "      'suffix': ''},\n",
       "     {'first': 'JH', 'middle': [], 'last': 'Park', 'suffix': ''},\n",
       "     {'first': 'E', 'middle': [], 'last': 'Eliyahu', 'suffix': ''},\n",
       "     {'first': 'N', 'middle': [], 'last': 'Shtraizent', 'suffix': ''},\n",
       "     {'first': 'MM', 'middle': [], 'last': 'McGovern', 'suffix': ''},\n",
       "     {'first': 'EH', 'middle': [], 'last': 'Schuchman', 'suffix': ''}],\n",
       "    'year': 2006,\n",
       "    'venue': 'Am J Hum Genet.',\n",
       "    'volume': '78',\n",
       "    'issn': '',\n",
       "    'pages': '865-70',\n",
       "    'other_ids': {'DOI': ['10.1086/503750']}},\n",
       "   'BIBREF79': {'title': 'Depression',\n",
       "    'authors': [{'first': 'GS', 'middle': [], 'last': 'Malhi', 'suffix': ''},\n",
       "     {'first': 'JJ', 'middle': [], 'last': 'Mann', 'suffix': ''}],\n",
       "    'year': 2018,\n",
       "    'venue': 'Lancet.',\n",
       "    'volume': '392',\n",
       "    'issn': '',\n",
       "    'pages': '2299-312',\n",
       "    'other_ids': {'DOI': ['10.1016/S0140-6736(18)31948-2']}},\n",
       "   'BIBREF80': {'title': 'Antidepressants might work for people with major depression: where do we go from here?',\n",
       "    'authors': [{'first': 'A', 'middle': [], 'last': 'Cipriani', 'suffix': ''},\n",
       "     {'first': 'G', 'middle': [], 'last': 'Salanti', 'suffix': ''},\n",
       "     {'first': 'TA', 'middle': [], 'last': 'Furukawa', 'suffix': ''},\n",
       "     {'first': 'M', 'middle': [], 'last': 'Egger', 'suffix': ''},\n",
       "     {'first': 'S', 'middle': [], 'last': 'Leucht', 'suffix': ''},\n",
       "     {'first': 'HG', 'middle': [], 'last': 'Ruhe', 'suffix': ''}],\n",
       "    'year': 2018,\n",
       "    'venue': 'Lancet Psychiatry.',\n",
       "    'volume': '5',\n",
       "    'issn': '',\n",
       "    'pages': '461-3',\n",
       "    'other_ids': {'DOI': ['10.1016/S2215-0366(18)30133-0']}},\n",
       "   'BIBREF81': {'title': 'High activity of acid sphingomyelinase in major depression',\n",
       "    'authors': [{'first': 'J',\n",
       "      'middle': [],\n",
       "      'last': 'Kornhuber',\n",
       "      'suffix': ''},\n",
       "     {'first': 'A', 'middle': [], 'last': 'Medlin', 'suffix': ''},\n",
       "     {'first': 'S', 'middle': [], 'last': 'Bleich', 'suffix': ''},\n",
       "     {'first': 'V', 'middle': [], 'last': 'Jendrossek', 'suffix': ''},\n",
       "     {'first': 'AW', 'middle': [], 'last': 'Henkel', 'suffix': ''},\n",
       "     {'first': 'J', 'middle': [], 'last': 'Wiltfang', 'suffix': ''}],\n",
       "    'year': 2005,\n",
       "    'venue': 'J Neural Transm.',\n",
       "    'volume': '112',\n",
       "    'issn': '',\n",
       "    'pages': '1583-90',\n",
       "    'other_ids': {'DOI': ['10.1007/s00702-005-0374-5']}},\n",
       "   'BIBREF82': {'title': 'Anxiety and depression symptoms in a general population and future risk of bloodstream infection: the HUNT study',\n",
       "    'authors': [{'first': 'A', 'middle': [], 'last': 'Askim', 'suffix': ''},\n",
       "     {'first': 'LT', 'middle': [], 'last': 'Gustad', 'suffix': ''},\n",
       "     {'first': 'J', 'middle': [], 'last': 'Paulsen', 'suffix': ''},\n",
       "     {'first': 'SK', 'middle': [], 'last': 'Reitan', 'suffix': ''},\n",
       "     {'first': 'A', 'middle': [], 'last': 'Mehl', 'suffix': ''},\n",
       "     {'first': 'RM', 'middle': [], 'last': 'Mohus', 'suffix': ''}],\n",
       "    'year': 2018,\n",
       "    'venue': 'Psychosom Med.',\n",
       "    'volume': '80',\n",
       "    'issn': '',\n",
       "    'pages': '673-9',\n",
       "    'other_ids': {'DOI': ['10.1097/PSY.0000000000000619']}},\n",
       "   'BIBREF83': {'title': 'The association of unipolar depression with thirty-day mortality after hospitalization for infection: a population-based cohort study in Denmark',\n",
       "    'authors': [{'first': 'DS', 'middle': [], 'last': 'Davydow', 'suffix': ''},\n",
       "     {'first': 'AR', 'middle': [], 'last': 'Ribe', 'suffix': ''},\n",
       "     {'first': 'HS', 'middle': [], 'last': 'Pedersen', 'suffix': ''},\n",
       "     {'first': 'M', 'middle': [], 'last': 'Vestergaard', 'suffix': ''},\n",
       "     {'first': 'M', 'middle': [], 'last': 'Fenger-Gron', 'suffix': ''}],\n",
       "    'year': 2016,\n",
       "    'venue': 'J Psychosom Res.',\n",
       "    'volume': '89',\n",
       "    'issn': '',\n",
       "    'pages': '32-8',\n",
       "    'other_ids': {'DOI': ['10.1016/j.jpsychores.2016.08.006']}},\n",
       "   'BIBREF84': {'title': 'Drug repurposing: progress, challenges and recommendations',\n",
       "    'authors': [{'first': 'S',\n",
       "      'middle': [],\n",
       "      'last': 'Pushpakom',\n",
       "      'suffix': ''},\n",
       "     {'first': 'F', 'middle': [], 'last': 'Iorio', 'suffix': ''},\n",
       "     {'first': 'PA', 'middle': [], 'last': 'Eyers', 'suffix': ''},\n",
       "     {'first': 'KJ', 'middle': [], 'last': 'Escott', 'suffix': ''},\n",
       "     {'first': 'S', 'middle': [], 'last': 'Hopper', 'suffix': ''},\n",
       "     {'first': 'A', 'middle': [], 'last': 'Wells', 'suffix': ''}],\n",
       "    'year': 2019,\n",
       "    'venue': 'Nat Rev Drug Discov.',\n",
       "    'volume': '18',\n",
       "    'issn': '',\n",
       "    'pages': '41-58',\n",
       "    'other_ids': {'DOI': ['10.1038/nrd.2018.168']}},\n",
       "   'BIBREF85': {'title': 'Synergistic drug combination effectively blocks ebola virus infection',\n",
       "    'authors': [{'first': 'W', 'middle': [], 'last': 'Sun', 'suffix': ''},\n",
       "     {'first': 'S', 'middle': [], 'last': 'He', 'suffix': ''},\n",
       "     {'first': 'C', 'middle': [], 'last': 'Martinez-Romero', 'suffix': ''},\n",
       "     {'first': 'J', 'middle': [], 'last': 'Kouznetsova', 'suffix': ''},\n",
       "     {'first': 'G', 'middle': [], 'last': 'Tawa', 'suffix': ''},\n",
       "     {'first': 'M', 'middle': [], 'last': 'Xu', 'suffix': ''}],\n",
       "    'year': 2017,\n",
       "    'venue': 'Antiviral Res.',\n",
       "    'volume': '137',\n",
       "    'issn': '',\n",
       "    'pages': '165-72',\n",
       "    'other_ids': {'DOI': ['10.1016/j.antiviral.2016.11.017']}},\n",
       "   'BIBREF86': {'title': 'Inhibition of acid sphingomyelinase by tricyclic antidepressants and analogons',\n",
       "    'authors': [{'first': 'N', 'middle': [], 'last': 'Beckmann', 'suffix': ''},\n",
       "     {'first': 'D', 'middle': [], 'last': 'Sharma', 'suffix': ''},\n",
       "     {'first': 'E', 'middle': [], 'last': 'Gulbins', 'suffix': ''},\n",
       "     {'first': 'KA', 'middle': [], 'last': 'Becker', 'suffix': ''},\n",
       "     {'first': 'B', 'middle': [], 'last': 'Edelmann', 'suffix': ''}],\n",
       "    'year': 2014,\n",
       "    'venue': 'Front Physiol.',\n",
       "    'volume': '5',\n",
       "    'issn': '',\n",
       "    'pages': None,\n",
       "    'other_ids': {'DOI': ['10.3389/fphys.2014.00331']}},\n",
       "   'BIBREF87': {'title': 'Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine',\n",
       "    'authors': [{'first': 'S', 'middle': [], 'last': 'Schloer', 'suffix': ''},\n",
       "     {'first': 'L', 'middle': [], 'last': 'Brunotte', 'suffix': ''},\n",
       "     {'first': 'J', 'middle': [], 'last': 'Goretzko', 'suffix': ''},\n",
       "     {'first': 'A', 'middle': [], 'last': 'Mecate-Zambrano', 'suffix': ''},\n",
       "     {'first': 'N', 'middle': [], 'last': 'Korthals', 'suffix': ''},\n",
       "     {'first': 'V', 'middle': [], 'last': 'Gerke', 'suffix': ''}],\n",
       "    'year': None,\n",
       "    'venue': 'Emerg Microbes Infect',\n",
       "    'volume': '9',\n",
       "    'issn': '',\n",
       "    'pages': '2245-2255',\n",
       "    'other_ids': {'DOI': ['10.1101/2020.07.27.222836']}},\n",
       "   'BIBREF88': {'title': 'Functional analysis of the glycosylation of murine acid sphingomyelinase',\n",
       "    'authors': [{'first': 'D',\n",
       "      'middle': [],\n",
       "      'last': 'Newrzella',\n",
       "      'suffix': ''},\n",
       "     {'first': 'W', 'middle': [], 'last': 'Stoffel', 'suffix': ''}],\n",
       "    'year': 1996,\n",
       "    'venue': 'J Biol Chem.',\n",
       "    'volume': '271',\n",
       "    'issn': '',\n",
       "    'pages': '32089-95',\n",
       "    'other_ids': {'DOI': ['10.1074/jbc.271.50.32089']}},\n",
       "   'BIBREF89': {'title': 'Functional characterization of the N-glycosylation sites of human acid sphingomyelinase by site-directed mutagenesis',\n",
       "    'authors': [{'first': 'K', 'middle': [], 'last': 'Ferlinz', 'suffix': ''},\n",
       "     {'first': 'R', 'middle': [], 'last': 'Hurwitz', 'suffix': ''},\n",
       "     {'first': 'H', 'middle': [], 'last': 'Moczall', 'suffix': ''},\n",
       "     {'first': 'S', 'middle': [], 'last': 'Lansmann', 'suffix': ''},\n",
       "     {'first': 'EH', 'middle': [], 'last': 'Schuchman', 'suffix': ''},\n",
       "     {'first': 'K', 'middle': [], 'last': 'Sandhoff', 'suffix': ''}],\n",
       "    'year': 1997,\n",
       "    'venue': 'Eur J Biochem.',\n",
       "    'volume': '243',\n",
       "    'issn': '',\n",
       "    'pages': '511-7',\n",
       "    'other_ids': {'DOI': ['10.1111/j.1432-1033.1997.511_1a.x']}},\n",
       "   'BIBREF90': {'title': 'Acid sphingomyelinase from human urine: purification and characterization',\n",
       "    'authors': [{'first': 'LE',\n",
       "      'middle': [],\n",
       "      'last': 'Quintern',\n",
       "      'suffix': ''},\n",
       "     {'first': 'G', 'middle': [], 'last': 'Weitz', 'suffix': ''},\n",
       "     {'first': 'H', 'middle': [], 'last': 'Nehrkorn', 'suffix': ''},\n",
       "     {'first': 'JM', 'middle': [], 'last': 'Tager', 'suffix': ''},\n",
       "     {'first': 'AW', 'middle': [], 'last': 'Schram', 'suffix': ''},\n",
       "     {'first': 'K', 'middle': [], 'last': 'Sandhoff', 'suffix': ''}],\n",
       "    'year': 1987,\n",
       "    'venue': 'Biochim Biophys Acta.',\n",
       "    'volume': '922',\n",
       "    'issn': '',\n",
       "    'pages': '323-36',\n",
       "    'other_ids': {'DOI': ['10.1016/0005-2760(87)90055-5']}},\n",
       "   'BIBREF91': {'title': 'The lysosomal trafficking of acid sphingomyelinase is mediated by sortilin and mannose 6-phosphate receptor',\n",
       "    'authors': [{'first': 'X', 'middle': [], 'last': 'Ni', 'suffix': ''},\n",
       "     {'first': 'CR', 'middle': [], 'last': 'Morales', 'suffix': ''}],\n",
       "    'year': 2006,\n",
       "    'venue': 'Traffic.',\n",
       "    'volume': '7',\n",
       "    'issn': '',\n",
       "    'pages': '889-902',\n",
       "    'other_ids': {'DOI': ['10.1111/j.1600-0854.2006.00429.x']}},\n",
       "   'BIBREF92': {'title': 'Monoclonal antibodies against human placental sphingomyelinase',\n",
       "    'authors': [{'first': 'SJ', 'middle': [], 'last': 'Freeman', 'suffix': ''},\n",
       "     {'first': 'DJ', 'middle': [], 'last': 'Davidson', 'suffix': ''},\n",
       "     {'first': 'P', 'middle': [], 'last': 'Shankaran', 'suffix': ''},\n",
       "     {'first': 'JW', 'middle': [], 'last': 'Callahan', 'suffix': ''}],\n",
       "    'year': 1983,\n",
       "    'venue': 'Biosci Rep.',\n",
       "    'volume': '3',\n",
       "    'issn': '',\n",
       "    'pages': '545-50',\n",
       "    'other_ids': {'DOI': ['10.1007/BF01120698']}},\n",
       "   'BIBREF93': {'title': 'The active site of lysosomal sphingomyelinase: evidence for the involvement of hydrophobic and ionic groups',\n",
       "    'authors': [{'first': 'JW',\n",
       "      'middle': [],\n",
       "      'last': 'Callahan',\n",
       "      'suffix': ''},\n",
       "     {'first': 'CS', 'middle': [], 'last': 'Jones', 'suffix': ''},\n",
       "     {'first': 'DJ', 'middle': [], 'last': 'Davidson', 'suffix': ''},\n",
       "     {'first': 'P', 'middle': [], 'last': 'Shankaran', 'suffix': ''}],\n",
       "    'year': 1983,\n",
       "    'venue': 'J Neurosci Res.',\n",
       "    'volume': '10',\n",
       "    'issn': '',\n",
       "    'pages': '151-63',\n",
       "    'other_ids': {'DOI': ['10.1002/jnr.490100205']}},\n",
       "   'BIBREF94': {'title': 'Purification of acid sphingomyelinase from human placenta: characterization and N-terminal sequence',\n",
       "    'authors': [{'first': 'S', 'middle': [], 'last': 'Lansmann', 'suffix': ''},\n",
       "     {'first': 'K', 'middle': [], 'last': 'Ferlinz', 'suffix': ''},\n",
       "     {'first': 'R', 'middle': [], 'last': 'Hurwitz', 'suffix': ''},\n",
       "     {'first': 'O', 'middle': [], 'last': 'Bartelsen', 'suffix': ''},\n",
       "     {'first': 'G', 'middle': [], 'last': 'Glombitza', 'suffix': ''},\n",
       "     {'first': 'K', 'middle': [], 'last': 'Sandhoff', 'suffix': ''}],\n",
       "    'year': 1996,\n",
       "    'venue': 'FEBS Lett.',\n",
       "    'volume': '399',\n",
       "    'issn': '',\n",
       "    'pages': '227-31',\n",
       "    'other_ids': {'DOI': ['10.1016/S0014-5793(96)01331-2']}},\n",
       "   'BIBREF95': {'title': 'An update of the enzymology and regulation of sphingomyelin metabolism',\n",
       "    'authors': [{'first': 'AH',\n",
       "      'middle': [],\n",
       "      'last': 'Merrill',\n",
       "      'suffix': 'Jr'},\n",
       "     {'first': 'DD', 'middle': [], 'last': 'Jones', 'suffix': ''}],\n",
       "    'year': 1990,\n",
       "    'venue': 'Biochim Biophys Acta.',\n",
       "    'volume': '1044',\n",
       "    'issn': '',\n",
       "    'pages': '1-12',\n",
       "    'other_ids': {'DOI': ['10.1016/0005-2760(90)90211-F']}},\n",
       "   'BIBREF96': {'title': 'Role of sphingomyelinase and ceramide in modulating rafts: do biophysical properties determine biologic outcome?',\n",
       "    'authors': [{'first': 'AE',\n",
       "      'middle': [],\n",
       "      'last': 'Cremesti',\n",
       "      'suffix': ''},\n",
       "     {'first': 'FM', 'middle': [], 'last': 'Goni', 'suffix': ''},\n",
       "     {'first': 'R', 'middle': [], 'last': 'Kolesnick', 'suffix': ''}],\n",
       "    'year': 2002,\n",
       "    'venue': 'FEBS Lett.',\n",
       "    'volume': '531',\n",
       "    'issn': '',\n",
       "    'pages': '47-53',\n",
       "    'other_ids': {'DOI': ['10.1016/S0014-5793(02)03489-0']}},\n",
       "   'BIBREF97': {'title': 'Stimulation of acid sphingomyelinase activity by lysosomal lipids and sphingolipid activator proteins',\n",
       "    'authors': [{'first': 'T', 'middle': [], 'last': 'Linke', 'suffix': ''},\n",
       "     {'first': 'G', 'middle': [], 'last': 'Wilkening', 'suffix': ''},\n",
       "     {'first': 'S', 'middle': [], 'last': 'Lansmann', 'suffix': ''},\n",
       "     {'first': 'H', 'middle': [], 'last': 'Moczall', 'suffix': ''},\n",
       "     {'first': 'O', 'middle': [], 'last': 'Bartelsen', 'suffix': ''},\n",
       "     {'first': 'J', 'middle': [], 'last': 'Weisgerber', 'suffix': ''}],\n",
       "    'year': 2001,\n",
       "    'venue': 'Biol Chem.',\n",
       "    'volume': '382',\n",
       "    'issn': '',\n",
       "    'pages': '283-90',\n",
       "    'other_ids': {'DOI': ['10.1515/BC.2001.035']}},\n",
       "   'BIBREF98': {'title': 'Human acid sphingomyelinase',\n",
       "    'authors': [{'first': 'S', 'middle': [], 'last': 'Lansmann', 'suffix': ''},\n",
       "     {'first': 'CG', 'middle': [], 'last': 'Schuette', 'suffix': ''},\n",
       "     {'first': 'O', 'middle': [], 'last': 'Bartelsen', 'suffix': ''},\n",
       "     {'first': 'J', 'middle': [], 'last': 'Hoernschemeyer', 'suffix': ''},\n",
       "     {'first': 'T', 'middle': [], 'last': 'Linke', 'suffix': ''},\n",
       "     {'first': 'J', 'middle': [], 'last': 'Weisgerber', 'suffix': ''}],\n",
       "    'year': 2003,\n",
       "    'venue': 'Eur J Biochem.',\n",
       "    'volume': '270',\n",
       "    'issn': '',\n",
       "    'pages': '1076-88',\n",
       "    'other_ids': {'DOI': ['10.1046/j.1432-1033.2003.03435.x']}},\n",
       "   'BIBREF99': {'title': 'Carboxyl-terminal disulfide bond of acid sphingomyelinase is critical for its secretion and enzymatic function',\n",
       "    'authors': [{'first': 'CY', 'middle': [], 'last': 'Lee', 'suffix': ''},\n",
       "     {'first': 'T', 'middle': [], 'last': 'Tamura', 'suffix': ''},\n",
       "     {'first': 'N', 'middle': [], 'last': 'Rabah', 'suffix': ''},\n",
       "     {'first': 'DY', 'middle': [], 'last': 'Lee', 'suffix': ''},\n",
       "     {'first': 'I', 'middle': [], 'last': 'Ruel', 'suffix': ''},\n",
       "     {'first': 'A', 'middle': [], 'last': 'Hafiane', 'suffix': ''}],\n",
       "    'year': 2007,\n",
       "    'venue': 'Biochemistry.',\n",
       "    'volume': '46',\n",
       "    'issn': '',\n",
       "    'pages': '14969-78',\n",
       "    'other_ids': {'DOI': ['10.1021/bi700817g']}},\n",
       "   'BIBREF100': {'title': 'Crystal structure of mammalian acid sphingomyelinase',\n",
       "    'authors': [{'first': 'A', 'middle': [], 'last': 'Gorelik', 'suffix': ''},\n",
       "     {'first': 'K', 'middle': [], 'last': 'Illes', 'suffix': ''},\n",
       "     {'first': 'LX', 'middle': [], 'last': 'Heinz', 'suffix': ''},\n",
       "     {'first': 'G', 'middle': [], 'last': 'Superti-Furga', 'suffix': ''},\n",
       "     {'first': 'B', 'middle': [], 'last': 'Nagar', 'suffix': ''}],\n",
       "    'year': 2016,\n",
       "    'venue': 'Nat Commun.',\n",
       "    'volume': '7',\n",
       "    'issn': '',\n",
       "    'pages': None,\n",
       "    'other_ids': {'DOI': ['10.1038/ncomms12196']}},\n",
       "   'BIBREF101': {'title': 'The urine from patients with peritonitis as a rich source for purifying human acid sphingomyelinase and other lysosomal enzymes',\n",
       "    'authors': [{'first': 'LE',\n",
       "      'middle': [],\n",
       "      'last': 'Quintern',\n",
       "      'suffix': ''},\n",
       "     {'first': 'TS', 'middle': [], 'last': 'Zenk', 'suffix': ''},\n",
       "     {'first': 'K', 'middle': [], 'last': 'Sandhoff', 'suffix': ''}],\n",
       "    'year': 1989,\n",
       "    'venue': 'Biochim Biophys Acta',\n",
       "    'volume': '1003',\n",
       "    'issn': '',\n",
       "    'pages': '121-4',\n",
       "    'other_ids': {'DOI': ['10.1016/0005-2760(89)90244-0']}},\n",
       "   'BIBREF102': {'title': 'The metabolism of sphingomyelin. II Evidence of an enzymatic deficiency in niemann-pick diseae',\n",
       "    'authors': [{'first': 'RO', 'middle': [], 'last': 'Brady', 'suffix': ''},\n",
       "     {'first': 'JN', 'middle': [], 'last': 'Kanfer', 'suffix': ''},\n",
       "     {'first': 'MB', 'middle': [], 'last': 'Mock', 'suffix': ''},\n",
       "     {'first': 'DS', 'middle': [], 'last': 'Fredrickson', 'suffix': ''}],\n",
       "    'year': 1966,\n",
       "    'venue': 'Proc Natl Acad Sci USA.',\n",
       "    'volume': '55',\n",
       "    'issn': '',\n",
       "    'pages': '366-9',\n",
       "    'other_ids': {'DOI': ['10.1073/pnas.55.2.366']}},\n",
       "   'BIBREF103': {'title': 'Zn2+-stimulated sphingomyelinase is secreted by many cell types and is a product of the acid sphingomyelinase gene',\n",
       "    'authors': [{'first': 'SL',\n",
       "      'middle': [],\n",
       "      'last': 'Schissel',\n",
       "      'suffix': ''},\n",
       "     {'first': 'EH', 'middle': [], 'last': 'Schuchman', 'suffix': ''},\n",
       "     {'first': 'KJ', 'middle': [], 'last': 'Williams', 'suffix': ''},\n",
       "     {'first': 'I', 'middle': [], 'last': 'Tabas', 'suffix': ''}],\n",
       "    'year': 1996,\n",
       "    'venue': 'J Biol Chem.',\n",
       "    'volume': '271',\n",
       "    'issn': '',\n",
       "    'pages': '18431-6',\n",
       "    'other_ids': {'DOI': ['10.1074/jbc.271.31.18431']}},\n",
       "   'BIBREF104': {'title': 'A new Zn2+-stimulated sphingomyelinase in fetal bovine serum',\n",
       "    'authors': [{'first': 'MW', 'middle': [], 'last': 'Spence', 'suffix': ''},\n",
       "     {'first': 'DM', 'middle': [], 'last': 'Byers', 'suffix': ''},\n",
       "     {'first': 'FB', 'middle': [], 'last': 'Palmer', 'suffix': ''},\n",
       "     {'first': 'HW', 'middle': [], 'last': 'Cook', 'suffix': ''}],\n",
       "    'year': 1989,\n",
       "    'venue': 'J Biol Chem.',\n",
       "    'volume': '264',\n",
       "    'issn': '',\n",
       "    'pages': '5358-63',\n",
       "    'other_ids': {'DOI': []}},\n",
       "   'BIBREF105': {'title': 'Acid sphingomyelinase deficient mice: a model of types A and B Niemann-Pick disease',\n",
       "    'authors': [{'first': 'K',\n",
       "      'middle': [],\n",
       "      'last': 'Horinouchi',\n",
       "      'suffix': ''},\n",
       "     {'first': 'S', 'middle': [], 'last': 'Erlich', 'suffix': ''},\n",
       "     {'first': 'DP', 'middle': [], 'last': 'Perl', 'suffix': ''},\n",
       "     {'first': 'K', 'middle': [], 'last': 'Ferlinz', 'suffix': ''},\n",
       "     {'first': 'CL', 'middle': [], 'last': 'Bisgaier', 'suffix': ''},\n",
       "     {'first': 'K', 'middle': [], 'last': 'Sandhoff', 'suffix': ''}],\n",
       "    'year': 1995,\n",
       "    'venue': 'Nat Genet.',\n",
       "    'volume': '10',\n",
       "    'issn': '',\n",
       "    'pages': '288-93',\n",
       "    'other_ids': {'DOI': ['10.1038/ng0795-288']}},\n",
       "   'BIBREF106': {'title': 'Role of increased sphingomyelinase activity in apoptosis and organ failure of patients with severe sepsis',\n",
       "    'authors': [{'first': 'RA', 'middle': [], 'last': 'Claus', 'suffix': ''},\n",
       "     {'first': 'AC', 'middle': [], 'last': 'Bunck', 'suffix': ''},\n",
       "     {'first': 'CL', 'middle': [], 'last': 'Bockmeyer', 'suffix': ''},\n",
       "     {'first': 'FM', 'middle': [], 'last': 'Brunkhorst', 'suffix': ''},\n",
       "     {'first': 'W', 'middle': [], 'last': 'Losche', 'suffix': ''},\n",
       "     {'first': 'R', 'middle': [], 'last': 'Kinscherf', 'suffix': ''}],\n",
       "    'year': 2005,\n",
       "    'venue': 'FASEB J.',\n",
       "    'volume': '19',\n",
       "    'issn': '',\n",
       "    'pages': '1719-21',\n",
       "    'other_ids': {'DOI': ['10.1096/fj.04-2842fje']}},\n",
       "   'BIBREF107': {'title': 'Activation of acid sphingomyelinase by protein kinase Cdelta-mediated phosphorylation',\n",
       "    'authors': [{'first': 'YH', 'middle': [], 'last': 'Zeidan', 'suffix': ''},\n",
       "     {'first': 'YA', 'middle': [], 'last': 'Hannun', 'suffix': ''}],\n",
       "    'year': 2007,\n",
       "    'venue': 'J Biol Chem.',\n",
       "    'volume': '282',\n",
       "    'issn': '',\n",
       "    'pages': '11549-61',\n",
       "    'other_ids': {'DOI': ['10.1074/jbc.M609424200']}},\n",
       "   'BIBREF108': {'title': 'Functional Inhibitors of Acid Sphingomyelinase (FIASMAs): a novel pharmacological group of drugs with broad clinical applications',\n",
       "    'authors': [{'first': 'J',\n",
       "      'middle': [],\n",
       "      'last': 'Kornhuber',\n",
       "      'suffix': ''},\n",
       "     {'first': 'P', 'middle': [], 'last': 'Tripal', 'suffix': ''},\n",
       "     {'first': 'M', 'middle': [], 'last': 'Reichel', 'suffix': ''},\n",
       "     {'first': 'C', 'middle': [], 'last': 'Muhle', 'suffix': ''},\n",
       "     {'first': 'C', 'middle': [], 'last': 'Rhein', 'suffix': ''},\n",
       "     {'first': 'M', 'middle': [], 'last': 'Muehlbacher', 'suffix': ''}],\n",
       "    'year': 2010,\n",
       "    'venue': 'Cell Physiol Biochem.',\n",
       "    'volume': '26',\n",
       "    'issn': '',\n",
       "    'pages': '9-20',\n",
       "    'other_ids': {'DOI': ['10.1159/000315101']}},\n",
       "   'BIBREF109': {'title': 'Absence of activation of DNA repair genes and excellent efficacy of phosphaplatins against human ovarian cancers: implications to treat resistant cancers',\n",
       "    'authors': [{'first': 'RN', 'middle': [], 'last': 'Bose', 'suffix': ''},\n",
       "     {'first': 'S', 'middle': [], 'last': 'Moghaddas', 'suffix': ''},\n",
       "     {'first': 'L', 'middle': [], 'last': 'Belkacemi', 'suffix': ''},\n",
       "     {'first': 'S', 'middle': [], 'last': 'Tripathi', 'suffix': ''},\n",
       "     {'first': 'NR', 'middle': [], 'last': 'Adams', 'suffix': ''},\n",
       "     {'first': 'P', 'middle': [], 'last': 'Majmudar', 'suffix': ''}],\n",
       "    'year': 2015,\n",
       "    'venue': 'J Med Chem.',\n",
       "    'volume': '58',\n",
       "    'issn': '',\n",
       "    'pages': '8387-401',\n",
       "    'other_ids': {'DOI': ['10.1021/acs.jmedchem.5b00732']}},\n",
       "   'BIBREF110': {'title': 'Solving the secretory acid sphingomyelinase puzzle: insights from lysosome-mediated parasite invasion and plasma membrane repair',\n",
       "    'authors': [{'first': 'NW',\n",
       "      'middle': [],\n",
       "      'last': 'Andrews',\n",
       "      'suffix': ''}],\n",
       "    'year': 2019,\n",
       "    'venue': 'Cell Microbiol.',\n",
       "    'volume': '21',\n",
       "    'issn': '',\n",
       "    'pages': None,\n",
       "    'other_ids': {'DOI': ['10.1111/cmi.13065']}},\n",
       "   'BIBREF111': {'title': 'Infections with human rhinovirus induce the formation of distinct functional membrane domains',\n",
       "    'authors': [{'first': 'S',\n",
       "      'middle': [],\n",
       "      'last': 'Dreschers',\n",
       "      'suffix': ''},\n",
       "     {'first': 'P', 'middle': [], 'last': 'Franz', 'suffix': ''},\n",
       "     {'first': 'C', 'middle': [], 'last': 'Dumitru', 'suffix': ''},\n",
       "     {'first': 'B', 'middle': [], 'last': 'Wilker', 'suffix': ''},\n",
       "     {'first': 'K', 'middle': [], 'last': 'Jahnke', 'suffix': ''},\n",
       "     {'first': 'E', 'middle': [], 'last': 'Gulbins', 'suffix': ''}],\n",
       "    'year': 2007,\n",
       "    'venue': 'Cell Physiol Biochem.',\n",
       "    'volume': '20',\n",
       "    'issn': '',\n",
       "    'pages': '241-54',\n",
       "    'other_ids': {'DOI': ['10.1159/000104170']}},\n",
       "   'BIBREF112': {'title': 'Acid sphingomyelinase of human brain. improved purification procedures and characterization',\n",
       "    'authors': [{'first': 'T', 'middle': [], 'last': 'Yamanaka', 'suffix': ''},\n",
       "     {'first': 'E', 'middle': [], 'last': 'Hanada', 'suffix': ''},\n",
       "     {'first': 'K', 'middle': [], 'last': 'Suzuki', 'suffix': ''}],\n",
       "    'year': 1981,\n",
       "    'venue': 'J Biol Chem.',\n",
       "    'volume': '256',\n",
       "    'issn': '',\n",
       "    'pages': '3884-9',\n",
       "    'other_ids': {'DOI': []}},\n",
       "   'BIBREF113': {'title': 'Rhinoviruses infect human epithelial cells via ceramide-enriched membrane platforms',\n",
       "    'authors': [{'first': 'H', 'middle': [], 'last': 'Grassme', 'suffix': ''},\n",
       "     {'first': 'A', 'middle': [], 'last': 'Riehle', 'suffix': ''},\n",
       "     {'first': 'B', 'middle': [], 'last': 'Wilker', 'suffix': ''},\n",
       "     {'first': 'E', 'middle': [], 'last': 'Gulbins', 'suffix': ''}],\n",
       "    'year': 2005,\n",
       "    'venue': 'J Biol Chem.',\n",
       "    'volume': '280',\n",
       "    'issn': '',\n",
       "    'pages': '26256-62',\n",
       "    'other_ids': {'DOI': ['10.1074/jbc.M500835200']}},\n",
       "   'BIBREF114': {'title': 'Ebolavirus requires acid sphingomyelinase activity and plasma membrane sphingomyelin for infection',\n",
       "    'authors': [{'first': 'ME', 'middle': [], 'last': 'Miller', 'suffix': ''},\n",
       "     {'first': 'S', 'middle': [], 'last': 'Adhikary', 'suffix': ''},\n",
       "     {'first': 'AA', 'middle': [], 'last': 'Kolokoltsov', 'suffix': ''},\n",
       "     {'first': 'RA', 'middle': [], 'last': 'Davey', 'suffix': ''}],\n",
       "    'year': 2012,\n",
       "    'venue': 'J Virol.',\n",
       "    'volume': '86',\n",
       "    'issn': '',\n",
       "    'pages': '7473-83',\n",
       "    'other_ids': {'DOI': ['10.1128/JVI.00136-12']}},\n",
       "   'BIBREF115': {'title': 'Acid sphingomyelinase deficiency increases susceptibility to fatal alphavirus encephalomyelitis',\n",
       "    'authors': [{'first': 'CG', 'middle': [], 'last': 'Ng', 'suffix': ''},\n",
       "     {'first': 'DE', 'middle': [], 'last': 'Griffin', 'suffix': ''}],\n",
       "    'year': 2006,\n",
       "    'venue': 'J Virol.',\n",
       "    'volume': '80',\n",
       "    'issn': '',\n",
       "    'pages': '10989-99',\n",
       "    'other_ids': {'DOI': ['10.1128/JVI.01154-06']}},\n",
       "   'BIBREF116': {'title': 'Acid sphingomyelinase amplifies redox signaling in Pseudomonas aeruginosa-induced macrophage apoptosis',\n",
       "    'authors': [{'first': 'Y', 'middle': [], 'last': 'Zhang', 'suffix': ''},\n",
       "     {'first': 'X', 'middle': [], 'last': 'Li', 'suffix': ''},\n",
       "     {'first': 'A', 'middle': [], 'last': 'Carpinteiro', 'suffix': ''},\n",
       "     {'first': 'E', 'middle': [], 'last': 'Gulbins', 'suffix': ''}],\n",
       "    'year': 2008,\n",
       "    'venue': 'J Immunol.',\n",
       "    'volume': '181',\n",
       "    'issn': '',\n",
       "    'pages': '4247-54',\n",
       "    'other_ids': {'DOI': ['10.4049/jimmunol.181.6.4247']}},\n",
       "   'BIBREF117': {'title': 'Regulation of Staphylococcus aureus infection of macrophages by CD44, reactive oxygen species, and acid sphingomyelinase',\n",
       "    'authors': [{'first': 'C', 'middle': [], 'last': 'Li', 'suffix': ''},\n",
       "     {'first': 'Y', 'middle': [], 'last': 'Wu', 'suffix': ''},\n",
       "     {'first': 'A', 'middle': [], 'last': 'Riehle', 'suffix': ''},\n",
       "     {'first': 'V', 'middle': [], 'last': 'Orian-Rousseau', 'suffix': ''},\n",
       "     {'first': 'Y', 'middle': [], 'last': 'Zhang', 'suffix': ''},\n",
       "     {'first': 'E', 'middle': [], 'last': 'Gulbins', 'suffix': ''}],\n",
       "    'year': 2018,\n",
       "    'venue': 'Antioxid Redox Signal.',\n",
       "    'volume': '28',\n",
       "    'issn': '',\n",
       "    'pages': '916-34',\n",
       "    'other_ids': {'DOI': ['10.1089/ars.2017.6994']}},\n",
       "   'BIBREF118': {'title': 'Staphylococcus aureus alpha-toxin induces inflammatory cytokines via lysosomal acid sphingomyelinase and ceramides',\n",
       "    'authors': [{'first': 'J', 'middle': [], 'last': 'Ma', 'suffix': ''},\n",
       "     {'first': 'E', 'middle': [], 'last': 'Gulbins', 'suffix': ''},\n",
       "     {'first': 'MJ', 'middle': [], 'last': 'Edwards', 'suffix': ''},\n",
       "     {'first': 'CC', 'middle': [], 'last': 'Caldwell', 'suffix': ''},\n",
       "     {'first': 'M', 'middle': [], 'last': 'Fraunholz', 'suffix': ''},\n",
       "     {'first': 'KA', 'middle': [], 'last': 'Becker', 'suffix': ''}],\n",
       "    'year': 2017,\n",
       "    'venue': 'Cell Physiol Biochem.',\n",
       "    'volume': '43',\n",
       "    'issn': '',\n",
       "    'pages': '2170-84',\n",
       "    'other_ids': {'DOI': ['10.1159/000484296']}},\n",
       "   'BIBREF119': {'title': 'Staphylococcus aureus alpha-toxin disrupts endothelial-cell tight junctions via acid sphingomyelinase and ceramide',\n",
       "    'authors': [{'first': 'KA', 'middle': [], 'last': 'Becker', 'suffix': ''},\n",
       "     {'first': 'B', 'middle': [], 'last': 'Fahsel', 'suffix': ''},\n",
       "     {'first': 'H', 'middle': [], 'last': 'Kemper', 'suffix': ''},\n",
       "     {'first': 'J', 'middle': [], 'last': 'Mayeres', 'suffix': ''},\n",
       "     {'first': 'C', 'middle': [], 'last': 'Li', 'suffix': ''},\n",
       "     {'first': 'B', 'middle': [], 'last': 'Wilker', 'suffix': ''}],\n",
       "    'year': 2018,\n",
       "    'venue': 'Infect Immun.',\n",
       "    'volume': '86',\n",
       "    'issn': '',\n",
       "    'pages': 'e00606-17',\n",
       "    'other_ids': {'DOI': ['10.1093/med/9780198738381.003.0024']}},\n",
       "   'BIBREF120': {'title': 'Acid sphingomyelinase inhibition protects mice from lung edema and lethal Staphylococcus aureus sepsis',\n",
       "    'authors': [{'first': 'H', 'middle': [], 'last': 'Peng', 'suffix': ''},\n",
       "     {'first': 'C', 'middle': [], 'last': 'Li', 'suffix': ''},\n",
       "     {'first': 'S', 'middle': [], 'last': 'Kadow', 'suffix': ''},\n",
       "     {'first': 'BD', 'middle': [], 'last': 'Henry', 'suffix': ''},\n",
       "     {'first': 'J', 'middle': [], 'last': 'Steinmann', 'suffix': ''},\n",
       "     {'first': 'KA', 'middle': [], 'last': 'Becker', 'suffix': ''}],\n",
       "    'year': 2015,\n",
       "    'venue': 'J Mol Med.',\n",
       "    'volume': '93',\n",
       "    'issn': '',\n",
       "    'pages': '675-89',\n",
       "    'other_ids': {'DOI': ['10.1007/s00109-014-1246-y']}},\n",
       "   'BIBREF121': {'title': 'Acidic sphingomyelinase mediates entry of N',\n",
       "    'authors': [{'first': 'H', 'middle': [], 'last': 'Grassme', 'suffix': ''},\n",
       "     {'first': 'E', 'middle': [], 'last': 'Gulbins', 'suffix': ''},\n",
       "     {'first': 'B', 'middle': [], 'last': 'Brenner', 'suffix': ''},\n",
       "     {'first': 'K', 'middle': [], 'last': 'Ferlinz', 'suffix': ''},\n",
       "     {'first': 'K', 'middle': [], 'last': 'Sandhoff', 'suffix': ''},\n",
       "     {'first': 'K', 'middle': [], 'last': 'Harzer', 'suffix': ''}],\n",
       "    'year': 1997,\n",
       "    'venue': '',\n",
       "    'volume': '91',\n",
       "    'issn': '',\n",
       "    'pages': '605-15',\n",
       "    'other_ids': {'DOI': ['10.1016/S0092-8674(00)80448-1']}},\n",
       "   'BIBREF122': {'title': 'Acid sphingomyelinase is involved in CEACAM receptor-mediated phagocytosis of neisseria gonorrhoeae',\n",
       "    'authors': [{'first': 'CR', 'middle': [], 'last': 'Hauck', 'suffix': ''},\n",
       "     {'first': 'H', 'middle': [], 'last': 'Grassme', 'suffix': ''},\n",
       "     {'first': 'J', 'middle': [], 'last': 'Bock', 'suffix': ''},\n",
       "     {'first': 'V', 'middle': [], 'last': 'Jendrossek', 'suffix': ''},\n",
       "     {'first': 'K', 'middle': [], 'last': 'Ferlinz', 'suffix': ''},\n",
       "     {'first': 'TF', 'middle': [], 'last': 'Meyer', 'suffix': ''}],\n",
       "    'year': 2000,\n",
       "    'venue': 'FEBS Lett.',\n",
       "    'volume': '478',\n",
       "    'issn': '',\n",
       "    'pages': '260-6',\n",
       "    'other_ids': {'DOI': ['10.1016/S0014-5793(00)01851-2']}},\n",
       "   'BIBREF123': {'title': 'Asymmetric distribution of phospholipids in biomembranes',\n",
       "    'authors': [{'first': 'A',\n",
       "      'middle': [],\n",
       "      'last': 'Yamaji-Hasegawa',\n",
       "      'suffix': ''},\n",
       "     {'first': 'M', 'middle': [], 'last': 'Tsujimoto', 'suffix': ''}],\n",
       "    'year': 2006,\n",
       "    'venue': 'Biol Pharm Bull.',\n",
       "    'volume': '29',\n",
       "    'issn': '',\n",
       "    'pages': '1547-53',\n",
       "    'other_ids': {'DOI': ['10.1248/bpb.29.1547']}},\n",
       "   'BIBREF124': {'title': 'Cryptosporidium parvum infects human cholangiocytes via sphingolipid-enriched membrane microdomains',\n",
       "    'authors': [{'first': 'JB', 'middle': [], 'last': 'Nelson', 'suffix': ''},\n",
       "     {'first': 'SP', 'middle': [], 'last': \"O'Hara\", 'suffix': ''},\n",
       "     {'first': 'AJ', 'middle': [], 'last': 'Small', 'suffix': ''},\n",
       "     {'first': 'PS', 'middle': [], 'last': 'Tietz', 'suffix': ''},\n",
       "     {'first': 'AK', 'middle': [], 'last': 'Choudhury', 'suffix': ''},\n",
       "     {'first': 'RE', 'middle': [], 'last': 'Pagano', 'suffix': ''}],\n",
       "    'year': 2006,\n",
       "    'venue': 'Cell Microbiol.',\n",
       "    'volume': '8',\n",
       "    'issn': '',\n",
       "    'pages': '1932-45',\n",
       "    'other_ids': {'DOI': ['10.1111/j.1462-5822.2006.00759.x']}},\n",
       "   'BIBREF125': {'title': 'Acid sphingomyelinase is required for lipid Raft TLR4 complex formation',\n",
       "    'authors': [{'first': 'J',\n",
       "      'middle': [],\n",
       "      'last': 'Cuschieri',\n",
       "      'suffix': ''},\n",
       "     {'first': 'E', 'middle': [], 'last': 'Bulger', 'suffix': ''},\n",
       "     {'first': 'J', 'middle': [], 'last': 'Billgrin', 'suffix': ''},\n",
       "     {'first': 'I', 'middle': [], 'last': 'Garcia', 'suffix': ''},\n",
       "     {'first': 'RV', 'middle': [], 'last': 'Maier', 'suffix': ''}],\n",
       "    'year': 2007,\n",
       "    'venue': 'Surg Infect.',\n",
       "    'volume': '8',\n",
       "    'issn': '',\n",
       "    'pages': '91-106',\n",
       "    'other_ids': {'DOI': ['10.1089/sur.2006.050']}},\n",
       "   'BIBREF126': {'title': 'Regulated secretion of acid sphingomyelinase: implications for selectivity of ceramide formation',\n",
       "    'authors': [{'first': 'RW', 'middle': [], 'last': 'Jenkins', 'suffix': ''},\n",
       "     {'first': 'D', 'middle': [], 'last': 'Canals', 'suffix': ''},\n",
       "     {'first': 'J', 'middle': [], 'last': 'Idkowiak-Baldys', 'suffix': ''},\n",
       "     {'first': 'F', 'middle': [], 'last': 'Simbari', 'suffix': ''},\n",
       "     {'first': 'P', 'middle': [], 'last': 'Roddy', 'suffix': ''},\n",
       "     {'first': 'DM', 'middle': [], 'last': 'Perry', 'suffix': ''}],\n",
       "    'year': 2010,\n",
       "    'venue': 'J Biol Chem.',\n",
       "    'volume': '285',\n",
       "    'issn': '',\n",
       "    'pages': '35706-18',\n",
       "    'other_ids': {'DOI': ['10.1074/jbc.M110.125609']}},\n",
       "   'BIBREF127': {'title': 'Doxorubicin enhances TRAIL-induced cell death via ceramide-enriched membrane platforms',\n",
       "    'authors': [{'first': 'CA', 'middle': [], 'last': 'Dumitru', 'suffix': ''},\n",
       "     {'first': 'A', 'middle': [], 'last': 'Carpinteiro', 'suffix': ''},\n",
       "     {'first': 'T', 'middle': [], 'last': 'Trarbach', 'suffix': ''},\n",
       "     {'first': 'UR', 'middle': [], 'last': 'Hengge', 'suffix': ''},\n",
       "     {'first': 'E', 'middle': [], 'last': 'Gulbins', 'suffix': ''}],\n",
       "    'year': 2007,\n",
       "    'venue': 'Apoptosis.',\n",
       "    'volume': '12',\n",
       "    'issn': '',\n",
       "    'pages': '1533-41',\n",
       "    'other_ids': {'DOI': ['10.1007/s10495-007-0081-9']}},\n",
       "   'BIBREF128': {'title': 'Ceramide signaling in fenretinide-induced endothelial cell apoptosis',\n",
       "    'authors': [{'first': 'A',\n",
       "      'middle': [],\n",
       "      'last': 'Erdreich-Epstein',\n",
       "      'suffix': ''},\n",
       "     {'first': 'LB', 'middle': [], 'last': 'Tran', 'suffix': ''},\n",
       "     {'first': 'NN', 'middle': [], 'last': 'Bowman', 'suffix': ''},\n",
       "     {'first': 'H', 'middle': [], 'last': 'Wang', 'suffix': ''},\n",
       "     {'first': 'MC', 'middle': [], 'last': 'Cabot', 'suffix': ''},\n",
       "     {'first': 'DL', 'middle': [], 'last': 'Durden', 'suffix': ''}],\n",
       "    'year': 2002,\n",
       "    'venue': 'J Biol Chem.',\n",
       "    'volume': '277',\n",
       "    'issn': '',\n",
       "    'pages': '49531-7',\n",
       "    'other_ids': {'DOI': ['10.1074/jbc.M209962200']}},\n",
       "   'BIBREF129': {'title': 'Targeting acid sphingomyelinase with anti-angiogenic chemotherapy',\n",
       "    'authors': [{'first': 'J', 'middle': [], 'last': 'Jacobi', 'suffix': ''},\n",
       "     {'first': 'M', 'middle': [], 'last': 'Garcia-Barros', 'suffix': ''},\n",
       "     {'first': 'S', 'middle': [], 'last': 'Rao', 'suffix': ''},\n",
       "     {'first': 'JA', 'middle': [], 'last': 'Rotolo', 'suffix': ''},\n",
       "     {'first': 'C', 'middle': [], 'last': 'Thompson', 'suffix': ''},\n",
       "     {'first': 'A', 'middle': [], 'last': 'Mizrachi', 'suffix': ''}],\n",
       "    'year': 2017,\n",
       "    'venue': 'Cell Signal.',\n",
       "    'volume': '29',\n",
       "    'issn': '',\n",
       "    'pages': '52-61',\n",
       "    'other_ids': {'DOI': ['10.1016/j.cellsig.2016.09.010']}},\n",
       "   'BIBREF130': {'title': 'Rituximab antiproliferative effect in B-lymphoma cells is associated with acid-sphingomyelinase activation in raft microdomains',\n",
       "    'authors': [{'first': 'C', 'middle': [], 'last': 'Bezombes', 'suffix': ''},\n",
       "     {'first': 'S', 'middle': [], 'last': 'Grazide', 'suffix': ''},\n",
       "     {'first': 'C', 'middle': [], 'last': 'Garret', 'suffix': ''},\n",
       "     {'first': 'C', 'middle': [], 'last': 'Fabre', 'suffix': ''},\n",
       "     {'first': 'A', 'middle': [], 'last': 'Quillet-Mary', 'suffix': ''},\n",
       "     {'first': 'S', 'middle': [], 'last': 'Muller', 'suffix': ''}],\n",
       "    'year': 2004,\n",
       "    'venue': 'Blood.',\n",
       "    'volume': '104',\n",
       "    'issn': '',\n",
       "    'pages': '1166-73',\n",
       "    'other_ids': {'DOI': ['10.1182/blood-2004-01-0277']}},\n",
       "   'BIBREF131': {'title': 'Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis',\n",
       "    'authors': [{'first': 'A',\n",
       "      'middle': [],\n",
       "      'last': 'Haimovitz-Friedman',\n",
       "      'suffix': ''},\n",
       "     {'first': 'CC', 'middle': [], 'last': 'Kan', 'suffix': ''},\n",
       "     {'first': 'D', 'middle': [], 'last': 'Ehleiter', 'suffix': ''},\n",
       "     {'first': 'RS', 'middle': [], 'last': 'Persaud', 'suffix': ''},\n",
       "     {'first': 'M', 'middle': [], 'last': 'McLoughlin', 'suffix': ''},\n",
       "     {'first': 'Z', 'middle': [], 'last': 'Fuks', 'suffix': ''}],\n",
       "    'year': 1994,\n",
       "    'venue': 'J Exp Med.',\n",
       "    'volume': '180',\n",
       "    'issn': '',\n",
       "    'pages': '525-35',\n",
       "    'other_ids': {'DOI': ['10.1084/jem.180.2.525']}},\n",
       "   'BIBREF132': {'title': 'Critical role of acidic sphingomyelinase in murine hepatic ischemia-reperfusion injury',\n",
       "    'authors': [{'first': 'L', 'middle': [], 'last': 'Llacuna', 'suffix': ''},\n",
       "     {'first': 'M', 'middle': [], 'last': 'Mari', 'suffix': ''},\n",
       "     {'first': 'C', 'middle': [], 'last': 'Garcia-Ruiz', 'suffix': ''},\n",
       "     {'first': 'JC', 'middle': [], 'last': 'Fernandez-Checa', 'suffix': ''},\n",
       "     {'first': 'A', 'middle': [], 'last': 'Morales', 'suffix': ''}],\n",
       "    'year': 2006,\n",
       "    'venue': 'Hepatology.',\n",
       "    'volume': '44',\n",
       "    'issn': '',\n",
       "    'pages': '561-72',\n",
       "    'other_ids': {'DOI': ['10.1002/hep.21285']}},\n",
       "   'BIBREF133': {'title': 'Oxidative stress triggers Ca-dependent lysosome trafficking and activation of acid sphingomyelinase',\n",
       "    'authors': [{'first': 'X', 'middle': [], 'last': 'Li', 'suffix': ''},\n",
       "     {'first': 'E', 'middle': [], 'last': 'Gulbins', 'suffix': ''},\n",
       "     {'first': 'Y', 'middle': [], 'last': 'Zhang', 'suffix': ''}],\n",
       "    'year': 2012,\n",
       "    'venue': 'Cell Physiol Biochem.',\n",
       "    'volume': '30',\n",
       "    'issn': '',\n",
       "    'pages': '815-26',\n",
       "    'other_ids': {'DOI': ['10.1159/000341460']}},\n",
       "   'BIBREF134': {'title': 'The challenge of lipid rafts',\n",
       "    'authors': [{'first': 'LJ', 'middle': [], 'last': 'Pike', 'suffix': ''}],\n",
       "    'year': 2009,\n",
       "    'venue': 'J Lipid Res.',\n",
       "    'volume': '50',\n",
       "    'issn': '',\n",
       "    'pages': 'S323-8',\n",
       "    'other_ids': {'DOI': ['10.1194/jlr.R800040-JLR200']}},\n",
       "   'BIBREF135': {'title': 'Ceramide enables fas to cap and kill',\n",
       "    'authors': [{'first': 'A', 'middle': [], 'last': 'Cremesti', 'suffix': ''},\n",
       "     {'first': 'F', 'middle': [], 'last': 'Paris', 'suffix': ''},\n",
       "     {'first': 'H', 'middle': [], 'last': 'Grassme', 'suffix': ''},\n",
       "     {'first': 'N', 'middle': [], 'last': 'Holler', 'suffix': ''},\n",
       "     {'first': 'J', 'middle': [], 'last': 'Tschopp', 'suffix': ''},\n",
       "     {'first': 'Z', 'middle': [], 'last': 'Fuks', 'suffix': ''}],\n",
       "    'year': 2001,\n",
       "    'venue': 'J Biol Chem.',\n",
       "    'volume': '276',\n",
       "    'issn': '',\n",
       "    'pages': '23954-61',\n",
       "    'other_ids': {'DOI': ['10.1074/jbc.M101866200']}},\n",
       "   'BIBREF136': {'title': 'Caspase-dependent and -independent activation of acid sphingomyelinase signaling',\n",
       "    'authors': [{'first': 'JA', 'middle': [], 'last': 'Rotolo', 'suffix': ''},\n",
       "     {'first': 'J', 'middle': [], 'last': 'Zhang', 'suffix': ''},\n",
       "     {'first': 'M', 'middle': [], 'last': 'Donepudi', 'suffix': ''},\n",
       "     {'first': 'H', 'middle': [], 'last': 'Lee', 'suffix': ''},\n",
       "     {'first': 'Z', 'middle': [], 'last': 'Fuks', 'suffix': ''},\n",
       "     {'first': 'R', 'middle': [], 'last': 'Kolesnick', 'suffix': ''}],\n",
       "    'year': 2005,\n",
       "    'venue': 'J Biol Chem.',\n",
       "    'volume': '280',\n",
       "    'issn': '',\n",
       "    'pages': '26425-34',\n",
       "    'other_ids': {'DOI': ['10.1074/jbc.M414569200']}},\n",
       "   'BIBREF137': {'title': 'Anti-ceramide antibody prevents the radiation gastrointestinal syndrome in mice',\n",
       "    'authors': [{'first': 'J', 'middle': [], 'last': 'Rotolo', 'suffix': ''},\n",
       "     {'first': 'B', 'middle': [], 'last': 'Stancevic', 'suffix': ''},\n",
       "     {'first': 'J', 'middle': [], 'last': 'Zhang', 'suffix': ''},\n",
       "     {'first': 'G', 'middle': [], 'last': 'Hua', 'suffix': ''},\n",
       "     {'first': 'J', 'middle': [], 'last': 'Fuller', 'suffix': ''},\n",
       "     {'first': 'X', 'middle': [], 'last': 'Yin', 'suffix': ''}],\n",
       "    'year': 2012,\n",
       "    'venue': 'J Clin Invest.',\n",
       "    'volume': '122',\n",
       "    'issn': '',\n",
       "    'pages': '1786-90',\n",
       "    'other_ids': {'DOI': ['10.1172/JCI59920']}},\n",
       "   'BIBREF138': {'title': 'Acid sphingomyelinase is required for efficient phago-lysosomal fusion',\n",
       "    'authors': [{'first': 'M', 'middle': [], 'last': 'Schramm', 'suffix': ''},\n",
       "     {'first': 'J', 'middle': [], 'last': 'Herz', 'suffix': ''},\n",
       "     {'first': 'A', 'middle': [], 'last': 'Haas', 'suffix': ''},\n",
       "     {'first': 'M', 'middle': [], 'last': 'Kronke', 'suffix': ''},\n",
       "     {'first': 'O', 'middle': [], 'last': 'Utermohlen', 'suffix': ''}],\n",
       "    'year': 2008,\n",
       "    'venue': 'Cell Microbiol.',\n",
       "    'volume': '10',\n",
       "    'issn': '',\n",
       "    'pages': '1839-53',\n",
       "    'other_ids': {'DOI': ['10.1111/j.1462-5822.2008.01169.x']}},\n",
       "   'BIBREF139': {'title': 'Fusogenicity of membranes: the impact of acid sphingomyelinase on innate immune responses',\n",
       "    'authors': [{'first': 'O',\n",
       "      'middle': [],\n",
       "      'last': 'Utermohlen',\n",
       "      'suffix': ''},\n",
       "     {'first': 'J', 'middle': [], 'last': 'Herz', 'suffix': ''},\n",
       "     {'first': 'M', 'middle': [], 'last': 'Schramm', 'suffix': ''},\n",
       "     {'first': 'M', 'middle': [], 'last': 'Kronke', 'suffix': ''}],\n",
       "    'year': 2008,\n",
       "    'venue': 'Immunobiology.',\n",
       "    'volume': '213',\n",
       "    'issn': '',\n",
       "    'pages': '307-14',\n",
       "    'other_ids': {'DOI': ['10.1016/j.imbio.2007.10.016']}},\n",
       "   'BIBREF140': {'title': 'Severe impairment in early host defense against Listeria monocytogenes in mice deficient in acid sphingomyelinase',\n",
       "    'authors': [{'first': 'O',\n",
       "      'middle': [],\n",
       "      'last': 'Utermohlen',\n",
       "      'suffix': ''},\n",
       "     {'first': 'U', 'middle': [], 'last': 'Karow', 'suffix': ''},\n",
       "     {'first': 'J', 'middle': [], 'last': 'Lohler', 'suffix': ''},\n",
       "     {'first': 'M', 'middle': [], 'last': 'Kronke', 'suffix': ''}],\n",
       "    'year': 2003,\n",
       "    'venue': 'J Immunol.',\n",
       "    'volume': '170',\n",
       "    'issn': '',\n",
       "    'pages': '2621-8',\n",
       "    'other_ids': {'DOI': ['10.4049/jimmunol.170.5.2621']}},\n",
       "   'BIBREF141': {'title': 'Generation of ceramide in murine macrophages infected with Leishmania donovani alters macrophage signaling events and aids intracellular parasitic survival',\n",
       "    'authors': [{'first': 'S', 'middle': [], 'last': 'Ghosh', 'suffix': ''},\n",
       "     {'first': 'S', 'middle': [], 'last': 'Bhattacharyya', 'suffix': ''},\n",
       "     {'first': 'S', 'middle': [], 'last': 'Das', 'suffix': ''},\n",
       "     {'first': 'S', 'middle': [], 'last': 'Raha', 'suffix': ''},\n",
       "     {'first': 'N', 'middle': [], 'last': 'Maulik', 'suffix': ''},\n",
       "     {'first': 'DK', 'middle': [], 'last': 'Das', 'suffix': ''}],\n",
       "    'year': 2001,\n",
       "    'venue': 'Mol Cell Biochem.',\n",
       "    'volume': '223',\n",
       "    'issn': '',\n",
       "    'pages': '47-60',\n",
       "    'other_ids': {'DOI': ['10.1023/A:1017996609928']}},\n",
       "   'BIBREF142': {'title': 'Reactive oxygen species limit neutrophil life span by activating death receptor signaling',\n",
       "    'authors': [{'first': 'D',\n",
       "      'middle': [],\n",
       "      'last': 'Scheel-Toellner',\n",
       "      'suffix': ''},\n",
       "     {'first': 'K', 'middle': [], 'last': 'Wang', 'suffix': ''},\n",
       "     {'first': 'R', 'middle': [], 'last': 'Craddock', 'suffix': ''},\n",
       "     {'first': 'PR', 'middle': [], 'last': 'Webb', 'suffix': ''},\n",
       "     {'first': 'HM', 'middle': [], 'last': 'McGettrick', 'suffix': ''},\n",
       "     {'first': 'LK', 'middle': [], 'last': 'Assi', 'suffix': ''}],\n",
       "    'year': 2004,\n",
       "    'venue': 'Blood.',\n",
       "    'volume': '104',\n",
       "    'issn': '',\n",
       "    'pages': '2557-64',\n",
       "    'other_ids': {'DOI': ['10.1182/blood-2004-01-0191']}},\n",
       "   'BIBREF143': {'title': 'The cellular trafficking and zinc dependence of secretory and lysosomal sphingomyelinase, two products of the acid sphingomyelinase gene',\n",
       "    'authors': [{'first': 'SL',\n",
       "      'middle': [],\n",
       "      'last': 'Schissel',\n",
       "      'suffix': ''},\n",
       "     {'first': 'GA', 'middle': [], 'last': 'Keesler', 'suffix': ''},\n",
       "     {'first': 'EH', 'middle': [], 'last': 'Schuchman', 'suffix': ''},\n",
       "     {'first': 'KJ', 'middle': [], 'last': 'Williams', 'suffix': ''},\n",
       "     {'first': 'I', 'middle': [], 'last': 'Tabas', 'suffix': ''}],\n",
       "    'year': 1998,\n",
       "    'venue': 'J Biol Chem.',\n",
       "    'volume': '273',\n",
       "    'issn': '',\n",
       "    'pages': '18250-9',\n",
       "    'other_ids': {'DOI': ['10.1074/jbc.273.29.18250']}},\n",
       "   'BIBREF144': {'title': 'TNFR1-induced sphingomyelinase activation modulates TCR signaling by impairing store-operated Ca2+ influx',\n",
       "    'authors': [{'first': 'LD', 'middle': [], 'last': 'Church', 'suffix': ''},\n",
       "     {'first': 'G', 'middle': [], 'last': 'Hessler', 'suffix': ''},\n",
       "     {'first': 'JE', 'middle': [], 'last': 'Goodall', 'suffix': ''},\n",
       "     {'first': 'DA', 'middle': [], 'last': 'Rider', 'suffix': ''},\n",
       "     {'first': 'CJ', 'middle': [], 'last': 'Workman', 'suffix': ''},\n",
       "     {'first': 'DA', 'middle': [], 'last': 'Vignali', 'suffix': ''}],\n",
       "    'year': 2005,\n",
       "    'venue': 'J Leukoc Biol.',\n",
       "    'volume': '78',\n",
       "    'issn': '',\n",
       "    'pages': '266-78',\n",
       "    'other_ids': {'DOI': ['10.1189/jlb.1003456']}},\n",
       "   'BIBREF145': {'title': 'Lipid asymmetry of the eukaryotic plasma membrane: functions and related enzymes',\n",
       "    'authors': [{'first': 'M', 'middle': [], 'last': 'Ikeda', 'suffix': ''},\n",
       "     {'first': 'A', 'middle': [], 'last': 'Kihara', 'suffix': ''},\n",
       "     {'first': 'Y', 'middle': [], 'last': 'Igarashi', 'suffix': ''}],\n",
       "    'year': 2006,\n",
       "    'venue': 'Biol Pharm Bull.',\n",
       "    'volume': '29',\n",
       "    'issn': '',\n",
       "    'pages': '1542-6',\n",
       "    'other_ids': {'DOI': ['10.1248/bpb.29.1542']}},\n",
       "   'BIBREF146': {'title': 'Exocytosis of acid sphingomyelinase by wounded cells promotes endocytosis and plasma membrane repair',\n",
       "    'authors': [{'first': 'C', 'middle': [], 'last': 'Tam', 'suffix': ''},\n",
       "     {'first': 'V', 'middle': [], 'last': 'Idone', 'suffix': ''},\n",
       "     {'first': 'C', 'middle': [], 'last': 'Devlin', 'suffix': ''},\n",
       "     {'first': 'MC', 'middle': [], 'last': 'Fernandes', 'suffix': ''},\n",
       "     {'first': 'A', 'middle': [], 'last': 'Flannery', 'suffix': ''},\n",
       "     {'first': 'X', 'middle': [], 'last': 'He', 'suffix': ''}],\n",
       "    'year': 2010,\n",
       "    'venue': 'J Cell Biol.',\n",
       "    'volume': '189',\n",
       "    'issn': '',\n",
       "    'pages': '1027-38',\n",
       "    'other_ids': {'DOI': ['10.1083/jcb.201003053']}},\n",
       "   'BIBREF147': {'title': 'Co-option of membrane wounding enables virus penetration into cells',\n",
       "    'authors': [{'first': 'S', 'middle': [], 'last': 'Luisoni', 'suffix': ''},\n",
       "     {'first': 'M', 'middle': [], 'last': 'Suomalainen', 'suffix': ''},\n",
       "     {'first': 'K', 'middle': [], 'last': 'Boucke', 'suffix': ''},\n",
       "     {'first': 'LB', 'middle': [], 'last': 'Tanner', 'suffix': ''},\n",
       "     {'first': 'MR', 'middle': [], 'last': 'Wenk', 'suffix': ''},\n",
       "     {'first': 'XL', 'middle': [], 'last': 'Guan', 'suffix': ''}],\n",
       "    'year': 2015,\n",
       "    'venue': 'Cell Host Microbe.',\n",
       "    'volume': '18',\n",
       "    'issn': '',\n",
       "    'pages': '75-85',\n",
       "    'other_ids': {'DOI': ['10.1016/j.chom.2015.06.006']}},\n",
       "   'BIBREF148': {'title': 'Damage control: cellular mechanisms of plasma membrane repair',\n",
       "    'authors': [{'first': 'NW', 'middle': [], 'last': 'Andrews', 'suffix': ''},\n",
       "     {'first': 'PE', 'middle': [], 'last': 'Almeida', 'suffix': ''},\n",
       "     {'first': 'M', 'middle': [], 'last': 'Corrotte', 'suffix': ''}],\n",
       "    'year': 2014,\n",
       "    'venue': 'Trends Cell Biol.',\n",
       "    'volume': '24',\n",
       "    'issn': '',\n",
       "    'pages': '734-42',\n",
       "    'other_ids': {'DOI': ['10.1016/j.tcb.2014.07.008']}},\n",
       "   'BIBREF149': {'title': 'Ceramide in plasma membrane repair',\n",
       "    'authors': [{'first': 'A', 'middle': [], 'last': 'Draeger', 'suffix': ''},\n",
       "     {'first': 'EB', 'middle': [], 'last': 'Babiychuk', 'suffix': ''}],\n",
       "    'year': 2013,\n",
       "    'venue': 'Handb Exp Pharmacol.',\n",
       "    'volume': '216',\n",
       "    'issn': '',\n",
       "    'pages': '341-53',\n",
       "    'other_ids': {'DOI': ['10.1007/978-3-7091-1511-4_17']}},\n",
       "   'BIBREF150': {'title': 'Down-regulation of acid sphingomyelinase and neutral sphingomyelinase-2 inversely determines the cellular resistance to plasmalemmal injury by pore-forming toxins',\n",
       "    'authors': [{'first': 'R',\n",
       "      'middle': [],\n",
       "      'last': 'Schoenauer',\n",
       "      'suffix': ''},\n",
       "     {'first': 'Y', 'middle': [], 'last': 'Larpin', 'suffix': ''},\n",
       "     {'first': 'EB', 'middle': [], 'last': 'Babiychuk', 'suffix': ''},\n",
       "     {'first': 'P', 'middle': [], 'last': 'Drucker', 'suffix': ''},\n",
       "     {'first': 'VS', 'middle': [], 'last': 'Babiychuk', 'suffix': ''},\n",
       "     {'first': 'E', 'middle': [], 'last': 'Avota', 'suffix': ''}],\n",
       "    'year': 2019,\n",
       "    'venue': 'FASEB J.',\n",
       "    'volume': '33',\n",
       "    'issn': '',\n",
       "    'pages': '275-85',\n",
       "    'other_ids': {'DOI': ['10.1096/fj.201800033R']}},\n",
       "   'BIBREF151': {'title': 'Co-operation of TLR4 and raft proteins in LPS-induced pro-inflammatory signaling',\n",
       "    'authors': [{'first': 'A',\n",
       "      'middle': [],\n",
       "      'last': 'Plociennikowska',\n",
       "      'suffix': ''},\n",
       "     {'first': 'A', 'middle': [], 'last': 'Hromada-Judycka', 'suffix': ''},\n",
       "     {'first': 'K', 'middle': [], 'last': 'Borzecka', 'suffix': ''},\n",
       "     {'first': 'K', 'middle': [], 'last': 'Kwiatkowska', 'suffix': ''}],\n",
       "    'year': 2015,\n",
       "    'venue': 'Cell Mol Life Sci.',\n",
       "    'volume': '72',\n",
       "    'issn': '',\n",
       "    'pages': '557-81',\n",
       "    'other_ids': {'DOI': ['10.1007/s00018-014-1762-5']}},\n",
       "   'BIBREF152': {'title': 'Stress-induced host membrane remodeling protects from infection by non-motile bacterial pathogens',\n",
       "    'authors': [{'first': 'C', 'middle': [], 'last': 'Tawk', 'suffix': ''},\n",
       "     {'first': 'G', 'middle': [], 'last': 'Nigro', 'suffix': ''},\n",
       "     {'first': 'I', 'middle': [], 'last': 'Rodrigues Lopes', 'suffix': ''},\n",
       "     {'first': 'C', 'middle': [], 'last': 'Aguilar', 'suffix': ''},\n",
       "     {'first': 'C', 'middle': [], 'last': 'Lisowski', 'suffix': ''},\n",
       "     {'first': 'M', 'middle': [], 'last': 'Mano', 'suffix': ''}],\n",
       "    'year': 2018,\n",
       "    'venue': 'EMBO J.',\n",
       "    'volume': '37',\n",
       "    'issn': '',\n",
       "    'pages': None,\n",
       "    'other_ids': {'DOI': ['10.15252/embj.201798529']}},\n",
       "   'BIBREF153': {'title': 'ATP redirects cytokine trafficking and promotes novel membrane TNF signaling via microvesicles',\n",
       "    'authors': [{'first': 'S', 'middle': [], 'last': 'Soni', 'suffix': ''},\n",
       "     {'first': 'KP', 'middle': [], 'last': \"O'Dea\", 'suffix': ''},\n",
       "     {'first': 'YY', 'middle': [], 'last': 'Tan', 'suffix': ''},\n",
       "     {'first': 'K', 'middle': [], 'last': 'Cho', 'suffix': ''},\n",
       "     {'first': 'E', 'middle': [], 'last': 'Abe', 'suffix': ''},\n",
       "     {'first': 'R', 'middle': [], 'last': 'Romano', 'suffix': ''}],\n",
       "    'year': 2019,\n",
       "    'venue': 'FASEB J.',\n",
       "    'volume': '33',\n",
       "    'issn': '',\n",
       "    'pages': '6442-55',\n",
       "    'other_ids': {'DOI': ['10.1096/fj.201802386R']}},\n",
       "   'BIBREF154': {'title': 'Ceramide domains in health and disease: a biophysical perspective',\n",
       "    'authors': [{'first': 'AE', 'middle': [], 'last': 'Ventura', 'suffix': ''},\n",
       "     {'first': 'B', 'middle': [], 'last': 'Mestre', 'suffix': ''},\n",
       "     {'first': 'LC', 'middle': [], 'last': 'Silva', 'suffix': ''}],\n",
       "    'year': 2019,\n",
       "    'venue': 'Adv Exp Med Biol.',\n",
       "    'volume': '1159',\n",
       "    'issn': '',\n",
       "    'pages': '79-108',\n",
       "    'other_ids': {'DOI': ['10.1007/978-3-030-21162-2_6']}},\n",
       "   'BIBREF155': {'title': 'Roles of ceramides and other sphingolipids in immune cell function and inflammation',\n",
       "    'authors': [{'first': 'S',\n",
       "      'middle': [],\n",
       "      'last': 'Albeituni',\n",
       "      'suffix': ''},\n",
       "     {'first': 'J', 'middle': [], 'last': 'Stiban', 'suffix': ''}],\n",
       "    'year': 2019,\n",
       "    'venue': 'Adv Exp Med Biol.',\n",
       "    'volume': '1161',\n",
       "    'issn': '',\n",
       "    'pages': '169-91',\n",
       "    'other_ids': {'DOI': ['10.1007/978-3-030-21735-8_15']}},\n",
       "   'BIBREF156': {'title': 'Sphingolipids and their metabolism in physiology and disease',\n",
       "    'authors': [{'first': 'YA', 'middle': [], 'last': 'Hannun', 'suffix': ''},\n",
       "     {'first': 'LM', 'middle': [], 'last': 'Obeid', 'suffix': ''}],\n",
       "    'year': 2018,\n",
       "    'venue': 'Nat Rev Mol Cell Biol.',\n",
       "    'volume': '19',\n",
       "    'issn': '',\n",
       "    'pages': '175-91',\n",
       "    'other_ids': {'DOI': ['10.1038/nrm.2017.107']}},\n",
       "   'BIBREF157': {'title': 'Sphingolipids in mitochondria',\n",
       "    'authors': [{'first': 'MJ',\n",
       "      'middle': [],\n",
       "      'last': 'Hernandez-Corbacho',\n",
       "      'suffix': ''},\n",
       "     {'first': 'MF', 'middle': [], 'last': 'Salama', 'suffix': ''},\n",
       "     {'first': 'D', 'middle': [], 'last': 'Canals', 'suffix': ''},\n",
       "     {'first': 'CE', 'middle': [], 'last': 'Senkal', 'suffix': ''},\n",
       "     {'first': 'LM', 'middle': [], 'last': 'Obeid', 'suffix': ''}],\n",
       "    'year': 2017,\n",
       "    'venue': 'Biochim Biophys Acta Mol Cell Biol Lipids.',\n",
       "    'volume': '1862',\n",
       "    'issn': '',\n",
       "    'pages': '56-68',\n",
       "    'other_ids': {'DOI': ['10.1016/j.bbalip.2016.09.019']}},\n",
       "   'BIBREF158': {'title': 'Hyperresponsiveness of mice deficient in plasma-secreted sphingomyelinase reveals its pivotal role in early phase of host response',\n",
       "    'authors': [{'first': 'N', 'middle': [], 'last': 'Jbeily', 'suffix': ''},\n",
       "     {'first': 'I', 'middle': [], 'last': 'Suckert', 'suffix': ''},\n",
       "     {'first': 'FA', 'middle': [], 'last': 'Gonnert', 'suffix': ''},\n",
       "     {'first': 'B', 'middle': [], 'last': 'Acht', 'suffix': ''},\n",
       "     {'first': 'CL', 'middle': [], 'last': 'Bockmeyer', 'suffix': ''},\n",
       "     {'first': 'SD', 'middle': [], 'last': 'Grossmann', 'suffix': ''}],\n",
       "    'year': 2013,\n",
       "    'venue': 'J Lipid Res.',\n",
       "    'volume': '54',\n",
       "    'issn': '',\n",
       "    'pages': '410-24',\n",
       "    'other_ids': {'DOI': ['10.1194/jlr.M031625']}},\n",
       "   'BIBREF159': {'title': 'Decreasing SMPD1 activity in BEAS-2B bronchial airway epithelial cells results in increased NRF2 activity, cytokine synthesis and neutrophil recruitment',\n",
       "    'authors': [{'first': 'E',\n",
       "      'middle': [],\n",
       "      'last': 'MacFadden-Murphy',\n",
       "      'suffix': ''},\n",
       "     {'first': 'L', 'middle': [], 'last': 'Roussel', 'suffix': ''},\n",
       "     {'first': 'G', 'middle': [], 'last': 'Martel', 'suffix': ''},\n",
       "     {'first': 'J', 'middle': [], 'last': 'Berube', 'suffix': ''},\n",
       "     {'first': 'S', 'middle': [], 'last': 'Rousseau', 'suffix': ''}],\n",
       "    'year': 2017,\n",
       "    'venue': 'Biochem Biophys Res Commun.',\n",
       "    'volume': '482',\n",
       "    'issn': '',\n",
       "    'pages': '645-50',\n",
       "    'other_ids': {'DOI': ['10.1016/j.bbrc.2016.11.087']}},\n",
       "   'BIBREF160': {'title': 'Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation',\n",
       "    'authors': [{'first': 'A',\n",
       "      'middle': [],\n",
       "      'last': 'Haimovitz-Friedman',\n",
       "      'suffix': ''},\n",
       "     {'first': 'C', 'middle': [], 'last': 'Cordon-Cardo', 'suffix': ''},\n",
       "     {'first': 'S', 'middle': [], 'last': 'Bayoumy', 'suffix': ''},\n",
       "     {'first': 'M', 'middle': [], 'last': 'Garzotto', 'suffix': ''},\n",
       "     {'first': 'M', 'middle': [], 'last': 'McLoughlin', 'suffix': ''},\n",
       "     {'first': 'R', 'middle': [], 'last': 'Gallily', 'suffix': ''}],\n",
       "    'year': 1997,\n",
       "    'venue': 'J Exp Med.',\n",
       "    'volume': '186',\n",
       "    'issn': '',\n",
       "    'pages': '1831-41',\n",
       "    'other_ids': {'DOI': ['10.1084/jem.186.11.1831']}},\n",
       "   'BIBREF161': {'title': 'Control of CD1d-restricted antigen presentation and inflammation by sphingomyelin',\n",
       "    'authors': [{'first': 'E', 'middle': [], 'last': 'Melum', 'suffix': ''},\n",
       "     {'first': 'X', 'middle': [], 'last': 'Jiang', 'suffix': ''},\n",
       "     {'first': 'KD', 'middle': [], 'last': 'Baker', 'suffix': ''},\n",
       "     {'first': 'MF', 'middle': [], 'last': 'Macedo', 'suffix': ''},\n",
       "     {'first': 'J', 'middle': [], 'last': 'Fritsch', 'suffix': ''},\n",
       "     {'first': 'CM', 'middle': [], 'last': 'Dowds', 'suffix': ''}],\n",
       "    'year': 2019,\n",
       "    'venue': 'Nat Immunol.',\n",
       "    'volume': '20',\n",
       "    'issn': '',\n",
       "    'pages': '1644-55',\n",
       "    'other_ids': {'DOI': ['10.1038/s41590-019-0504-0']}},\n",
       "   'BIBREF162': {'title': 'Types A and B niemann-pick disease',\n",
       "    'authors': [{'first': 'EH',\n",
       "      'middle': [],\n",
       "      'last': 'Schuchman',\n",
       "      'suffix': ''},\n",
       "     {'first': 'MP', 'middle': [], 'last': 'Wasserstein', 'suffix': ''}],\n",
       "    'year': 2016,\n",
       "    'venue': 'Pediatr Endocrinol Rev.',\n",
       "    'volume': '13',\n",
       "    'issn': 'Suppl. 1',\n",
       "    'pages': '674-81',\n",
       "    'other_ids': {'DOI': ['10.1016/j.ymgme.2016.12.008']}},\n",
       "   'BIBREF163': {'title': 'Spectrum of SMPD1 mutations in Asian-Indian patients with acid sphingomyelinase (ASM)-deficient Niemann-Pick disease',\n",
       "    'authors': [{'first': 'P',\n",
       "      'middle': [],\n",
       "      'last': 'Ranganath',\n",
       "      'suffix': ''},\n",
       "     {'first': 'D', 'middle': [], 'last': 'Matta', 'suffix': ''},\n",
       "     {'first': 'GS', 'middle': [], 'last': 'Bhavani', 'suffix': ''},\n",
       "     {'first': 'S', 'middle': [], 'last': 'Wangnekar', 'suffix': ''},\n",
       "     {'first': 'JM', 'middle': [], 'last': 'Jain', 'suffix': ''},\n",
       "     {'first': 'IC', 'middle': [], 'last': 'Verma', 'suffix': ''}],\n",
       "    'year': 2016,\n",
       "    'venue': 'Am J Med Genet A.',\n",
       "    'volume': '170',\n",
       "    'issn': '',\n",
       "    'pages': '2719-30',\n",
       "    'other_ids': {'DOI': ['10.1002/ajmg.a.37817']}},\n",
       "   'BIBREF164': {'title': 'Four novel p.N385K, p.V36A, c.1033-1034insT and c.1417-1418delCT mutations in the sphingomyelin phosphodiesterase 1 (SMPD1) gene in patients with types A and B niemann-pick disease (NPD)',\n",
       "    'authors': [{'first': 'MD',\n",
       "      'middle': [],\n",
       "      'last': 'Manshadi',\n",
       "      'suffix': ''},\n",
       "     {'first': 'B', 'middle': [], 'last': 'Kamalidehghan', 'suffix': ''},\n",
       "     {'first': 'F', 'middle': [], 'last': 'Keshavarzi', 'suffix': ''},\n",
       "     {'first': 'O', 'middle': [], 'last': 'Aryani', 'suffix': ''},\n",
       "     {'first': 'S', 'middle': [], 'last': 'Dadgar', 'suffix': ''},\n",
       "     {'first': 'A', 'middle': [], 'last': 'Arastehkani', 'suffix': ''}],\n",
       "    'year': 2015,\n",
       "    'venue': 'Int J Mol Sci.',\n",
       "    'volume': '16',\n",
       "    'issn': '',\n",
       "    'pages': '6668-76',\n",
       "    'other_ids': {'DOI': ['10.3390/ijms16046668']}},\n",
       "   'BIBREF165': {'title': 'A very unusual presentation of Niemann-Pick disease type B in an infant: similar findings to congenital lobar emphysema',\n",
       "    'authors': [{'first': 'IS', 'middle': [], 'last': 'Arda', 'suffix': ''},\n",
       "     {'first': 'A', 'middle': [], 'last': 'Gencoglu', 'suffix': ''},\n",
       "     {'first': 'M', 'middle': [], 'last': 'Coskun', 'suffix': ''},\n",
       "     {'first': 'N', 'middle': [], 'last': 'Ozbek', 'suffix': ''},\n",
       "     {'first': 'B', 'middle': [], 'last': 'Demirhan', 'suffix': ''},\n",
       "     {'first': 'A', 'middle': [], 'last': 'Hicsonmez', 'suffix': ''}],\n",
       "    'year': 2005,\n",
       "    'venue': 'Eur J Pediatr Surg.',\n",
       "    'volume': '15',\n",
       "    'issn': '',\n",
       "    'pages': '283-6',\n",
       "    'other_ids': {'DOI': ['10.1055/s-2004-830362']}},\n",
       "   'BIBREF166': {'title': 'Pulmonary involvement in niemann-pick disease: a state-of-the-art review',\n",
       "    'authors': [{'first': 'FM',\n",
       "      'middle': [],\n",
       "      'last': 'von Ranke',\n",
       "      'suffix': ''},\n",
       "     {'first': 'HM', 'middle': [], 'last': 'Pereira Freitas', 'suffix': ''},\n",
       "     {'first': 'AD', 'middle': [], 'last': 'Mancano', 'suffix': ''},\n",
       "     {'first': 'RS', 'middle': [], 'last': 'Rodrigues', 'suffix': ''},\n",
       "     {'first': 'B', 'middle': [], 'last': 'Hochhegger', 'suffix': ''},\n",
       "     {'first': 'D', 'middle': [], 'last': 'Escuissato', 'suffix': ''}],\n",
       "    'year': 2016,\n",
       "    'venue': 'Lung.',\n",
       "    'volume': '194',\n",
       "    'issn': '',\n",
       "    'pages': '511-8',\n",
       "    'other_ids': {'DOI': ['10.1007/s00408-016-9893-0']}},\n",
       "   'BIBREF167': {'title': 'Sphingolipid metabolism and neutral sphingomyelinases',\n",
       "    'authors': [{'first': 'MV', 'middle': [], 'last': 'Airola', 'suffix': ''},\n",
       "     {'first': 'YA', 'middle': [], 'last': 'Hannun', 'suffix': ''}],\n",
       "    'year': 2013,\n",
       "    'venue': 'Handb Exp Pharmacol.',\n",
       "    'volume': '215',\n",
       "    'issn': '',\n",
       "    'pages': '57-76',\n",
       "    'other_ids': {'DOI': ['10.1007/978-3-7091-1368-4_3']}},\n",
       "   'BIBREF168': {'title': 'Morbidity and mortality in type B Niemann-Pick disease',\n",
       "    'authors': [{'first': 'MM',\n",
       "      'middle': [],\n",
       "      'last': 'McGovern',\n",
       "      'suffix': ''},\n",
       "     {'first': 'N', 'middle': [], 'last': 'Lippa', 'suffix': ''},\n",
       "     {'first': 'E', 'middle': [], 'last': 'Bagiella', 'suffix': ''},\n",
       "     {'first': 'EH', 'middle': [], 'last': 'Schuchman', 'suffix': ''},\n",
       "     {'first': 'RJ', 'middle': [], 'last': 'Desnick', 'suffix': ''},\n",
       "     {'first': 'MP', 'middle': [], 'last': 'Wasserstein', 'suffix': ''}],\n",
       "    'year': 2013,\n",
       "    'venue': 'Genet Med.',\n",
       "    'volume': '15',\n",
       "    'issn': '',\n",
       "    'pages': '618-23',\n",
       "    'other_ids': {'DOI': ['10.1038/gim.2013.4']}},\n",
       "   'BIBREF169': {'title': 'Disease manifestations and burden of illness in patients with acid sphingomyelinase deficiency (ASMD)',\n",
       "    'authors': [{'first': 'MM',\n",
       "      'middle': [],\n",
       "      'last': 'McGovern',\n",
       "      'suffix': ''},\n",
       "     {'first': 'R', 'middle': [], 'last': 'Avetisyan', 'suffix': ''},\n",
       "     {'first': 'BJ', 'middle': [], 'last': 'Sanson', 'suffix': ''},\n",
       "     {'first': 'O', 'middle': [], 'last': 'Lidove', 'suffix': ''}],\n",
       "    'year': 2017,\n",
       "    'venue': 'Orphanet J Rare Dis.',\n",
       "    'volume': '12',\n",
       "    'issn': '',\n",
       "    'pages': None,\n",
       "    'other_ids': {'DOI': ['10.1186/s13023-017-0572-x']}},\n",
       "   'BIBREF170': {'title': 'Analysis of the lung pathology and alveolar macrophage function in the acid sphingomyelinase–deficient mouse model of Niemann-Pick disease',\n",
       "    'authors': [{'first': 'R', 'middle': [], 'last': 'Dhami', 'suffix': ''},\n",
       "     {'first': 'X', 'middle': [], 'last': 'He', 'suffix': ''},\n",
       "     {'first': 'RE', 'middle': [], 'last': 'Gordon', 'suffix': ''},\n",
       "     {'first': 'EH', 'middle': [], 'last': 'Schuchman', 'suffix': ''}],\n",
       "    'year': 2001,\n",
       "    'venue': 'Lab Invest.',\n",
       "    'volume': '81',\n",
       "    'issn': '',\n",
       "    'pages': '987-99',\n",
       "    'other_ids': {'DOI': ['10.1038/labinvest.3780311']}},\n",
       "   'BIBREF171': {'title': 'Alveolar lipoproteinosis in an acid sphingomyelinase-deficient mouse model of Niemann-Pick disease',\n",
       "    'authors': [{'first': 'M', 'middle': [], 'last': 'Ikegami', 'suffix': ''},\n",
       "     {'first': 'R', 'middle': [], 'last': 'Dhami', 'suffix': ''},\n",
       "     {'first': 'EH', 'middle': [], 'last': 'Schuchman', 'suffix': ''}],\n",
       "    'year': 2003,\n",
       "    'venue': 'Am J Physiol Lung Cell Mol Physiol.',\n",
       "    'volume': '284',\n",
       "    'issn': '',\n",
       "    'pages': 'L518-25',\n",
       "    'other_ids': {'DOI': ['10.1152/ajplung.00258.2002']}},\n",
       "   'BIBREF172': {'title': 'Pulmonary involvement by Niemann-Pick disease. a report of six cases histopathology',\n",
       "    'authors': [{'first': 'AG',\n",
       "      'middle': [],\n",
       "      'last': 'Nicholson',\n",
       "      'suffix': ''},\n",
       "     {'first': 'R', 'middle': [], 'last': 'Florio', 'suffix': ''},\n",
       "     {'first': 'DM', 'middle': [], 'last': 'Hansell', 'suffix': ''},\n",
       "     {'first': 'RM', 'middle': [], 'last': 'Bois', 'suffix': ''},\n",
       "     {'first': 'AU', 'middle': [], 'last': 'Wells', 'suffix': ''},\n",
       "     {'first': 'P', 'middle': [], 'last': 'Hughes', 'suffix': ''}],\n",
       "    'year': 2006,\n",
       "    'venue': 'Lung.',\n",
       "    'volume': '48',\n",
       "    'issn': '',\n",
       "    'pages': '596-603',\n",
       "    'other_ids': {'DOI': ['10.1111/j.1365-2559.2006.02355.x']}},\n",
       "   'BIBREF173': {'title': 'Cause of death in patients with chronic visceral and chronic neurovisceral acid sphingomyelinase deficiency (Niemann-Pick disease type B and B variant): literature review and report of new cases',\n",
       "    'authors': [{'first': 'D', 'middle': [], 'last': 'Cassiman', 'suffix': ''},\n",
       "     {'first': 'S', 'middle': [], 'last': 'Packman', 'suffix': ''},\n",
       "     {'first': 'B', 'middle': [], 'last': 'Bembi', 'suffix': ''},\n",
       "     {'first': 'HB', 'middle': [], 'last': 'Turkia', 'suffix': ''},\n",
       "     {'first': 'M', 'middle': [], 'last': 'Al-Sayed', 'suffix': ''},\n",
       "     {'first': 'M', 'middle': [], 'last': 'Schiff', 'suffix': ''}],\n",
       "    'year': 2016,\n",
       "    'venue': 'Mol Genet Metab.',\n",
       "    'volume': '118',\n",
       "    'issn': '',\n",
       "    'pages': '206-13',\n",
       "    'other_ids': {'DOI': ['10.1016/j.ymgme.2016.05.001']}},\n",
       "   'BIBREF174': {'title': 'Bacterial sphingomyelinases and phospholipases as virulence factors',\n",
       "    'authors': [{'first': 'M',\n",
       "      'middle': [],\n",
       "      'last': 'Flores-Diaz',\n",
       "      'suffix': ''},\n",
       "     {'first': 'L', 'middle': [], 'last': 'Monturiol-Gross', 'suffix': ''},\n",
       "     {'first': 'C', 'middle': [], 'last': 'Naylor', 'suffix': ''},\n",
       "     {'first': 'A', 'middle': [], 'last': 'Alape-Giron', 'suffix': ''},\n",
       "     {'first': 'A', 'middle': [], 'last': 'Flieger', 'suffix': ''}],\n",
       "    'year': 2016,\n",
       "    'venue': 'Microbiol Mol Biol Rev.',\n",
       "    'volume': '80',\n",
       "    'issn': '',\n",
       "    'pages': '597-628',\n",
       "    'other_ids': {'DOI': ['10.1128/MMBR.00082-15']}},\n",
       "   'BIBREF175': {'title': 'Regulation of the inflammasome by ceramide in cystic fibrosis lungs',\n",
       "    'authors': [{'first': 'H', 'middle': [], 'last': 'Grassme', 'suffix': ''},\n",
       "     {'first': 'A', 'middle': [], 'last': 'Carpinteiro', 'suffix': ''},\n",
       "     {'first': 'MJ', 'middle': [], 'last': 'Edwards', 'suffix': ''},\n",
       "     {'first': 'E', 'middle': [], 'last': 'Gulbins', 'suffix': ''},\n",
       "     {'first': 'KA', 'middle': [], 'last': 'Becker', 'suffix': ''}],\n",
       "    'year': 2014,\n",
       "    'venue': 'Cell Physiol Biochem.',\n",
       "    'volume': '34',\n",
       "    'issn': '',\n",
       "    'pages': '45-55',\n",
       "    'other_ids': {'DOI': ['10.1159/000362983']}},\n",
       "   'BIBREF176': {'title': 'Instigation of NLRP3 inflammasome activation and glomerular injury in mice on the high fat diet: role of acid sphingomyelinase gene',\n",
       "    'authors': [{'first': 'KM', 'middle': [], 'last': 'Boini', 'suffix': ''},\n",
       "     {'first': 'M', 'middle': [], 'last': 'Xia', 'suffix': ''},\n",
       "     {'first': 'S', 'middle': [], 'last': 'Koka', 'suffix': ''},\n",
       "     {'first': 'TW', 'middle': [], 'last': 'Gehr', 'suffix': ''},\n",
       "     {'first': 'PL', 'middle': [], 'last': 'Li', 'suffix': ''}],\n",
       "    'year': 2016,\n",
       "    'venue': 'Oncotarget.',\n",
       "    'volume': '7',\n",
       "    'issn': '',\n",
       "    'pages': '19031-44',\n",
       "    'other_ids': {'DOI': ['10.18632/oncotarget.8023']}},\n",
       "   'BIBREF177': {'title': 'Endothelial NLRP3 inflammasome activation and arterial neointima formation associated with acid sphingomyelinase during hypercholesterolemia',\n",
       "    'authors': [{'first': 'S', 'middle': [], 'last': 'Koka', 'suffix': ''},\n",
       "     {'first': 'M', 'middle': [], 'last': 'Xia', 'suffix': ''},\n",
       "     {'first': 'Y', 'middle': [], 'last': 'Chen', 'suffix': ''},\n",
       "     {'first': 'OM', 'middle': [], 'last': 'Bhat', 'suffix': ''},\n",
       "     {'first': 'X', 'middle': [], 'last': 'Yuan', 'suffix': ''},\n",
       "     {'first': 'KM', 'middle': [], 'last': 'Boini', 'suffix': ''}],\n",
       "    'year': 2017,\n",
       "    'venue': 'Redox Biol.',\n",
       "    'volume': '13',\n",
       "    'issn': '',\n",
       "    'pages': '336-44',\n",
       "    'other_ids': {'DOI': ['10.1016/j.redox.2017.06.004']}}}},\n",
       " {'paper_id': 'PMC8412383',\n",
       "  'metadata': {'title': 'Limit. Ein Essay zur Lage der Weltbevölkerung. Teil 2: Lösungsansätze und Schlussfolgerungen',\n",
       "   'authors': [{'first': 'Nikolaus',\n",
       "     'middle': [],\n",
       "     'last': 'Scholik',\n",
       "     'suffix': '',\n",
       "     'email': 'ncscholik@aon.at',\n",
       "     'affiliation': {}}]},\n",
       "  'body_text': [{'text': 'Der vorliegende Essay befasst sich in zwei Teilen mit der Lage der humanen Weltbevölkerung, also des Homo sapiens. Dessen dominante Rolle hat zu Entwicklungen geführt, die nicht ausschließlich positiv zu beurteilen sind und die in ihren Auswirkungen auf den Planeten bzw. die Natur ein Ausmaß erreicht haben, das diese/n in der Funktionalität gefährdet. Die Abhandlung stellt eine politikwissenschaftliche Erörterung des Ist-Zustandes dar.',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Einleitung',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Der erste Teil (Scholik 2021) diente der Vorstellung zentraler Grenzen und Herausforderungen, mit denen sich die Menschheit konfrontiert sieht. Mit den Bereichen Weltbevölkerung, Klima und Umwelt, Energie und Rohstoffe, politische Systeme sowie Wirtschaft und Finanzen wurden fünf Problemfelder identifiziert, in denen sich die heutigen Staatensysteme an der Grenze (Limit) der Belastbarkeit befinden. Darauf aufbauend stellt Teil 2 Vorschläge für Lösungen, Änderungen und Verbesserungen vor.',\n",
       "    'cite_spans': [{'start': 24,\n",
       "      'end': 28,\n",
       "      'mention': '2021',\n",
       "      'ref_id': 'BIBREF5'}],\n",
       "    'section': 'Einleitung',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Alle Überlegungen und Lehren aus Teil 1 sollen nun dazu dienen, auf dem jeweiligen Problemfeld an Verbesserungen und Änderungen zu arbeiten. Das geschieht indes schon heute. In allen Systemen bzw. Bereichen arbeiten Menschen an deren Optimierung und Verbesserung – mit mehr oder weniger Erfolg. Die Globalisierung der Wirtschaft, Kommunikation und Wissenschaft hat in den vergangenen 20–25 Jahren ungeahnte Kräfte und Möglichkeiten freigesetzt, aber auch ein gerütteltes Maß an schwierigsten Problemen offengelegt. Wie immer, wenn der Mensch bahnbrechende Entdeckungen macht oder Forschungsergebnisse erreicht, ist Dual Use1 im Spiel. Nehmen wir das Internet: Noch nie war es für die Menschen so einfach, das (fast) ganze, gemeinsame Wissen auf Fingerdruck bei „Mr. Google“ abzufragen oder global mit Wort, Text, Bild, Ton etc. jederzeit (fast) uneingeschränkt zu kommunizieren. Noch nie war es aber auch so leicht, ein Kommunikationssystem für derart viele negative Ziele einzusetzen; Desinformation, Fake News, Diebstahl, Betrug, Kommunikation für Terrorismus, organisierte Kriminalität sind nur einige von vielen Beispielen. Gen- und Nanotechnologie, Laserwaffen und medizinischer Fortschritt ständig zunehmenden Ausmaßes öffnen neue Dimensionen und erzeugen gleichzeitig große Sorgen, bedenkt man die anderen Seiten der Anwendung.',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Einleitung',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Im Folgenden geht es darum, aus dem in Teil 1 sowie in dieser Einleitung skizzierten „Puzzle“ ein praktisch anwendbares Ordnungssystem zu kreieren, Prioritäten zu reihen und Lösungsansätze zu überlegen sowie aufzuzeigen, warum dies notwendig ist.',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Einleitung',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Wie in Teil 1 des Essays erläutert, sahen und sehen die Menschen sich im beginnenden 21. Jahrhundert mit Grenzen und Herausforderungen konfrontiert, deren Dimensionen bislang unbekannt, ja undenkbar waren. Das Erkennen und Schaffen des Verständnisses für die notwendigen, vernetzten Denk- und Handlungsansätze ist deshalb unerlässlich: Wie kann das internationale, anarchische Staatensystem dazu gebracht werden zu verstehen, dass diese Probleme, die gesamte Menschheit ohne Unterschied betreffend, nur gemeinsam gelöst werden können? Welche Antworten können oder müssen Philosophie, Religion und Kunst, Wissenschaft, Wirtschaft und Politik geben? Wie kann das allgemeine Verständnis der Menschen – unabhängig der politischen, sozialen oder gar religiösen Sichtweisen – geformt werden? Und wie kann die Politik dazu gebracht werden, auf globaler Ebene gemeinsam zu handeln? In allen Bereichen des nun globalen menschlichen Zusammenlebens müssen wir diese Grenzen, Probleme und Gefahren erkennen und daraus resultierend rasch Lösungen finden sowie diese umsetzen. Der Essay befasst sich daher mit der Suche nach Mitteln, Ansätzen und Möglichkeiten bzw. mit der Fragestellung: Welche zu Antworten führenden Wege gibt es im Hinblick auf die vielen aufgeworfenen Fragen?',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Grundlagen',\n",
       "    'ref_spans': []},\n",
       "   {'text': '„Wie kann die Politik dazu gebracht werden, global gemeinsam zu handeln?“ scheint einer der Schlüsselsätze dieses Essays zu sein. Ungeachtet des politischen Systems oder der Form verfügt nur die Politik über die Führungs- und Entscheidungsinstrumente. Teil 1 hat die Bedeutung von Global Governance bereits adressiert. Diese tritt in verschiedenen Formen in Erscheinung, allerdings nicht in der eines Global Government. Gleichzeitig scheint es ohne Government bei künftig zehn Milliarden Menschen undenkbar, auf schnellem Wege eine gemeinsame Zielsetzung zu erreichen. Auch der ins Spiel gebrachte Fluchtweg in die Nationalstaatlichkeit ist angesichts der Hauptproblematik Klimaenergie völlig ungeeignet; die Natur erkennt ausschließlich den globalen Ausstoß, dieser trägt keine nationalen Identifikationen. Eine Hilfe könnte die ebenfalls in Teil 1 angeschnittene Zweck-Ziel-Mittel-Relation nach Carl von Clausewitz (2010 [1984]) sein.',\n",
       "    'cite_spans': [{'start': 918,\n",
       "      'end': 922,\n",
       "      'mention': '2010',\n",
       "      'ref_id': 'BIBREF1'}],\n",
       "    'section': 'Grundlagen',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Was muss warum und mit welchen Mitteln erreicht werden? Dies sind drei kurze, aber bedeutungsschwere Fragen, wobei die nach den Mitteln die bedeutungsvollste ist: Clausewitz’ Relation kommt aus der militärischen Welt, in der die Mittelfrage zwar nicht die alleinige, aber die mit höchster Priorität ist. Während Ziel und Zweck eher Spielraum für philosophische und andere Betrachtungsweisen geben, ist bei den Mitteln nur eine einzige Wahl gestattet: die realistische. Ohne Mittel ist nichts möglich. Diese werden in der betrachteten Problematik weder ausschließlich Hard Power noch exklusiv Soft Power sein können, sondern überwiegend eine Kombination aus beidem (Smart Power) sein müssen.2',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Grundlagen',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Es muss nun überlegt werden, wie man die aus den Analysen der fünf Bereiche abgeleiteten notwendigen Schritte bzw. Änderungen zusammenfasst und als „Überlebenspaket“ der Menschheit der Natur anbietet (Ziel). Zweck dieser Aktion ist ganz einfach der Fortbestand des Homo sapiens. Die Mittel sind den Abschnitten 4.1 bis 4.5 aus Teil 1 zu entnehmen. Das klingt sehr einfach, ist aber (fast) übermenschlich schwierig, betrachtet man die Ausgangsbasis und unser bisheriges „Krisenmanagement“, das in Wahrheit einer der ältesten und schlechtesten Managementmethoden entspricht: der Ablage (Etikett: „Später erledigen!“). Die Mittel sind als Ergebnisse der fünf Untersuchungen abzuleiten, zu gruppieren, abzustimmen, festzulegen und umzusetzen.',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Grundlagen',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Die drei horizontalen Komponenten in Abb. 1 – Ausrichtung der politischen Systeme sowie des Bereichs Wirtschaft und Finanzen und die Entwicklung der Weltbevölkerung – liegen grundsätzlich in unserer Hand und sind, in einem gewissen Ausmaß, variabel. Die vertikalen Komponenten Klima und Umwelt sowie Energie und Rohstoffe unterliegen nicht allein unserer Kontrolle bzw. Flexibilität in dem Sinn, dass sie von der Natur vorgegeben, gemessen und reaktiv überwacht, toleriert oder sanktioniert werden. Hier besteht wenig Spielraum, aber nicht kein Spielraum, wie uns manch Weltuntergangsfanatiker3 weismachen möchte – aber, zugegeben: Der Spielraum wird nicht mehr lange gegeben sein.',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Grundlagen',\n",
       "    'ref_spans': [{'start': 42, 'end': 43, 'mention': '1', 'ref_id': None}]},\n",
       "   {'text': 'Es wäre der Blick in die Glaskugel des Zauberers notwendig, um an dieser Stelle mit konkreten Maßnahmen und Urteilen aufzufahren. All das muss hart, ernsthaft und schnell erarbeitet werden. Geführt von der Politik müssen Philosophie, Wissenschaft, Forschung und Technik organisiert auf diesen zentralen Ebenen arbeiten. Dabei muss die Politik klug lenken und die Wirtschaft alle notwendigen Mittel bereitstellen.',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Grundlagen',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Die Coronakrise hat einen Vorgeschmack auf zu erwartende, mögliche Szenarien gegeben, wenngleich nicht im 1:1-Vergleich. Der läge sehr falsch. Zunächst haben wir es bei der derzeitigen Pandemie mit einer nicht ungewöhnlichen Auseinandersetzung zwischen zwei Teilen/Spezies der Natur zu tun. Diese ist gewissermaßen schwieriger als die bekannten Kriege der Menschheit untereinander, nur Homo sapiens betreffend, weil der Feind unsichtbar und mittels der bekannten militärischen Methoden nicht fassbar ist. Die Auseinandersetzung ist aber nicht neu, weil in der Geschichte der Menschheit Seuchen von jeher eine große Gefahr bedeuteten, bis es Homo sapiens dank Personen wie Robert Koch oder Louis Pasteur gelang, durch Fortschritte in Biologie und Medizin grundsätzlich seine Dominanz zu behaupten. Da ist allerdings die kleine Unannehmlichkeit, dass heute, trotz unseres Wissens und unserer Möglichkeiten auf allen Ebenen, ein Nachteil gegenüber früheren Pandemien sehr erschwerend wirkt: die physische Vernetzung der Menschheit. Diese muss nun – koste es, was es wolle; – temporär unter- bzw. gebrochen werden, bis der Gegner (SARS-CoV-2) besiegt ist. Dann werden zwar die globale Wirtschaft und die gesamten sozialen Systeme schwer beschädigt sein, aber es wird keine – wie bei unseren human-internen Auseinandersetzungen üblichen – Zerstörungen und Verwüstungen geben.',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Grundlagen',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Das, was uns aber unabhängig von der Pandemie konfrontiert, ist ungleich schwieriger zu bekämpfen. Es steht uns ein anscheinend unbesiegbares Etwas gegenüber, kein Feind, kein Gegner, sichtbar und doch nicht: unsere eigene Blindheit, ja Dummheit, da wir selbst immer stärker gegen unseren Lebensraum, gegen dessen mehr als vier Milliarden Jahre alte Regeln verstoßen. In Summe bedeutet das: Wir bräuchten ein Wunder …',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Grundlagen',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'In allen politischen Systemen war und ist nach wie vor die Führungsfrage entscheidend. In der Politik, aber auch in anderen Bereichen, könnte man vielleicht folgendermaßen definieren: Führung ist das Ausführen planender, kontrollierter Tätigkeiten durch Menschen, Gruppen oder Organisationen. Auf der militärischen Ebene, wo Führung unter anderen, strengeren Voraussetzungen und durch das Mittel des Befehls, der keiner Diskussion oder Veränderung durch den oder die Geführten unterliegt, wird folgendermaßen definiert: Führung ist dasTreffen von Entscheidungen mit gewollter Wirkung in der Zukunft,fortdauernde Auslösen und Steuern von Verhaltensweisen und Handlungen anderer Menschen zur Verwirklichung von Zielvorstellungen,Steuern von verschiedenen Einzelaktivitäten in einer Organisation im Hinblick auf das übergeordnete Ganze.',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Führung ::: Voraussetzungen',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Der Führende (Politiker/Kommandant) ist der Führungsverantwortliche. Er führt seinen Staat bzw. seine Truppe. Er trifft alleinverantwortlich (der Politiker anders als der Militär) die Entscheidungen und setzt sie durch Anordnungen/Befehle an Bevölkerung/Unterstellte in die Tat um. Führungsverantwortung erfordert: Vorausdenken, Entschlusskraft, Organisationstalent, Improvisationsvermögen, schnelle und klare Vorgaben/Befehlsgebung und Einsatz der eigenen Persönlichkeit. Letztlich lässt sich daraus das Führungssystem ableiten. Es dient der Erfüllung von Aufgaben und ist der geordnete Zusammenhalt von Organisation – Verfahren – Mitteln.',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Führung ::: Voraussetzungen',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Warum hat dieses Element eine derartige Bedeutung? Weil es in der von uns nun offengelegten Problematik ohne Führungspersönlichkeiten auf vielen entscheidenden Ebenen, später in der Durchführung von einer obersten Führung, zusammengefasst und umgesetzt werden muss. Im militärischen Bereich ergeben sich aus all dem nun die sogenannten Führungsgrundsätze (Bundesministerium für Inneres, 2007, S. 13–15): Einheit der Führung, klares Ziel, Einfachheit, Schwergewichtsbildung, Reservenbildung, Handlungsfreiheit, Beweglichkeit, Ökonomie der Kräfte, Verhältnismäßigkeit.',\n",
       "    'cite_spans': [{'start': 387,\n",
       "      'end': 391,\n",
       "      'mention': '2007',\n",
       "      'ref_id': 'BIBREF0'}],\n",
       "    'section': 'Führung ::: Voraussetzungen',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Als Paradebeispiel einer politischen Führung in extremster Krise (Fortbestand des Staates oder Untergang) darf der britische Premierminister (1940–1945) Winston Churchill genannt werden. In Krisenzeiten hängt der Fortbestand immer auch und vorrangig von der Persönlichkeit und Führungsstärke des Verantwortlichen ab.',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Führung ::: Voraussetzungen',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Die Clausewitz-Relation ist in Kap. 2 dargelegt worden. Aufgrund der Komplexität des Problems und vor allem wegen des Imperativs der globalen Lösung wird in allen Phasen und Teilkomponenten des endgültigen Ansatzes immer wieder die Ziel-Zweck-Mittel-Relation zu untersuchen, analysieren und beurteilen sowie ein planrelevantes Entwickeln von Lösungsschritten notwendig sein.',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Ziel-Zweck-Mittel ::: Voraussetzungen',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Dem Grundsatz der Einheit der Führung folgend muss eine Organisationsform oder ein Organisationsorgan bestimmt werden, respektive sich herauskristallisieren, empfehlen bzw. die Macht und Führungsrolle übernehmen: ein Staat, eine internationale Organisation, ein Global Player, Hegemon oder Imperium?',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Handelndes Organ ::: Voraussetzungen',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Bei realistischer Betrachtung der derzeitigen globale Lage, des Zeitrahmens und der voraussichtlichen Entwicklung über die nächsten ein bis zwei Dekaden kommen eigentlich nur zwei Global Player bezüglich der Führungsrolle in Frage: die Vereinigten Staaten oder China. Allerdings befinden sich beide bereits mitten in der Frage bzw. Auseinandersetzung um die globale Führung – ohne zunächst unser Thema Limits im Zentrum zu sehen. Kap. 4 stellt zwar eine Lösung als Vorschlag vor, allerdings prinzipiell eher in Richtung einer zuarbeitenden Komponente für eine oder mehrere wissenschaftliche Lösungsmöglichkeiten. Auch dort wird die entscheidende Frage sein: Wer führt politisch, wer hat die Stärke? Hier gibt es Ähnlichkeiten zum rein politischen Fall der Frage nach einem führenden Imperium, weil ja nur dieses die inneren politischen Verhältnisse anderer Staaten beeinflussen kann.',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Handelndes Organ ::: Voraussetzungen',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Als wichtigste Erkenntnis bleibt die Notwendigkeit der Einheit der Führung. Das amerikanische und das chinesische politische Modell unterscheiden sich fundamental und basieren auf zwei völlig gegensätzlichen Eckpfeilern – dem demokratisch/individuellen gegen den autoritär/gemeinschaftlichen.4 Die Frage, welches der beiden so unterschiedlichen Systeme Führungsmacht im Sinne der untersuchten Problematik übernehmen kann, will oder wird, ist derzeit nicht zu beantworten.',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Handelndes Organ ::: Voraussetzungen',\n",
       "    'ref_spans': []},\n",
       "   {'text': '\\nDie Zukunft hat viele Namen. Für Schwache ist sie das Unerreichbare, für Furchtsame das Unbekannte, für die Mutigen die Chance. (Victor Hugo)\\n',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Möglichkeiten',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Trotz der großen Schwierigkeit, im Rahmen dieses Beitrags Möglichkeiten für Ansatz und Beginn mit Gewissheit anbieten zu können, bedarf jede Analyse auch einer Beurteilung, einer Durchführungsidee. Hier ist das Eis nun besonders dünn – sind doch, wie in Kap. 4.3 (Energie und Rohstoffe) in Teil 1 schon erwähnt, alle Bemühungen seit nun fast 70 Jahren ohne wirklichen Erfolg geblieben. Es gilt nun zunächst zusammenzuführen, was an Strukturen zu einer Problemlösung vorhanden, funktionstüchtig und belastbar ist. Das ist nicht unbedingt viel versprechend, aber auch nicht ganz hoffnungslos. Da gibt es zum einen die Vereinten Nationen: völlig ineffizient, um Frieden auf dem gemeinsamen, einzigen Planeten zu sichern. Wie bei anderen internationalen Unternehmungen – nicht allen! – ist auch hier schon der Keim des Todes in die Wiege gelegt worden. Es sei nur, und das genügt, an das Vetorecht der fünf ständigen Mitglieder des UN-Sicherheitsrates erinnert. Mehr als sonst gilt hier das Morgenthau-Credo der „Interessen, als Macht definiert“. Allerdings bietet die UN eine Struktur, in der alle Staaten der Welt vertreten sind. Diese Struktur könnte sich unter Druck wandeln bzw. anpassen. Und mit dem International Thermonuclear Experimental Reactor (ITER) Projekt gibt es ein solides Beispiel (Scholik 2021), leider nur eines, für eine über viele Jahre gehende dauerhafte, wissenschaftlich-technische Kooperation, trotz Spannungen unter den Teilnehmerstaaten bis zur Kriegsgefahr (USA-UdSSR, Kuba-Krise 1962). Das Beispiel könnte ein, vielleicht der Hoffnungsschimmer sein, auf den sich aufbauen ließe. Wie könnte nun ein derartiger Anstoß organisatorisch aussehen?',\n",
       "    'cite_spans': [{'start': 1304,\n",
       "      'end': 1308,\n",
       "      'mention': '2021',\n",
       "      'ref_id': 'BIBREF5'}],\n",
       "    'section': 'Möglichkeiten',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Im Zentrum des angedachten Ansatzes steht die Weiterentwicklung einer schon älteren, in Teil 1 bereits vorgestellten Idee: eine neue Version des betagten Club of Rome. Es könnte eine Institution im Rahmen der UN sein, um die Arbeit den Nationalstaaten zu entziehen; die in ihr Tätigen wären auf die Dauer ihrer Tätigkeit „Weltbürger“, keine Bürger eines Nationalstaates. Das klingt schon (fast) unerfüllbar. Doch warum sollte es nicht funktionieren, beispielsweise mit Wissenschaftlern der verschiedensten Fachrichtungen, primär die der fünf Limit-Bereiche, ergänzt um Philosophen, Historiker und Sozialwissenschaftler. Ähnlich dem Institut de France als eine globale, elitäre Denkfabrik organisiert, von jedem Nationalstaat mit Vertretern beschickt, wäre die einzige und wichtigste Aufgabe, in Gruppen und Untersuchungsbereiche geteilt, für die „globale Politik“ jene Elemente zu erforschen, festzulegen und in Vorschläge zu kleiden, die als Mittel dem Zweck dienen. Doch im klaren Gegensatz zum Club of Rome oder anderen NGOs stünde ein solcher Globaler Wissenschaftlicher Rat (GWR) bzw. Global Scientific Council (GSC) – von einem Staatenbund der willig-entschlossenen Staaten, z. B. nach dem Muster von ITER geschaffen – auf einer völlig anderen Ebene. Der GWR wird vom Staatenbund gegründet und finanziert, beschickt und – rein wirtschaftlich, nicht sachlich/fachlich oder bezüglich der Tätigkeit, wie ITER – kontrolliert. Er könnte jederzeit weitere Wissenschaftler in dem ihm als notwendig erscheinenden Ausmaß temporär oder permanent beiziehen. Das Geld sollte, würde der Schritt getan, keine Rolle spielen.',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Möglichkeiten',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Auf Basis dieser Vorschläge fällt der Staatenbund bindende politische Entscheidungen zur Zielerreichung. Das hat mehr als nur einen Hauch von Global Governance, scheint aber angesichts der Herausforderungen alternativlos. Die Voraussetzung für einen funktionierenden GWR wäre natürlich der diesbezüglich einzugehende Staatenbund, wenn irgend möglich, zunächst aus den gleichen Staaten zusammengesetzt wie ITER. Das klingt noch utopischer als der GWR selbst. Aber auch hier besteht Hoffnung. So wie für die Verschleierungspolitik Chinas zu Beginn der Coronakrise in Wuhan rasch Game Over gekommen ist und danach offen und energisch gegen diese Bedrohung vorgegangen wurde – viele europäische Staaten haben das Virus zunächst, so wie die Vereinigten Staaten und das Vereinigte Königreich, nicht ernst genommen. So müssen die ungleich größeren Probleme, von denen wir hier sprechen, angegangen werden.',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Möglichkeiten',\n",
       "    'ref_spans': []},\n",
       "   {'text': '\\nDie Hoffnungslosigkeit ist schon vorweggenommene Niederlage. (Karl Jaspers)\\n',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Zusammenfassung',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Dieses Kapitel zieht mit Unterstützung einer grafischen Darstellung ein Resümee. Einer der wichtigsten Grundsätze im militärischen Führungsverfahren lautet: Einfachheit (s. Kap. 3) – je komplexer das Problem, umso notwendiger! Wenngleich manches nicht so klar oder eindeutig behandelt werden konnte, so ist zumindest die indirekte Darstellung der Komplexität (hoffentlich) gelungen. Die Verzahnungen der Probleme, ihre Ausstrahlung auf einfach alle Bereiche des menschlich-staatlichen Lebens sind die komplexeste Situation, der sich Homo sapiens seit dem „sapiens“ im Namen gegenübersieht. Es geht deshalb vorrangig und primär um das Erkennen des vernetzten Ansatzes. Die erste Schlussfolgerung lautet folglich: Keine singulär auch noch so gut angedachte oder konzipierte Maßnahme kann das wahre Problem lösen. Es bietet sich an, diese Schlussfolgerung in Form von vier Hauptfakten und vier daraus abgeleiteten Thesen darzustellen (Tab. 1).',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Zusammenfassung',\n",
       "    'ref_spans': [{'start': 937, 'end': 938, 'mention': '1', 'ref_id': None}]},\n",
       "   {'text': 'Das Akzeptieren der Thesen aus Tab. 1 führt wiederum zu den in Abb. 2 zusammengefassten Schlussfolgerungen.',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Zusammenfassung',\n",
       "    'ref_spans': [{'start': 68, 'end': 69, 'mention': '2', 'ref_id': None},\n",
       "     {'start': 36, 'end': 37, 'mention': '1', 'ref_id': None}]},\n",
       "   {'text': 'Die vier Grundfelder der Abb. 2 können so interpretiert werden, dass die Menschheit:nicht einem Gegner „Natur“ gegenübersteht,derzeit und auch noch mehrere Generationen in der Zukunft keine Möglichkeit des „Ortswechsels“ in Betracht ziehen kann,das Spielen „auf Zeit“ ebenfalls unmöglich istund eben das globale Handeln in Anbetracht der dargestellten Faktenlage in Summe betrachtet werden muss. In allen Fällern führt aber Nichtbeachtung und Haltungsänderungsverweigerung eben zur Selbstauslöschung.',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Zusammenfassung',\n",
       "    'ref_spans': [{'start': 30, 'end': 31, 'mention': '2', 'ref_id': None}]},\n",
       "   {'text': 'Es mag sich nun der Gedanke aufdrängen, dass das alles Utopie sei, undurchführbar, nicht oder gar in diesem Ausmaß eintreffend, noch genug Zeit da wäre und überhaupt… – wahrscheinlich denken wir alle instinktiv so. Oder?',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Zusammenfassung',\n",
       "    'ref_spans': []},\n",
       "   {'text': '\\nWer in der Zukunft lesen will muss in der Vergangenheit blättern. (André Malraux)\\n',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Epilog',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Der Essay wurde inmitten der Coronakrise beendet, mit ihren für uns so eindrücklichen Folgen, die thematisch so gut zum Titel und Plan des Schreibens beigetragen haben. Die aufgezwungene Wegsperrung von uns allen vor uns allen hat uns rasch und effizient vor Augen geführt, dass der Homo sapiens seine Grenzen hat. Dabei waren wir uns unserer Sache doch schon so sicher – ungeahnte Möglichkeiten wurden für die Zukunft diskutiert, angedeutet, mit Milliardenbeträgen werden Forschung und Entwicklung gefördert und „zum Wohle der Menschheit“ Grenzen überschritten, die dafür nicht freigegeben waren.',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Epilog',\n",
       "    'ref_spans': []},\n",
       "   {'text': 'Aufgrund all der Euphorie haben wir vergessen, dass unsere Anzahl nicht nur unserem Wirt, sondern immer rascher uns selbst zu schaffen macht – noch nicht äußerst bedrohlich, aber immerhin. Das Überschreiten von Grenzen – doppelsinnig wie Vieles, was Menschen tun – war der Gegenstand dieser Betrachtungen. Die Sicht war dabei primär politikwissenschaftlich – für die anderen betroffenen Ebenen fehlt einfach die gesicherte Basis –, aber doch zielorientiert im Hinblick auf das Problem und eine eventuelle Möglichkeit eines Lösungsansatzes, nicht mehr, aber auch nicht weniger.',\n",
       "    'cite_spans': [],\n",
       "    'section': 'Epilog',\n",
       "    'ref_spans': []}],\n",
       "  'ref_entries': {},\n",
       "  'back_matter': [],\n",
       "  'bib_entries': {'BIBREF0': {'title': '',\n",
       "    'authors': [],\n",
       "    'year': 2007,\n",
       "    'venue': 'Richtlinie für das Führen im Katastropheneinsatz',\n",
       "    'volume': '',\n",
       "    'issn': '',\n",
       "    'pages': None,\n",
       "    'other_ids': {'DOI': []}},\n",
       "   'BIBREF1': {'title': '',\n",
       "    'authors': [],\n",
       "    'year': None,\n",
       "    'venue': '',\n",
       "    'volume': '',\n",
       "    'issn': '',\n",
       "    'pages': None,\n",
       "    'other_ids': {'DOI': []}},\n",
       "   'BIBREF2': {'title': '',\n",
       "    'authors': [],\n",
       "    'year': None,\n",
       "    'venue': '',\n",
       "    'volume': '',\n",
       "    'issn': '',\n",
       "    'pages': None,\n",
       "    'other_ids': {'DOI': []}},\n",
       "   'BIBREF3': {'title': '',\n",
       "    'authors': [],\n",
       "    'year': None,\n",
       "    'venue': '',\n",
       "    'volume': '',\n",
       "    'issn': '',\n",
       "    'pages': None,\n",
       "    'other_ids': {'DOI': []}},\n",
       "   'BIBREF4': {'title': 'Partei und Staat',\n",
       "    'authors': [{'first': 'S', 'middle': [], 'last': 'Heilmann', 'suffix': ''},\n",
       "     {'first': 'L', 'middle': [], 'last': 'Shih', 'suffix': ''},\n",
       "     {'first': 'S', 'middle': [], 'last': 'Heep', 'suffix': ''}],\n",
       "    'year': 2016,\n",
       "    'venue': 'Das politische System der Volksrepublik China',\n",
       "    'volume': '',\n",
       "    'issn': '',\n",
       "    'pages': '27-139',\n",
       "    'other_ids': {'DOI': []}},\n",
       "   'BIBREF5': {'title': 'Limit. Ein Essay zur Lage der Weltbevölkerung. Teil 1: Grenzen und Herausforderungen',\n",
       "    'authors': [{'first': 'N', 'middle': [], 'last': 'Scholik', 'suffix': ''}],\n",
       "    'year': 2021,\n",
       "    'venue': 'Zeitschrift für Außen- und Sicherheitspolitik',\n",
       "    'volume': '14',\n",
       "    'issn': '2',\n",
       "    'pages': '189-212',\n",
       "    'other_ids': {'DOI': ['10.1007/s12399-021-00862-9']}},\n",
       "   'BIBREF6': {'title': '',\n",
       "    'authors': [{'first': 'B', 'middle': [], 'last': 'Oldopp', 'suffix': ''}],\n",
       "    'year': 2005,\n",
       "    'venue': 'Das politische System der USA. Eine Einführung',\n",
       "    'volume': '',\n",
       "    'issn': '',\n",
       "    'pages': None,\n",
       "    'other_ids': {'DOI': []}}}})"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "b.take(4)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "id": "c6d2052a",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>0</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>paper_id</th>\n",
       "      <td>PMC8283625</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>metadata</th>\n",
       "      <td>{'title': 'COVID-19 emergency in Sicily and in...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                          0\n",
       "paper_id                                         PMC8283625\n",
       "metadata  {'title': 'COVID-19 emergency in Sicily and in..."
      ]
     },
     "execution_count": 29,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "bag = dd.read_json(common_path + 'pmc_json/PMC8283625.xml.json', orient='index')\n",
    "bag.head(2)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "a46774ef",
   "metadata": {},
   "outputs": [],
   "source": [
    "def read__json(path):\n",
    "    with os.scandir(path) as fil:\n",
    "        if fil.endswith('.json'):"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "b717a2d6",
   "metadata": {},
   "source": [
    "# CLOSE CLUSTER AND CLIENT WHEN DONE\n",
    "I've found the shutdown thing, I don't know if it's the holy way"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "927eacd6",
   "metadata": {},
   "outputs": [],
   "source": [
    "client.close()  # closes the client (cluster is still up)\n",
    "cluster.close()\n",
    "# client.shutdown()  # shutdowns cluster and client\n",
    "# client.restart()  # restarts everything"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "ffde5bd5",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "mapd",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.13.5"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
